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Quorum Sensing – Social Interaction in Bacteria
The moment of revelation 
The discovery of microorganisms in the late 18th century uncovered the formerly 
concealed realm of microscopic creatures. Multiple branches of microbiology 
flourished, but no attention to the social life of bacteria was given, until 1970s. 
Through meticulous observations, J. W. Hastings and colleagues revealed that the 
bioluminescence production in the marine bacterium Vibrio fischeri is not a consecutive 
event, but a self-inducible phenomenon that they dubbed as “autoinduction” [1,2]. The 
bacterial cells secrete a small diffusible compound called autoinducer that accumulates 
in the environment as the population density increases. Once the bacteria sense that the 
autoinducer reaches a critical level, the expression of luciferase (lux) genes is activated. 
Thus, when V. fischeri is cultured in broth, the luminescence production was observed 
only at the late exponential and the early stationary growth phase. Luminescence 
production in the early log-phase culture can be induced by the supplementation of 
cell-free extract from the stationary-phase culture [1]. 
The autoinducer of V. fischeri was elucidated soon after, revealed to be N-(3-oxo-
hexanoyl)-3-aminodihydro-2(3H)-furanone [3], that is commonly known as N-(3-
oxo-hexanoyl)-homoserine lactone (simplified into 3-oxo-C6-HSL in this thesis). The 
molecular mechanism of autoinduction came to light when the lux operon from V. 
fischeri was isolated and characterized [4,5]. The lux operon consists of 5 lux genes 
(lux CDABE) that are responsible for the expression of the luciferase enzyme as well 
as synthesis or recycling of the aldehyde substrate. Upstream of these genes lies the 
luxI gene for the synthesis of autoinducer, and the luxR gene which is transcribed in 
the opposite direction, for the transcription activator that responds to the autoinducer. 
When a critical intracellular level of autoinducer is reached, the autoinducer binds 
to the LuxR protein, forming a functional transcription activator. The LuxR/3-oxo-
C6-HSL complex then binds to the specific site within the lux operon and induces 
transcription. Initially thought to be exclusive for marine bacteria, the homolog of 
LuxR-LuxI system apparently exists in terrestrial microbes, such as plant pathogen 
Erwinia carotovora [6]. Interestingly, despite of the distinct habitat, E. carotovora 
also uses 3-oxo-C6-HSL as its signaling molecule. In this bacterium, the autoinducer 
is involved in the regulation of carbapenem antibiotic biosynthesis. These acylated 
homoserine lactone (AHL) signaling molecules were later found to be produced in 
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many other bacteria and being the best-studied autoinducer in Gram-negative bacteria 
so far. 
These findings suggest that bacteria do not live a mere reclusive life, but they are 
capable of engaging social behavior by talking to each other. This communication 
appears to be their strategy to take a census of the population, and consecutively 
conduct a synchronized population behavior. Remarkable as it may sound, the idea 
of social interactions within a bacterial population was difficult to comprehend at 
that time. In fact, it took nearly 30 years after the earliest finding for the concept 
to be fully acknowledged. This bacterial communication is later generically termed 
as “quorum sensing” (QS) [7], in which a quorum of bacteria refers to a minimum 
behavioral unit that allows activation of the signaling system. Nowadays, QS in myriad 
bacterial species from various sources has been characterized, and this system is now 
acknowledged as a part of bacterial way of life.
Quorum sensing in pathogenic bacteria: the study of  
Pseudomonas aeruginosa
Pseudomonas aeruginosa is a rod-shaped, Gram-negative bacterium that inhabits both 
terrestrial and aquatic environments. This bacterium had been referred to with different 
names throughout history, such as Bacillus pyocyaneus, Pseudomonas polycolor, 
Bacteria aeruginosa, and Pseudomonas pyocyanea, before it was standardized into 
Pseudomonas aeruginosa in 1951 [8]. The first documentation of this bacterium dates 
back to the 1850s when a French surgeon named C.E. Sédillot observed a frequent 
green-blue discharge on surgical wound dressings [9]. The pigment that is responsible 
for the green-blue coloration was characterized as pyocyanin by J. Fordos in 1860. 
Later in 1882, the pyocyanin-producing bacterium was successfully isolated from 
patients for the first time by C. Gessard. This discovery was documented in his doctoral 
thesis and a publication entitled “On the Blue and Green Coloration that Appears on 
Bandages” [10]. In the following decades after Gessard’s work, the infection of P. 
aeruginosa was recurrently witnessed in hospital settings, and its pathogenicity is 
gradually being understood. 
P. aeruginosa is an opportunistic pathogen that only causes infections in patients with 
compromised immunity. Hospitalized patients with ruptures in their skin or mucosal 
barrier caused by surgery, catheters, ventilators, implants or severe thermal injury 
are particularly vulnerable to P. aeruginosa infections. In addition, P. aeruginosa is 
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notorious as the predominant pathogen in the oftentimes fatal pulmonary infections 
in cystic fibrosis patients. Cystic fibrosis is a congenital disorder caused by mutations 
in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that encodes 
a membrane transport protein for chloride ions. The defective CFTR gene causes 
dysregulation in fluid transport in epithelial cells, that in turn interferes with the 
functionality of multiple systems, such as respiratory, digestive, reproduction and 
integumentary [11]. Despite of the wide-range clinical manifestations, the main cause 
of mortality in cystic fibrosis patients is the chronic P. aeruginosa pulmonary infection. 
Over the past years, advances in the prognosis and implementation of a more effective 
treatment lead to a better control of bacterial infections, and dramatically improved 
overall life quality of the patients [12]. Unfortunately, the disease complexity is still 
increasing due to the emergence of antibiotic-resistance bacteria.
P. aeruginosa equips itself with a sophisticated weaponry and protection to ensure the 
highest chance to successfully invade the hosts. These include cell-associated virulence 
factors (flagellum, pilus, adhesin, alginate) and extracellular virulence factors (toxins, 
protease, hemolysins, siderophore) that are important in the colonization and infection 
establishment [13]. In chronic infections, P. aeruginosa often resides as microcolonies 
surrounded by polymer-rich matrix, the structure known as biofilm. The biofilm mode 
of growth shields the bacteria from antibiotics and host’s defense mechanisms, thus 
gives support for the infection to persist. Interestingly, production of many virulence 
factors and formation of biofilm in P. aeruginosa are regulated by QS systems. 
QS in P. aeruginosa is one of the most studied among Gram-negative bacteria. It is a 
complex molecular machinery with two sets LuxR-LuxI homologs as the core system, 
called the Las and the Rhl system. These systems are organized hierarchically in a way 
that the Las system has a transcriptional control over the activation of the Rhl system. 
Both systems consist of an autoinducer synthase (LasI and RhlI), an autoinducer 
(3-oxo-C12-HSL and C4-HSL) and a highly specific transcriptional activator (LasR 
and RhlR). More than 100 genes in P. aeruginosa are regulated by QS, including those 
which are responsible for the production of extracellular virulence determinants such 
as LasA elastase, LasB elastase, alkaline protease, exotoxin A, pyocyanin siderophore, 
rhamnolipid and phospholipase C [13,14]. These virulence factors are heavily involved 
in acute infections, by causing tissue disruption that may lead to blood invasion and 
dissemination. For example, rhamnolipid, a glycolipid biosurfactant, alters respiratory 
epithelial ion transport resulting in an interference of normal tracheal ciliary functions 
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[15], and causing an impaired mucocilliary clearance. The protease LasA and LasB 
elastase work synergistically in degrading protein elastin, a major component in human 
lung tissue and blood vessels [16], causing tissue destruction and opening the way for 
dissemination. Exotoxin A induces ADP-ribosylation of Translation Elongation Factor 
2, resulted in the inhibition of protein synthesis and cell death [17].  
Quorum Quenching – Communication Breakdown
Inhibition of quorum sensing as an antibacterial strategy 
QS is a vital regulatory system for virulence factors production not only in P. 
aeruginosa, but also in many pathogens. This system is essential in the establishment 
of a successful infection both in vitro and in vivo. Inhibition of QS (termed as quorum 
quenching, QQ) renders the bacteria avirulent, unable to produce the arsenal of 
virulence determinants to attack the host. Mutants with defect QS systems are less 
infectious compared to their wild-type counterparts. Similar attenuation outcomes 
are also achieved by supplementing the bacteria with compounds that can block QS. 
In the midst of race to find novel antibacterial targets/compounds, QQ is perceived 
as a promising strategy to combat bacterial infections. Conventional antibiotics give 
a strong selective pressure to pathogens by targeting their essential systems, such 
as DNA replication, protein synthesis and cell wall synthesis. Hence, by disarming 
the pathogens rather than killing them, the QQ approach provokes weaker selection 
pressure for resistance. Several QQ possibilities can be deducted by observing the 
QS system scheme. QQ can be achieved by employing small molecule inhibitors to 
block the signaling molecule synthesis, or to inhibit interaction between transcriptional 
activator protein and the signaling molecule [18]. Another obvious method is by 
preventing the accumulation of signaling molecules by enzymatic inactivation of the 
signaling molecules themselves.
To date, three classes of AHL-inactivating enzymes are known, they are: AHL-
lactonase, AHL-acylase and AHL-oxidoreductase [19]. AHL-lactonase targets ester 
bond of the homoserine lactone (HSL) ring, resulting in an acyl homoserine product 
that is not recognized as a signaling molecule. This class of enzyme has a broad AHLs 
substrate specificity, due to the conserved HSL ring and only nonspecific interactions 
occur between acyl chains and active site residues of the enzyme [20]. The second 
class of enzyme, AHL-acylase, catalyzes irreversible hydrolysis of the amide bond, 
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releasing HSL ring from the acyl chain moiety. In contrast to the AHL-lactonase, the 
majority of known AHL-acylases exhibit substrate specificity based on the variety of 
acyl chain length and modification. In AHL-acylase, interaction between acyl chain 
and the binding pocket residues is necessary to direct the correct substrate orientation 
[21]. The third class of enzyme, oxidoreductase, modifies the AHL by oxidizing or 
reducing the acyl side chain into an inactive form, rather than degrading it [22].  
AHL quorum quenching acylases
Within two decades following the first discovery of AHL-acylase activity from a 
soil microorganism [23], numerous other enzymes were identified. The majority 
of the characterized bacterial AHL-acylases belong to the N-terminal nucleophile 
(Ntn) hydrolase group. It is a structural superfamily of enzymes that shares a 
common αββα fold, and uses the side chain of the N-terminal residue as a catalytic 
nucleophile (cysteine, serine or threonine) [24]. Members of this superfamily include 
20S proteasome, glutamine amidotransferase and the enzyme widely used in the 
production of synthetic β-lactam antibiotics, penicillin acylase. Penicillin acylase can 
be classified based on its substrate preference for either benzyl penicillin (Penicillin 
G, PGAs) or phenoxymethyl penicillin (Penicillin V, PVAs) [25]. They share strikingly 
similar catalytic arrangements, but differ in nucleophilic residues (serine for PGAs, and 
cysteine for PVAs) and in their subunit composition (PGAS are heterodimeric, while 
PVAs are homotetramers) [26]. In some cases, substrate cross-reactivity between AHL-
acylase and penicillin acylases are evident. AhlM AHL-acylase from Streptomyces 
sp. and HacB (PA0305) from P. aeruginosa PAO1 deacylate Penicillin G to some 
extent [27,28]. Whereas KcPGA from Kluyvera citrophila, AtPVA from Agrobacterium 
tumefasciens and PaPVA from Pectobacterium atrosepticum are reported to hydrolyze 
AHLs [29,30].
Among known AHL-acylases, one of the most studied to date is PvdQ, a periplasmic 
enzyme produced by P. aeruginosa. PvdQ shared a high homology with glutaryl acylase 
from Pseudomonas SY-77 and was initially considered to be a putative β-lactamase. 
Despite the similarity, no activity towards β-lactam compounds are detected. Instead, 
PvdQ deacylates long chain AHLs including 3-oxo-C12-HSL that is produced by P. 
aeruginosa [31]. Further studies indicate that this AHL-hydrolyzing activity is indeed 
a role of PvdQ in P. aeruginosa, next to its function in the maturation of siderophore 
pyoverdine [32]. Overexpression of PvdQ in P. aeruginosa leads to a reduction of 
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QS-regulated virulence factors and in a weaker infection in Caenorhabditis elegans 
infection model [31,33], revealing its potential to be a therapeutic agent. 
Animal Models in Drug Development Pipeline
Animal model is an integral part of modern medicine progression. Not only that they 
are employed for understanding disease pathogenesis, but also for proving biological 
significance or safety of certain compounds. Pre-clinical studies of medicinal 
drugs in relevant animal model(s) is strictly mandatory prior to the clinical trials in 
human. Regardless of the heated public discussion of the ethics, animal testing is 
indispensable for the translation of drugs research from bench to bedside. Rodents 
have been preferred as animal models compared to other non-human mammals, due 
to their small size, ease of handling, cheap housing and wide-range possibilities for 
genetic modifications. For ethical considerations however, preliminary experiments 
with simpler models such as invertebrates or cell lines must be performed in advance. 
Despite of their simple nature, these models can bridge the gap in the extrapolation 
from in vitro experiments to complex animal models. The well-known invertebrate 
models among others are the nematode C. elegans, larvae of wax moth Galleria 
mellonella and larvae of fruit fly Drosophila melanogaster. High-throughput screening 
of compound libraries is thus possible to be performed in these animal models, without 
worrying about ethical considerations. Preliminary screenings in simple animal models 
help ensuring only the best drug candidates will be assessed in higher animal models. 
Scope of the Thesis
The research presented in this thesis focuses on the utilization of AHL-acylases to 
attenuate P. aeruginosa virulence. The studies simulate two early stages of drug 
development process: compound discovery and preliminary in vivo testing. Chapter 2 
features an overview of quorum sensing system in P. aeruginosa and an exhaustive list 
of infection models for studying P. aeruginosa infection. Further, different approaches 
to inhibit quorum sensing and the example of compounds to perform the task are 
discussed. A more thorough overview of C. elegans as a P. aeruginosa infection 
model is presented in Chapter 3. Characterization of two novel Penicillin V acylase 
enzymes in hydrolyzing AHLs signaling molecules is presented Chapter 4. These 
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enzymes are found in two Gram-negative plant pathogens, namely Agrobacterium 
tumefasciens (AtPVA) and Pectobacterium atrosepticum (PaPVA). These PVAs 
showed not only excellent Penicillin V deacylation activities, but also QQ activities 
for P. aeruginosa PAO1 in vitro and in G. mellonella infection model. Chapter 5 
focuses in the development of a mouse model of P. aeruginosa PAO1 lung infection and 
the efficacy study of PvdQ. The deposition of intranasally administered PvdQ in the 
airways of the mice at different stage of infection was detected using in vivo imaging. 
PvdQ is proven to be effective in attenuating quorum sensing of P. aeruginosa in a 
lethal and sublethal mouse infection models. 
As illustrated in the previous two studies, AHL-acylase holds a great potential as a 
novel bacterial infection treatment. Hence, it is not surprising that majority of the 
published studies emphasized in their clinical applications. Given the abundance of 
AHL-acylases in nature, one might ask what physiological functions of AHL-acylases 
are. We revisit this question in Chapter 6 by recapitulating reports from AHL-acylase 
studies. A list of characterized AHL-acylases is presented, along with their known 
functions in different level of interactions (interspecies, intraspecies and interkingdom), 
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Abstract
Bacteria, although considered for decades to be antisocial organisms whose sole 
purpose is to find nutrients and multiply are, in fact, highly communicative organisms. 
Referred to as quorum sensing, cell-to-cell communication mechanisms have been 
adopted by bacteria in order to co-ordinate their gene expression. By behaving as 
a community rather than as individuals, bacteria can simultaneously switch on 
their virulence factor production and establish successful infections in eukaryotes. 
Understanding pathogen-host interactions requires the use of infection models. As the 
use of rodents is limited, for ethical considerations and the high costs associated with 
their use, alternative models based on invertebrates have been developed. Invertebrate 
models have the benefits of low handling costs, limited space requirements and 
rapid generation of results. This review presents examples of such models available 
for studying the pathogenicity of the Gram-negative bacterium Pseudomonas 
aeruginosa. Quorum sensing interference, known as quorum quenching, suggests a 
promising disease-control strategy since quorum-quenching mechanisms appear to 
play important roles in microbe-microbe and host-pathogen interactions. Examples 
of natural and synthetic quorum sensing inhibitors and their potential as antimicrobials 
in Pseudomonas-related infections are discussed in the second part of this review.
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1. Introduction
For many years, scientists considered bacteria as autonomous unicellular organisms 
designed to proliferate under various conditions but with little capacity for interaction 
with each other and for collective response to environmental stimuli [34]. However, 
this view began to change around four decades ago, when emerging data provided 
evidence that cell-to-cell communication referred to as quorum sensing (QS) is a 
generic regulatory mechanism. QS enables bacteria to behave as a community and, 
via a density-dependent manner, launch a collective response to accomplish tasks 
which would be difficult, if not impossible, to achieve by an individual cell [35–37]. 
QS systems are widespread among many human opportunistic pathogens and are 
highly advantageous in situations where niche adaptation and symbiosis are important. 
Adaptation to morphological forms with better resistance to environmental threats is 
also aided by bacterial communication. Where establishment of successful infections 
is required, communication between bacteria enables them to coordinate the expression 
of virulence factors and overcome the defence systems of higher organisms including 
humans. This review discusses: (a) the QS-regulated virulence of the Gram-negative 
bacterium P. aeruginosa; (b) a number of infection models available for pathogen-host 
interaction studies; and (c) certain natural, and synthetic compounds, tested for their 
potential to rescue the infection models from P. aeruginosa toxicity.
2. Quorum Sensing in Pseudomonas aeruginosa
One of the most extensively studied QS systems is that of the Gram-negative 
opportunistic pathogen P. aeruginosa [38,39]. In this organism, the cell-to-cell 
communication is highly complex and consists of two hierarchically ordered, acyl 
homoserine lactone (AHL)-dependent QS systems referred to as the Las and the 
Rhl systems [40]. The Las system consists of the LasR transcriptional activator and 
of the AHL synthase LasI, which directs the synthesis of the N-3-oxo-dodecanoyl-
homoserine lactone (3-oxo-C12-HSL) signal molecule [41]. Expression of a number 
of virulence factors including elastase, LasA protease, alkaline protease, and exotoxin 
A, is under the control of the Las system. Apart from its involvement in the regulation 
of various virulence factors, the Las system also regulates the expression of lasI itself, 
thereby creating a positive feedback loop [42] (Figure 1). By acting as an antagonist 
to the 3-oxo-C12-HSL-LasR complex, RsaL binds to lasI promoter, thus repressing the 
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expression of LasI [43]. Additionally, RsaL represses production of AHL-dependent 
virulence factors, such as pyocyanin and cyanide [43]. LasR expression is also tightly 
regulated via multiple factors involving Vfr and GacA (positive feedback) or QteE 
(negative feedback) [44–46].
Next to its function as a signal molecule, 3-oxo-C12-HSL also acts as a virulence 
determinant in its own right by modulating the responses of the host’s defence [40]. 
3-oxo-C12-HSL down-regulates the host defence by inhibiting activation of dendritic- 
and T-cells [47], promotes apoptosis of neutrophils and macrophages [48], and provokes 
production of inflammatory cytokines in a calcium-dependent manner [49][50].
The Rhl system consists of the transcriptional activator RhlR and the RhlI synthase 
which directs the synthesis of the N-butanoyl-homoserine lactone (C4-HSL) signal 
molecule (Figure 1). Production of rhamnolipids, including elastase, LasA protease, 
hydrogen cyanide, pyocyanin, the stationary-phase sigma factor RpoS, siderophores 
and the LecA and LecB lectins are all under the control of the Rhl system [42,51,52]. 
The R proteins of both systems show high fidelity for their cognate AHL and are not 
significantly responding to their noncognate AHL. In fact, 3-oxo-C12-HSL exerts 
only minimal RhlR activation whereas C4-HSL has no obvious effect on LasR. 
However, the Las and the Rhl systems are organized hierarchically in such a way that 
the Las system exerts transcriptional control over both rhlR and rhlI [40]. Despite this 
hierarchy, expression of rhlI and rhlR is not exclusively dependent on a functional Las 
system and the expression of genes such as lecA [53], pyocyanin, rhamnolipids and 
C4-HSL in a lasR mutant is delayed rather than abolished [54]. Transcriptome studies 
by Schuster [55] and by Wagner [56] brought to light the existence of Las- and Rhl-
regulated genes and operons throughout the chromosome supporting the idea that the 
P. aeruginosa QS circuitry constitutes a global regulatory system. 
The Las and the Rhl systems are further modulated by the P. aeruginosa quinolone 
signal 2-heptyl-3-hydroxy-4-quinolone (PQS) which increases the level of complexity to 
the QS network. PQS synthesis is controlled by both the Las and Rhl systems, whereas 
PQS itself controls the expression of RhlR and RhlI [57]. The PQS biosynthesis is 
aided by pqsABCD operon and regulated by the PqsR regulator, also referred to as 
MvfR. PqsR is a membrane-associated transcriptional activator that also regulates the 
production of elastase, 3-oxo-C12-HSL, phospholipase and pyocyanin [58]. Exogenous 
PQS was shown to induce expression of elastase B and of rhlI [39]. Aendekerk and 
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co-workers [59] added to the understanding of PQS’s function by demonstrating that 
P. aeruginosa strains carrying mutations in the QS-regulated multi-drug efflux pump 
MexGHI-OpmD, that they were unable to produce wild type levels of either PQS or 
AHL and that these mutant strains were also unable to establish successful infections 
in mice and plant models. In addition, growth defects as well as altered antibiotic 
susceptibility profiles were observed for these strains. However, the phenotypes 
of these mutants could be restored to wild-type by the addition of exogenous PQS 
suggesting that the AHL/PQS-dependent QS-regulatory network plays a central role 
in coordinating virulence, antibiotic resistance and fitness in P. aeruginosa [59].
Since QS hierarchical order is observed in P. aeruginosa grown in rich medium, 
interesting behaviours can be seen under different growing conditions [60]. For 
instance, under phosphate-depletion conditions, the Las system seems to be dispensable 
for rhl and pqs activation. A recently published paper [61] suggested that amb genes 
in ambBCDE operon are responsible for the biosynthesis of 2-(2-hydroxyphenyl)-
thiazole-4-carbaldehyde (IQS), a molecule important in integrating quorum sensing 
and stress response. This system was further modulated by phosphate signalling, 
particularly PhoB. Production of IQS circumvents the las null mutation and activates 
QS- and virulence-associated genes in a las-independent manner [61]. This finding 
might explain the enigmatic phenomena where the las-defective clinical isolate 
maintains persistent infection, as for example in the pulmonary infection observed in 
cystic fibrosis (CF) patients. 
3. P. aeruginosa-Related Human Infections 
P. aeruginosa is a ubiquitous Gram-negative pathogen adapted to a variety of niches 
and has been described as one of the most common causes of nosocomial infections. 
This pathogen is capable of infecting virtually all tissues and nearly all clinical cases 
of P. aeruginosa infections can be associated with the compromise of host defence [62]. 
The high-risk groups for acquiring P. aeruginosa infections include severely-burned, 
HIV- and neutropenic-patients. CF patients also suffer from chronic P. aeruginosa 
infections, and this pathogen has been described as the major cause of mortality 
among this group [63,64]. Despite the aggressive antibiotic intervention, currently 
used in an attempt to clear the P. aeruginosa infection from CF patients, clearance is 
almost impossible to achieve. As a result, the majority of patients become persistently 
colonized by P. aeruginosa that leads to eventual death. Recent studies have also 
2
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Figure 1. Quorum sensing (QS) in Pseudomonas aeruginosa. The hierarchical organisation of the 
two AHL-dependent QS systems in P. aeruginosa and its correlation with the P. aeruginosa 
quinolone signal (PQS) system is presented in the scheme below. (Skull represents virulence 
factor expression).
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demonstrated P. aeruginosa to be the principal etiological agent of microbial keratitis 
(MK) associated with contact lens wear. Around 140 million people worldwide are 
contact-lens users and therefore at risk of developing a Pseudomonas-related MK 
infection which in extreme cases can result in complete sight loss [9,65]. In addition, 
colonization by P. aeruginosa has been described in cases of otitis, endocarditis, as 
well as in cases of acute and chronic non CF-associated pulmonary infections [9]. 
A large variety of QS-regulated virulence factors including lipopolysaccharide, pili, 
proteases, exoenzymes, hydrogen cyanide, exotoxin A, and rhamnolipids are crucial for 
the establishment of a successful P. aeruginosa infection in the eukaryotic host [66].
4. Models Available for Studying the Pathogenicity of P. 
aeruginosa 
Understanding the pathogen-host relationship at both the cellular and molecular level 
is essential for identification of new targets and for development of new strategies to 
fight infection. Hence, molecular analysis of host-pathogen interactions would benefit 
from the use of model systems that allow a systematic study of the factors involved. 
A number of evolutionary divergent hosts such as mammalian cell lines [67], amoeba 
[68], nematodes [69], insects [70], and rodents [71] have been chosen for studying 
the pathogenesis of P. aeruginosa. Important experimental data that contributed to 
the understanding of P. aeruginosa pathogenesis have been derived, but none of the 
available models resemble the pathology of the disease as experienced by humans. 
Bigger and more complex animals, such as the CF pig model and the rodents, may 
not be feasible to use in studies due to the cost, space requirements and ethical 
considerations (Table 1). On the other hand, invertebrate model hosts, for example 
nematodes, have major drawbacks such as the lack of an adaptive immunity, a true 
complement system and an immune cell multilineage complexity, all of which are 
characteristics of humans. Hereby, we described animal models utilized for studying 
P. aeruginosa pathogenesis, followed by the feasibility of studying alternative drugs, 
such as quorum sensing inhibitors in these models.
4.1. Plants 
Plants, due to their Toll-like receptors, are considered excellent alternative models 
for studying the pathogenesis of several microbes. The plant Arabidopsis thaliana 
was used as a model to study the virulence of a P. aeruginosa clinical isolate and the 
results indicated that the pathogen employs a similar subset of virulence factors to elicit 
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disease in plants as it does in animals [72]. Lemna minor (duckweed) is widely used 
as a plant model for studies in plant physiology, genetics, ecology and environmental 
monitoring [73]. The reasons that make duckweeds a preferred model for such 
studies are their small size, their ability to rapidly undergo vegetative reproduction 
thus forming genetically uniform clones, and their high sensitivity to organic and 
inorganic substances. In 2010, Zhang and colleagues [73] developed an experimental 
model system using the duckweed as a simple and convenient host allowing for 
large scale studies on bacterial infections [73]. The authors also demonstrated the 
potential of using this model system to screen antibacterial compounds by co-
cultivation of duckweeds with pathogenic bacteria. A small amount of P. aeruginosa 
PAO1 suspension was enough to elicit disease symptoms to the duckweed. These 
symptoms included collapsing of the fronds and inhibition of both reproduction and 
growth at day 1 after inoculation, followed by chlorosis and complete maceration at 
day 2–3 post-inoculation. Bacterial biofilm formation on the roots was detectable on 
day 5 post-inoculation. PAO1 recombinant strains overexpressing quorum quenching 
enzymes (hPONs and Bacillus AiiA) had less profound effects on duckweed growth 
and displayed a reduced virulence at day 5 post-inoculation compared to the wild-type 
[73]. Attenuated virulence could be also observed for PAO1 QS mutant strains of ∆rhlI, 
∆lasI and ∆rhlI/∆lasI. Based on the above observations, it can be concluded that the 
duckweed model provides a highly sensitive and effective assay system for studying the 
pathogenesis of P. aeruginosa strains and it can possibly serve as a model system to test 
the functions of virulence genes of pathogenic bacteria in general [73]. Plant models 
face, however, limitations such as growth and size differences between individuals.
4.2. Cell Lines
At the cellular and molecular level, the bacterial pathogenesis mechanism and host 
response of cells have been studied using human cell lines. Using a microarray 
approach, Ichikawa et al. in 2000 [67] revealed alterations in gene expressions of 
A549 human lung carcinoma cells upon interaction with P. aeruginosa. An important 
gene encoding transcription factor IRF-1 (interferon regulatory factor 1), is upregulated 
in such a setting [67]. Exposure of IRF-1-deficient mice to lipopolysaccharide (LPS) 
and exotoxin A of P. aeruginosa showed reduction in production of tumor necrosis 
factor alpha (TNF-α) and interleukin 1 (IL-1), which indicates the importance of IRF-1 
in eliminating P. aeruginosa infection [74]. The Caco-2 cell line (human intestinal 
epithelial cell) is sensitive to 3-oxo-C12-HSL, which causes apoptosis of the cells [49]. 
Transfection of PvdQ, an acylase active against 3-oxo-C12-HSL into these cells have 
proven to be effective to protect the cells from apoptosis [75]. This result indicates that 
quorum quenching can be a potential therapy for P. aeruginosa infection. A collection 
25
Chapter 2 | Infection model for Pseudomonas
of numerous wild-type and Cftr -/- null cell lines, which can be cultured as either 
polarized or non-polarized, is currently available for mimicking CF infection in vitro. 
CF-lung-derived primary epithelial cells have also added significant knowledge to 
the cell biology of CF [76–80]. However, using cell lines has a major drawback due to 
the lack of differentiation in phenotypes and lack of complexity in intact organs [76]. 
4.3. Dictyostelium discoideum
The simplest organism that has been established as a model to study P. aeruginosa-
host interactions is the social soil amoeba Dictyostelium discoideum [68,81,82]. The 
genome size of D. discoideum is about 34 Mb and the haploid nature of this genome 
offers D. discoideum a major advantage to other infection models as it allows the 
generation of a rich variety of mutants. P. aeruginosa virulence factors have been 
studied in D. discoideum by using simple plating assays comparing P. aeruginosa 
parental and mutant strains [83]. The Rhl system plays an essential role in controlling 
virulence of P. aeruginosa in D. discoideum infection models, since isogenic mutants 
deficient in Rhl system showed reduced virulence [68]. An important finding that 
supports the establishment of this amoeba as a pathogenesis model is the positive 
correlation between D. discoideum and a rat model infected with less virulent, MexEF-
OprN-efflux pump-overproducer strain [68]. The contribution of phenazines and 
rhamnolipids to the killing of D. discoideum was examined and the results indicated 
that these factors are not responsible for P. aeruginosa virulence in D. discoideum 
[84]. Furthermore, purified pyocyanin, a phenazine that applies oxidative stress to 
eukaryotic cells, when added to D. discoideum at concentrations sufficient to kill 
mammalian cells, did not affect the viability of D. discoideum. This can be explained 
by the fact that D. discoideum is a soil organism that usually encounters a variety of 
different oxidative radicals. It is therefore expected that D. discoideum has evolved a 
wide range of mechanisms to deactivate such radicals [84]. Despite its many advantages 
as an infection model, the inability of Dictyostelium to survive at temperatures above 
27 °C is a major drawback as P. aeruginosa and many other pathogens express most 
of their virulence traits at higher temperatures [85].
4.4. Caenorhabditis elegans
One of the simplest invertebrate models for studying P. aeruginosa-host interactions is 
the nematode Caenorhabditis elegans normally found in the soil. The hermaphrodite 
C. elegans which can grow up to 1 mm in length possesses several advantages as a 
model. Examples of such advantages are its small size, the simple conditions it requires 
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for growth and its rapid generation time. The nematodes are routinely propagated in the 
laboratory on petri dishes containing lawns of the auxotroph Escherichia coli OP50. 
Regardless of its simplicity, the innate immunity pathway of this nematode shares 
similarity with that of mammals. Antimicrobial proteins in C. elegans are produced 
via the PMK-1 p38 mitogen-activated protein kinase (MAPK) signalling cassette, 
which is related to the Toll-like receptor cascade found in mammals [86]. The well-
developed genetic and molecular tools, as well as the complete genome sequence being 
available, contribute to the advantages of using C. elegans as a model for studies on 
bacterial pathogenesis [87–89]. 
Depending on the experimental conditions used, in agar-based assay, P. aeruginosa is 
known to kill C. elegans in four distinct ways. When grown on a rich, high-osmolarity 
medium, this pathogen causes lethal paralysis to the nematodes via a diffusible toxin, 
phenazine-1-carboxylic acid, in a pH-dependent manner [90]. However, when PA14 
is grown on a minimal medium, the nematodes undergo a slow infection process 
that lasts several days and involves accumulation of bacterial cells in the nematode’s 
intestines [91,92]. Yet another virulence mechanism was reported by Darby et al. 
[93]. This killing mechanism is the result of the action of hydrogen cyanide which 
requires the functionality of both the Las and the Rhl QS systems and causes a rapid 
neuromuscular paralysis [93]. In addition, “red death” of C. elegans occurs when the 
bacteria are grown in minimal medium with depletion of phosphate, where there is 
an activation of the phosphate signaling (PhoB)—the MvfR-PQS pathway of QS—
and the pyoverdin iron acquisition system [94]. In a different setting termed as liquid 
killing assay, a recently discovered killing mechanism of P. aeruginosa is based on 
the siderophore pyoverdin that induces a hypoxia response and death in C. elegans in 
a liquid medium [95].
Despite its simplicity as an organism, C. elegans has significantly contributed to the 
understanding of both the pathogen’s and the host’s behaviour during the infection. It 
has been demonstrated that lethal paralysis of the nematodes by P. aeruginosa requires 
a functional copy of EGL-9, a protein strongly expressed in the nematode body wall 
and pharyngeal muscles [93]. Functional lasR seems to be only necessary for slow-
killing and not for fast-killing of C. elegans by P. aeruginosa PA14 [88]. Even though 
C. elegans is a suitable and highly preferred model for studying the pathogenesis of P. 
aeruginosa, the nematode faces limitation in a lack of adaptive immunity.
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4.5. Drosophila melanogaster (Fruit Flies)
The diptera Drosophila melanogaster has a long history as an animal model. Initiated 
by T.H. Morgan in 1910 as a model for studying heredity [96], by the year 2000 
nearly 120 Mb of the fly’s genome had been successfully sequenced and annotated 
[97]. One of the advantages of this animal as a model for performing pathogenesis 
study is the shared similarity to the mammalian innate immune response. In both 
D. melanogaster and mammals, Toll family receptors signal through Rel family 
transactivators, mediating responses that are specific to different classes of pathogens 
[98]. D. melanogaster has an innate immune system similar to that of mammals and 
this makes it a favourable model for studying bacterial pathogenesis.
Even though physical barriers and antimicrobial substances protect D. melanogaster 
from microbial attacks, pathogens such as P. aeruginosa are capable of penetrating 
the exoskeleton or the intestinal epithelium and cause an infection following what is 
referred to as the “physiological” or “natural” route of infection [98]. P. aeruginosa 
in particular can cause infection by two ways: (a) it can be distributed in the food 
used to feed D. melanogaster larvae or adult flies; or (b) it can be used for pricking 
the dorsal part of the fly thorax body cavity with a sharp needle previously dipped 
into P. aeruginosa suspension. However, the latter method is invasive and faces the 
disadvantage of interfering to some extent with the host defence. Depending on the 
route of inoculation, there seems to be a difference in the D. melanogaster defence 
response [99], as well as a difference in the requirement of virulence factors for full 
bacterial pathogenesis. P. aeruginosa needs fully functional Las and Rhl QS systems 
in the fly feeding method, but not in the pricking method, since most of the QS mutants 
do not show attenuation in lethality, except for RhlI mutant [100]. It has been found that 
in the fly feeding method, RhlR is crucial in counteracting the host’s cellular immune 
response, possibly at the early stages of infection [101]. Experiments by D’Argenio 
and coworkers [102] showed that the mutation in pil chp genes, important in twitching 
motility, reduced P. aeruginosa PAO1 virulence in the fly pricking method. In addition, 
discovery of QscR function in LasI inhibition was aided by using this fly as an animal 
model for the assessment of mutants’ virulence [103].
When compared to alternative hosts for pathogen-host interaction studies, there are 
several practical limitations in using D. melanogaster as a model besides the inability 
of the fly to survive at 37 °C. Only a few strains of P. aeruginosa can infect via the 
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“physiological route” and the administration of exact doses of either microorganisms or 
antimicrobial substances requires laborious techniques due to the small size of the fly.
4.6. Galleria mellonella (Wax Moth)
Larvae of the greater wax moth Galleria mellonella from Lepidoptera family are also 
used as a model to study human-pathogen interactions. Pathogenesis of numerous 
bacteria and yeasts are tested in this model, including Acinetobacter baumannii [104], 
Burkholderia cepacia complex [105], Enterococcus faecium [106], Enteropathogenic 
Escherichia coli [107], Legionella pneumophila [108], Listeria monocytogenes 
[109,110], Pseudomonas aeruginosa [111–115], Staphylococcus aureus [116], 
Streptococcus pneumonia [117], Aspergillus flavus [118], Aspergillus fumigatus [119], 
Candida albicans [120,121], Cryptococcus neoformans [122], and  Fusarium spp. 
[123]. 
Compared to D. melanogaster, G. mellonella larvae are larger in size (250 mg), and 
therefore enable convenient injection of precise bacterial amounts into the hemocoel. 
In contrast to the C. elegans and the Drosophila models, a microscope is not required 
for the manipulation of G. mellonella. The ability to grow at 37 °C is another major 
advantage over the other invertebrates which cannot grow at this temperature [124]. 
Benefited by its large size, determination of bacterial LD50 is possible in wax moth 
larvae. Injection of bacterial mutants revealed the positive correlation between 
increased LD50 and reduced virulence in burned mice models [125], indicating that 
this animal is an excellent model for studying relevant virulence factors in mammals.
Introduction of bacterial lipopolysaccharide (LPS) to the wax moth induces expression 
of genes important in pathogen recognition and the ability of the host to fight the 
infection [126]. Interestingly, pre-exposure of the wax moth to non-lethal amounts 
of pathogen increases cellular and humoral response in a dose-dependent manner 
preparing the host to subsequent infection [119]. These data show that despite the 
absence of adaptive immunity, the animal is able to mount effective protection in 
response to prior pathogen exposure. A study conducted by Andrejko et al. in 2009 
[115] showed that elastase B, a metalloprotease, from P. aeruginosa is able to degrade 
an antibacterial produced by G. mellonella during infection. This is in line with the 
observed role of elastase B in mammalian systems, in which the protease is able to 
destroy immune components, such as complements, cytokines, IgA and IgG [115]. 
Protease IV of P. aeruginosa is known to degrade apolipophorin-III (apoLp-III) from 
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the hemocytes and fat body of G. mellonella [127]. Recently, G. mellonella larvae has 
been used as a model to study the efficacy of niclosamide, an antihelminthic drug, as a 
quorum sensing inhibitor (QSI) for P. aeruginosa [128]. Administration of niclosamide 
gave full protection to the larvae against acute P. aeruginosa infection [128]. 
4.7. Bombyx mori (Silkworm)
Studying bacterial pathogenicity and therapeutic effects of antibiotics becomes easier 
when a larger animal such as the silkworm, a larva of Bombyx mori, is used as an 
infection model. The body size of the instar larvae stage of the silkworm is 5 cm, 
which makes handling of this model easy. Injecting bacterial and drug samples into the 
hemolymph or the gut of the larvae is neither hard to perform nor monitor with the help 
of a marker [129]. The tissues responsible for drug metabolism can be isolated from the 
silkworm larvae allowing studies for the pharmacodynamics of certain compounds. A 
number of pathogenic bacteria including P. aeruginosa are able to kill silkworms with 
the 50% lethal dose of Pseudomonas exotoxin A being 0.14 µg∙g−1. Moreover, GacA, 
which is important for full pathogenicity in burned mouse model, is also crucial in 
silkworm infection [130]. The silkworm model, like C. elegans, D. melanogaster and 
G. mellonella, lacks adaptive immunity, and thus, is not an ideal model for studies in 
which a simulation of immune responses as shown by humans is crucial [129].
4.8. Danio rerio (Zebrafish)
A model host that combines the advantages of both the invertebrate and the rodent 
models is Danio rerio, the zebrafish. It has served as a model to study infections with 
a number of pathogens including Mycobacterium marinum [131], Salmonella enteric 
serovar Typhimurium [132], Edwardsiella tarda [133], S. aureus [134], Streptococcus 
iniae [135] and P. aeruginosa [136]. Zebrafish is 6.4 cm in size and relatively easy to 
handle. The embryos/larvae can be kept in a 96-well plate during the first five days 
of development. A single mating of a single adult pair of fish can generate about 200 
embryos. The optical transparency of the embryos further adds to the advantages of 
zebrafish as a host model by allowing visualization of infection progression in real 
time [136]. Zebrafish has an innate as well as an adaptive immunity, both of which 
resemble the respective immunity of mammals. For example, zebrafish expresses Toll-
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P. aeruginosa is able to establish lethal infections in zebrafish embryos, which are 
influenced by the inoculum size and by the presence of known virulence determinants 
such as lasR, mvfR and pscD, the developmental stage of the zebrafish embryos and 
the presence of immune cells. Clatworthy and coworkers [136] reported that a higher 
number of bacterial cells are required to achieve 100% lethality in embryos inoculated 
at 50 h post-fertilization (hpf) than in embryos inoculated at 28 hpf. These observations 
suggest that P. aeruginosa requires its full virulence arsenal in 50 hpf embryos in 
order to create a niche where it can survive and divide, and that 28 hpf embryos are 
less immunocompetent than 50 hpf embryos.
4.9. Rodents
Although the previously described models already gave valuable information about P. 
aeruginosa pathogenesis, further study in a complex organism is indispensable. Small 
mammals, especially rodents, are the preferable model to be used. With regards to 
QS, numerous studies have been conducted, either for understanding host-pathogen 
interactions or for QS inhibition.
4.9.1. Cystic Fibrosis Model 
P. aeruginosa infections are the major cause of mortality (80%) among CF patients. 
The respiratory tract of CF patients offers a convenient, yet challenging, environment 
for bacterial growth. Infection by P. aeruginosa in such an environment often starts 
by an intermittent colonization phase, and eventually develops into a chronic infection. 
It is of high importance to understand the pathogenesis of P. aeruginosa as presented 
in the CF lung environment. Because no natural animal models of CF exist, scientists 
developed a number of different CF mouse models to aid the understanding of the 
progression of P. aeruginosa infection in a CF lung. To date, transgenic mice with CF 
transmembrane conductance regulator (CFTR)-defects relating to CF and lung disease 
have been established. The currently available CF mouse models can be broadly 
classified into three main categories: (1) mouse models with a complete knockout of 
the Cftr gene which contain mutations that result in a complete loss of function [137]; 
(2) mouse models retaining the potential for reversion to wild-type, generated using 
an “insertional strategy” into the target gene [138]; and (3) the later-in-time generated 
recombinant CF mouse-models which contain clinically relevant mutations in Cftr, 
created by introducing specific human mutations, including the ∆F508 and G551D 
into the equivalent mouse loci. These mouse models have been extensively reviewed 
elsewhere [76,139,140]. Although mouse models have been widely used and have 
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provided precious information about CF progression, two larger animal models were 
developed that closer resemble the disease manifestation as observed in humans. The 
Cftr knockout pig and ferret develop a CF manifestation in multiple organs including 
the lungs, pancreas and gastrointestinal tract [141].
The first P. aeruginosa chronic pulmonary infection was developed in rats, using 
bacteria-containing agarose beads, introduced via the intratracheal route [142]. In 
1987, Starke et al. [143] adapted the P. aeruginosa-embedded agar beads method to 
develop infection in mice, and they showed similar histopathological effects as in larger 
animals, such as rats, guinea pigs and cats [143,144]. Replacement of agarose with 
seaweed alginate has been performed in a chronic bronchopulmonary infection model 
developed by Pedersen et al. [145]. Agarose, agar or seaweed alginate act as artificial 
biofilms, retaining the bacteria in the airways and protecting them from mechanical 
clearing [146]. It is also possible to use a mucA mutant, making artificially embedded 
material redundant, since this isolate shows a hyperproduction of alginate [147].
Using Cftr -/- mouse model, Hoffman et al. [148] examined the effect of azithromycin 
towards chronic lung P. aeruginosa infection. Azithromycin is known to be active 
against Gram-positive bacteria, and a study revealed that the sub-MIC concentration 
of azithromycin is capable of inhibiting QS-regulated virulence factors [149]. In the 
abovementioned study, it is proven that azithromycin also inhibits alginate production 
and increases bacterial susceptibility of the host’s complement system [148].
4.9.2. Burn Wound Model
Patients with burn wounds are at great risk of acquiring bacterial infections from 
pathogens such as P. aeruginosa. Local colonization of this bacterium may develop 
into systemic sepsis, which is often associated with a high degree of mortality. In 
order to understand the pathophysiology of the bacterial infection, P. aeruginosa-
infected burned mouse models have been developed [150–154]. Topical inoculation 
of P. aeruginosa PAO1 in the burn wound induced sepsis shock indicated by elevated 
levels of pro-inflammatory and anti-inflammatory cytokines [151]. The importance of 
QS in P. aeruginosa pathogenicity in burn wounds was confirmed by the virulence 
attenuation of mutations in lasI, lasR, rhlI, lasI/rhlI [150] and gacA genes [153]. The 
inability of lasR and lasI/rhlI mutants to spread within the wound and cause septicemia 
is possibly caused by the low level of QS associated-virulence other than lasA, lasB, 
toxA and rpoS [150]. High incidence of bacterial infection in burn wounds, along 
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with the increasing rate of antibiotic-resistance strains, makes the finding of novel 
antibacterials a crucial necessity. However, the main obstacle in studying potential 
antimicrobials is that these animal models often develop complications which are 
burn wound related, rather than caused by bacterial pathogenesis [152]. One of the 
well-known QSI, garlic extract, showed an in vitro inhibition of biofilm formation 
in burn wound isolates of Gram-negative bacteria, including P. aeruginosa [155]. In 
vivo examination of garlic, especially in ointment dose form, will be beneficial for its 
development as an antivirulence substrate. 
4.9.3. Foreign Body Implants Model
Another group of patients at great risk of P. aeruginosa-related infections are those who 
make use of prosthetic indwelling devices such as catheters, tracheostomy tube, and 
cardiac pacemakers [156]. Once the biofilm-forming bacteria, such as P. aeruginosa, 
colonize the foreign bodies, removal of the implant is usually the only alternative, since 
the biofilm is almost impossible to eradicate [157,158]. The protocol for in vivo study 
of antibacterial candidates using intraperitoneal foreign-body infection in a mouse 
model has been established [157–159]. In these studies, application of QSI (furanone 
C-30, ajoene or horseradish extract) solely increased bacterial clearance by the host 
innate immune system as compared to placebo treatment. Interestingly, synergistic 
antimicrobial efficacy was observed in administration of QSI in combination with 
tobramycin [158]. Bacterial biofilm is a compact structure, tolerant to antibiotics and 
to the bactericidal activity of polymorphonuclear cells (PMNs) [160]. QSI not only 
negatively influences biofilm formation, but also disrupts production of QS-mediated 
virulent factors, including rhamnolipids which act as a “shield” against PMNs. 
Therefore, with QSI-treatment, the biofilm is more susceptible to tobramycin and, at 
the same time, PMNs are more active against the pathogen [157,158,160].
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Table 1. Comparison of the infection models available for Pseudomonas pathogenicity studies.









Size 2–4 mm 1 mm 2.5 mm 2 cm 5 cm 6.4 cm 10 cm
Generation 






handling very easy very easy very easy `easy easy easy difficult
Costs low low low low low low high
Space re-
quirements minor minor minor minor minor minor major
High 
throughput yes yes yes yes yes yes no
Speed of 
outcome days days days days days days months
Temperature 21–25 °C 15–25 °C 18–29 °C 25–37 °C 27 °C 29 °C 37 °C
Innate 
immunity yes yes yes yes yes yes yes
Adaptive 
immunity no no no no no yes yes
Biological 




siderations no no no no no yes yes
4.9.4. Urinary Tract Infections (UTIs) Model
P. aeruginosa is a common pathogen found in nosocomial catheter-associated urinary 
tract infections (UTIs). The tendency of this pathogen to form biofilms often leads to 
chronicity and recurrence of the infection [161]. A significant antibiotic resistance is 
rarely found in UTI cases, possibly because the urine sample used in in vitro assay only 
represents planktonic populations, without considering phenotypically distinct bacteria 
within biofilms [162]. Oral administration of garlic extract as a prophylactic treatment 
to mouse models prior to renal P. aeruginosa biofilm challenge significantly reduced 
bacterial colonization [161]. Azithromycin treatment either orally or intravenously to 
P. aeruginosa-associated UTI mouse model resulted in bacterial clearance [163]. This 
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effect might be attributed to the inability of the bacteria to form mature biofilms in 
the presence of azithromycin [163]. 
5. Quorum Quenching
Scientists are focussing on three main approaches by which one could interfere with 
bacterial QS: (a) interfering with signal generation; (b) preventing signal accumulation; 
and (c) prohibiting signal reception (for a review, see references [164–166]). In this 
review, we discuss the current findings of QSIs using the above-mentioned interference 
methods in the three QS systems of P. aeruginosa.
A great amount of work has been performed in order to elaborate the complex QS 
system of P. aeruginosa. The gained knowledge leads to the possibility of finding 
alternative targets, such as pathway inhibition, for the development of novel therapies. 
It is suggested that the acyl group of the HSL of P. aeruginosa is provided by the fatty 
acid biosynthesis (Fab) pathway, consisting of a set of Fab proteins. Interference of 
this pathway, as performed by triclosan in inhibiting FabI to complete the fatty acid 
elongation, resulted in less production of both 3-oxo-C12-HSL and C4-HSL [167]. Yet 
another strategy was implemented to provide analogues of precursors important in 
P. aeruginosa signal generation. In a multistep reaction, condensation of anthranilate 
and β-keto-decanoic acid resulted in formation of PQS molecules. Addition of methyl 
anthranilate, as an analogue of anthranilate, inhibited the production of both PQS 
and elastase without affecting the bacterial growth [168]. Lesic and colleagues [169] 
introduced further potent analogues of anthranilate, termed as 6FABA, 6CABA, and 
4CABA. These compounds inhibit the production of 4-hydroxy-2-alkylquinolines 
(HAQs), the intermediate in PQS production, and are proven to be effective in 
hampering P. aeruginosa infection in burned mouse models [169].
After the signal molecules have been synthesized and secreted into the extracellular 
medium, it is possible to interfere with their accumulation either by completely 
degrading or by inactivating them. Two types of enzymes able to degrade the AHL 
signal molecules have been described up to this date: (a) AHL-lactonases and (b) 
AHL-acylases. The least studied quorum quenching enzyme, the oxireductase, 
belongs to a class of enzymes capable of inactivating AHL without degradation, but 
via modification. Thus, these enzymes limit the amount of bioactive AHL present in 
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the environment. AHL-lactonases hydrolyse the lactone ring in the homoserine moiety 
of AHLs without affecting the structure of the signal molecule any further. One of the 
first described and extensively studied AHL-lactonases is the AiiA produced by the 
Gram-positive Bacillus sp. 240B1 [170]. AiiA, when expressed in P. aeruginosa PAO1, 
resulted in a decrease of elastase, rhamnolipids, pyocyanin and cyanide production 
levels [171]. Oral administration of AiiA via food supplementation showed a reduction 
of virulence, since Aeromonas hydrophila infection in zebrafish was attenuated 
[172]. Despite the promising outcomes of signal degradation by AHL-lactonases, an 
important drawback of this approach is presented by the reversibility of the lactonolysis 
reaction at acidic pHs, regardless of the method used to open the lactone ring [173]. 
The second class of enzymes, known as AHL-acylases, is also employed by bacteria 
for the degradation of the AHL signal molecules. The bacterium Variovorax paradoxus 
VAI-C was the first host in which an AHL-acylase enzyme was detected [23]. Today, at 
least five AHL-acylases produced by a diverse range of bacteria have been extensively 
studied and shown to attenuate virulence in P. aeruginosa. These are the AiiD from 
Ralstonia eutropha [174], the AhlM from Streptomyces sp. [27], and the PvdQ, QuiP 
and HacB produced by P. aeruginosa PAO1 [28,175]. All of the abovementioned 
enzymes hydrolyse the amide bond between the acyl chain and the homoserine 
lactone in the AHL molecule, thus generating the corresponding free fatty acid and 
the homoserine lactone.
In 2003, the AiiD acylase from Ralstonia was described and when expressed in P. 
aeruginosa PAO1 it exhibited profound effects on the pathogen’s virulence [174]. In the 
presence of AiiD AHL-acylase, the swarming ability of P. aeruginosa was reduced. In 
addition, there was a significant reduction in the production of virulence factors such 
as elastase and pyocyanin [174]. The most important outcome of the study performed 
by Lin et al. [174] was the demonstration that AiiD can attenuate the virulence of 
P. aeruginosa in the C. elegans infection model where it was shown to rescue the 
nematodes from lethal paralysis. The latter observation hints on the possibility that this 
type of enzymes might be, in the future, effectively used as antimicrobial therapeutic 
agents. 
One of the AHL-acylases in P. aeruginosa, PvdQ, has been studied in depth. It 
has been previously reported that the in vitro substrate specificity of purified PvdQ 
includes AHLs with side chains ranging in length from 11 to 14 carbon atoms [31]. 
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The specificity of the PvdQ does not seem to be influenced by the substituent at the 
3’ position of the N-linked acyl side chain [176]. In the presence of purified PvdQ, 
the accumulation levels of the 3-oxo-C12-HSL in growing P. aeruginosa cultures 
are severely reduced and the degradation of 3-oxo-C12-HSL by the protein leads to 
a delay in the production of PQS. Production and accumulation of C4-HSL are not 
influenced by the presence of PvdQ, confirming the inactivity of the acylase towards 
AHLs with short side chains. Extracellular addition of the protein and intracellular 
production of the enzyme produced the same results. In both cases, the production 
levels of the virulence factors elastase and pyocyanin significantly dropped [31]. Since 
both expression of PvdQ in the bacterium and administration of the protein to growing 
P. aeruginosa cultures resulted in quorum quenching in vitro, the nematode C. elegans 
was used as an infection model to monitor the pathogenicity of P. aeruginosa [33]. It 
has been reported that PvdQ, when overproduced in the bacterium, rescues more than 
70% of the nematodes from lethal paralysis. Under different conditions which result in 
the slow death of the nematodes by bacterial accumulation in their gut, morphological 
appearance examination indicated that the development of disease-like symptoms is 
occurring at a slower rate when PvdQ is overproduced [33]. The importance of this 
AHL-acylase in interfering with QS, and in subsequently attenuating the virulence 
of P. aeruginosa, is further supported by data showing that deletion of pvdQ leads to 
higher bacterial toxicity [33].
The effect of the oxireductase enzyme has been studied by Bijtenhoorn et al. [177]. 
Oxireductase is a NADP-dependent reductase isolated from soil metagenome and 
designated as Bpi09. It was suggested that this enzyme might not only reduce 3-oxo-
C12-HSL, but also 3-oxo-acyl-ACP, thus interfering with the synthesis of the signal 
molecule itself. Expression of Bpi09 in P. aeruginosa PAO1 leads to the reduction of 
pyocyanin production, as well as in decreased motility and poor biofilm formation. 
Furthermore, in vivo analysis using C. elegans paralysis assay, reveals the ability of 
Bpi09 to suppress virulence production in P. aeruginosa [177]. 
Enzymatic degradation of PQS signal molecule is also feasible, by the 3-Hydroxy-2-
methyl-4(1H)-quinolone 2,4-dioxygenase (Hod) of Arthrobacter nitroguajacolicus 
strain Rü61 [178]. This enzyme catalyses the cleavage of PQS into carbon monoxide 
and N-octanoylanthranilic acid. Although purified Hod is shown to be active in the 
inhibition of PQS-signalling in vitro, the efficiency of the enzyme is reduced by the 
presence of exoprotease in the culture supernatant. PQS inactivation via pqsA mutation 
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or addition of purified Hod showed virulence attenuation in planta using lettuce leafs 
[178].
The third approach of interfering with bacterial QS is by blocking the binding of the 
signal to the receptor, or by destroying the receptor protein. QSIs in this group are 
the ones that compete with AHLs for the receptor-binding site and must meet certain 
requirements. First, the QSI must be a molecule of a low-molecular-mass and second, 
it must be able to significantly reduce the expression of genes that are under QS control 
[173]. Equally important is the necessity for the QSI to withstand a possible clearance 
or degradation by the host, as well as the necessity for this molecule to be nontoxic 
to the infected host. Many attempts have been made to identify possible QSIs. Over 
the years, a number of synthetic as well as natural compounds have been identified as 
potential candidates and have been screened for their ability to reduce the pathogen’s 
virulence. The positive correlation of several QSIs effect in C. elegans and mice model 
is presented in Table 2. 
5.1. Natural QSIs
Plants including tomato, pea seedlings, garlic, chili, water lily, soybean, carrots, 
crown vetch, gingko biloba, horseradish, rosemary, Tasmanian blue gum, brown algae 
(Ascophyllum nodosum), Ayuverda spice clove (Syzigium aromaticum), Dalbergia 
thiocarpa and Terminalia chebula, all produce QSIs [179–186]. Some bioactive 
compounds have been characterized as responsible for the quorum sensing inhibitor 
properties. Examples of such compounds are ajoene (4,5,9-trithia-dodeca-1,6,11-
triene 9-oxide) in garlic extract [158,187], eugenol in clove extract [185] iberin in 
horseradish extract [181] and ellagic acid derivatives in Terminalia chebula [186]. The 
abovementioned natural QSIs have been verified to reduce production of virulence 
determinants such as the rhamnolipid and pyocyanin of P. aeruginosa in vitro. Some 
of these QSIs have been tested in vivo, using C. elegans, D. melanogaster or even a 
mouse model. It has been reported by Bjarnsholt and colleagues [173] that in vitro, 
garlic-treated P. aeruginosa biofilms are not only susceptible to tobramycin, but also 
to PMNs. These observations are identical to the ones made by Rasmussen et al. 
[188] when they exposed P. aeruginosa biofilms to patulin derived from the fungal 
Penicillium coprobium.
Efficacy of garlic extract was not only observed in C. elegans [179], but also in mouse 
models infected with P. aeruginosa via different routes. Oral administration of fresh 
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garlic extract prior to mice urinary infection results in significantly lower renal 
bacterial counts and in protection of the mouse kidney from tissue destruction [161]. 
Furthermore, the garlic treatment was clinically tested and showed a lung function 
improvement in CF patients. However, the sample group was too small to give a 
statistically significant clinical outcome [189].
5.2. Synthetic QSIs
Production of synthetic AHL antagonists by modifying the AHL structure has been 
studied. Synthesis of AHL autoinducer analogues by Persson et al. [190] has shown 
that compounds in which the C-3 carbon on the side chain is replaced with sulphur 
block activity of LuxR and LasR proteins. Replacement of the head part of 3-oxo-
C12-HSL with different aromatic rings as well as modification in the tail part showed 
an inhibition of LasR activity [191–193]. Screening of potential QSIs from synthetic 
compound library reveals the presence of PD12 (tetrazole with a 12-carbon alkyl tail) 
and V-06-018 (phenyl ring with a 12-carbon alkyl tail) as 3-oxo-C12-HSL analogues 
[194]. Based on the design of a previously synthesized compound, named N-octanoyl 
cyclopentylamide (C8-CPA), Ishida et al. [195] successfully produced N-decanoyl 
cyclopentylamide (C10-CPA); a stronger QSI that interferes with expression of P. 
aeruginosa virulence factors regulated by the las and rhl quorum-sensing systems. 
Synthetic S-phenyl-l-cysteine sulfoxide and diphenyl disulfide are not only proven to 
inhibit P. aeruginosa QS in vitro, but also in vivo, as seen in the Drosophila infection 
model [196].
Owing to the presence of high-throughput screening technique, numerous QSIs from 
natural sources have been found and characterized. However, isolating the compounds 
from its endogenous source is not a practical method, especially if an endangered 
species is utilized. Therefore, attempting to produce synthetic compounds is a better 
approach. Based on the chemical structure of natural furanones, such as that of Delisea 
pulchra, a synthetic derivative referred to as furanone C-30 was generated. The 
classification of C-30 as a QSI was supported by a DNA microarray analysis showing 
that 80% of the furanone repressed genes in P. aeruginosa are also QS-controlled 
[197]. C-30 influenced the production of exoproteases and pyoverdin. Injection of 7 
µM furanone C-30 every 8 h for a six-day period into P. aeruginosa-infected mice 
resulted in a ~3 logs reduction of bacterial cell numbers in the infected lung tissues 
[197]. In addition, a different study by Wu et al. [198] showed that furanone C-30, 
as well as the synthetic furanone C-56, significantly increased the survival time of 
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mice with lethal P. aeruginosa infections, assisted bacterial clearance by the host and 
reduced the lung pathology. Thus, synthetic furanones appear to be promising novel 
antimicrobial agents. Worries about toxicity, however, remain.
Using QSI selector systems, Rasmussen et al. [179] identified a number of QSI 
compounds with structures unrelated to the signal molecules. Examples of such 
compounds are the 4-nitro-pyridine-N-oxide (4-NPO), indole, p-benzoquinone, 
2,4,5-tribromoimidazole, and 3-nitrobenzene sulphone amide. Of these, 4-NPO 
proved to be the most effective downregulating 37% of the QS-controlled genes in P. 
aeruginosa as demonstrated by DNA microarray-based transcriptomics. A search for 
the specific genes affected revealed a distinct specificity for the RhlR as the target 
for 4-NPO [173]. In the presence of 4-NPO, the mortality of C. elegans fed on P. 
aeruginosa dropped to 5%. The other potent QSI found in this study [158,187] was the 
garlic extract, which as explained earlier, contains ajoene as its bioactive compound. 
Synthetic ajoene showed synergistic antimicrobial effect with tobramycin on biofilm 
degradation in vitro and promoted clearance of P. aeruginosa pulmonary infection in 
mice as compared to the placebo-treatment group [187].
(R)-Bgugaine, a pyrrolidine alkaloid from Arisarum vulgare is proven to have antifungal 
and antibacterial activity. Application of synthetic norbgugaine (demethylated 
bgugaine) to P. aeruginosa showed an inhibition of QS-regulated virulence factors, 
including pyocyanin, rhamnolipid, LasA protease as well as a reduction of swarming 
motility and biofilm production [199].
Azithromycin influences, by its presence, 10.4% of the genes of the general QS regulon 
of P. aeruginosa. Nalca et al. [200] reported that azithromycin-treated P. aeruginosa 
cultures exhibit a reduced expression of various proteins which are required for 
flagellum biosynthesis. The result was a reduced flagellum-driven motility on swimming 
agar plates. The same group also observed that in the presence of azithromycin, P. 
aeruginosa undergoes an impaired oxidative stress response which might account 
for the significant reduction of P. aeruginosa viability after prolonged incubation 
with sub-MIC (minimum inhibitory concentration) of azithromycin [200]. The in vivo 
effect of azithromycin was revealed using a mouse model of chronic P. aeruginosa 
lung infection. Treatment of such mice with azithromycin significantly improved the 
clearance of alginate biofilms and reduced the severity of lung pathology [146]. In a 
one-year period, 45 CF patients with chronic P. aeruginosa infection received a low-
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dose azithromycin treatment as an integral part of their routine treatment [201]. The 
study resulted in an improvement of lung function and reduction of mucoid strains of 
P. aeruginosa in sputum sample. Furthermore, a pilot clinical trial of azithromycin 
has been carried out in randomized, intubated colonized patients, who are at risk 
of rhamnolipid-dependent ventilation-associated pneumonia (VAP) [202]. Reduced 
occurrence of VAP was observed in the azithromycin-treated group, suggesting that 
virulence inhibition is a promising strategy. All these observations raise the hopes 
that administration of azithromycin to patients suffering from P. aeruginosa-related 
infections, including CF, might help in the management and possible eradication of 
these infections. 
Table 2. Natural and synthetic quorum sensing inhibitors tested in C. elegans and mouse-models. 
QSIs C. elegans Mouse-models References
AHL-acylases + N.D. [174][33]
Furanones + + [157][158][197][198][203]
Garlic + + [158] [161][187][204][179] 
4-NPO + N.D. [179]
Azithromycin N.D. + [148] [163][205] 




Studying human diseases requires testing of microorganisms in appropriate model 
systems. Traditionally, mammalian models have been the first choice for human 
pathogen studies, as they show similarities to human responses to infection. However, 
negative factors have to be taken into consideration. For instance, the large number of 
animals required to be sacrificed for such studies is by itself ethically questionable. In 
addition, the large size of animals, and thus, the space requirements associated with 
it, as well as the costs and the time required for the execution of experiments, resulted 
in the necessity for the establishment of alternative models for studying bacterial 
pathogenesis. To overcome these problems, laboratories have employed models such 
as C. elegans, silkworms, D. melanogaster and zebrafish for studying pathogen-host 
interactions. Using these genetically tractable models, a lot of knowledge has been 
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gained about the mechanisms employed by P. aeruginosa for the establishment of 
infections.
The pathogenesis of P. aeruginosa in evolutionary distant hosts revealed conserved 
virulence factors required in causing an infection in multihost systems. Hence, 
interference of the central system controlling this virulence production, such as 
deactivation of QS, will lead to bacterial attenuation, which may be observed in 
different hosts. Hitherto, three QS circuits are studied thoroughly: the Las, the Rhl 
and the PQS system. Several—but not all—key proteins in each of the QS systems 
are shown to be indispensable in the establishment of infection of a host model, in a 
particular experimental setting. LasR, for example, is important in a slow-killing, and 
not in a fast-killing, assay of C. elegans. This regulator is also essential for the full 
virulence required for zebrafish infection. Bacterial colonization occurring in the slow-
killing assay in C. elegans is also occurring in a similar manner in zebrafish embryo 
infected with P. aeruginosa [91,136]. Mutation of GacA, the response regulator of the 
GAC two-component system, leads to a reduced bacterial virulence not only in A. 
thaliana, C. elegans, G. mellonella and silkworm, but also in burned mouse model 
[69,125,130,153,206].
The positive correlation of the animal models’ response in these observations 
strengthens the credibility of non-mammalian hosts in studying bacterial pathogenesis. 
The important applications for these findings are that fundamental studies and drug 
development can be initiated from even the simplest animal models. Since high-
throughput screening and whole-body infection systems are feasible in invertebrates, 
analysis of large libraries of drug candidates with regards to interfering with host 
pathogen-interaction is possible to perform [207]. Although eventual pharmacokinetics 
analysis in higher animal models is irreplaceable, preliminary studies in invertebrates 
can be an effective start. 
Increasing emergence and prevalence of antibiotic-resistant bacteria makes the 
currently available antibiotic less effective. While the need of novel antibacterial is 
alarming, screening and development of the potential drug candidate is a laboriously 
long process, which could take 20 years before the drugs would be allowed on 
market. Therefore, to circumvent this issue, the study of the novel antibacterial has 
to be constantly performed. Targeting virulence attenuation, instead of killing the 
pathogen, is considered an attractive alternative, since it gives less pressure to develop 
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resistance. Using this approach, quorum quenching in P. aeruginosa serves as an 
excellent candidate, as it has been extensively studied and also proved to be active in 
eradicating bacterial infection in vivo.
QS in P. aeruginosa consists of complex molecular machineries, and its activity is 
induced by the environmental stimulus. Hence, exposure to different conditions during 
development of P. aeruginosa infection leads to different activity levels of QS, since the 
importance of QS is dissimilar in each stage. QS seems dispensable in P. aeruginosa 
acute infection, where the type III secretion system which is negatively regulated by 
QS plays a dominant part [208]. On the other hand, QS is proven to be involved in 
biofilm formation, verifying its importance in the initial steps of persistent infection. 
Deactivation of AHL-dependent QS, either by mutation of LasRI and RhlRI or by 
addition of QSIs, results in a thin, flat biofilm structure of P. aeruginosa mutant, 
which is susceptible to antimicrobial challenge and phagocytosis by PMNs [160,197]. 
Biofilms are thought to be an ideal configuration for persistent infection, since they 
provide protection from both antibacterials and the host’s immune system. Within 
biofilm populations, diverse bacterial entities can be found due to the nutrient and 
oxygen gradient along the biofilm matrix. 
Genotypic and phenotypic alterations occur during the progression of persistent 
infections such as those observed in CF patients. Mutation in the QS systems –mostly 
in the Las and Rhl systems–are frequently found in the chronic CF isolates. Despite 
this, however, the presence of 3-oxo-C12-HSL, C4-HSL, PQS and QS-associated 
virulence factors such as rhamnolipids in the sputa sample, indicates that some QS 
activity still remains [63,209,210]. This phenomenon could be due to the existence of 
wild type bacteria within the population or due to the activation of a las-independent 
pathway operated under the PQS system or conceivably under a newly discovered IQS 
signal molecule. Although this knowledge reveals the possibility of targeting PQS 
for chronic infection, it was observed, in vitro, that reducing PQS levels leads to the 
increase of cytotoxin secretion by the type III secretion system. Therefore, the delivery 
of PQS inhibitor should be coupled with type III blocking therapy and appropriate 
antimicrobials [211]. 
In a search for compounds that can act as QSI, many candidates, natural or synthetic, 
have been revealed. Examples of natural QSIs include the halogenated furanones 
produced by D. pulchra and garlic extracts, which have been shown to effectively 
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interfere with the QS-related P. aeruginosa pathogenicity in the C. elegans and mouse 
infection models. The availability of appropriate infection models makes screening for 
compounds that result in the rescue of such models from threatening P. aeruginosa 
infections possible. However, the goal of finding an infection model that will be able 
to simulate bacterial infection precisely as seen in humans is yet to be reached. In 
addition, despite the successful application of a number of QSI in such models, their use 
in humans must be judged with care. Even though garlic-treatment has been successful 
in clearing P. aeruginosa infections in C. elegans and mice, it is far from becoming an 
easy treatment in clinical cases of P. aeruginosa infections acquired by humans. The 
low level of active compound in garlic requires a person to take 50 garlic bulbs a day 
to achieve an effective treatment, and as a result, patients tend to withdraw from such 
treatment. Although ajoene, the bioactive compound in garlic, has been successfully 
synthesized and proven to be efficacious in eliminating P. aeruginosa infection in 
vitro and in vivo, it must be first proven to be clinically safe before it can be approved 
as an applicable drug for humans.
7. Conclusions
It can therefore be concluded that generating a top model for studying host-pathogen 
interactions and for identifying appropriate QSIs of clinical importance is challenging 
and has yet not been reached. Modulating QSIs to aid their successful application in 
clinical treatment of P. aeruginosa-infected patients and finding a model in which 
the outcomes of testing such compounds can be directly correlated to humans remain 
important topics at which further research efforts should be directed.
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Abstract
The susceptibility of Caenorhabditis elegans to different virulent phenotypes of 
Pseudomonas aeruginosa makes the nematode an excellent model for studying host-
pathogen interactions. Including the recently described Liquid-Killing, now five 
different killing assays are available, offering excellent possibilities to perform high-
throughput screenings for novel antibiotics using a whole-body infection system.
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Caenorhabditis elegans: animal model for Pseudomonas 
aeruginosa infection
Bacteria are astonishing creatures which evolve rapidly to survive the harsh condition 
they are exposed to. Humans who are living in bacterial realm, constantly interact with 
bacteria in both positive and negative ways. The latter has led to the introduction and 
extensive use of antibiotics, that create a permanent selective pressure and giving rise 
to recalcitrant pathogens. One infamous bacterium which often causes serious health 
problems is Pseudomonas aeruginosa, a Gram-negative, opportunistic pathogen. It is 
a common infectious agent in hospital-acquired infections, immune-compromised and 
cystic fibrosis patients. Effectiveness of antibiotics that are used to treat pseudomonal 
infections is declining because of the emergence of resistance strains, imposing 
discovery of novel antibiotics. [14,90,94,95,212]. The search for novel antibacterial 
therapeutics is greatly depending on representative infection models that mimic 
pathogenesis in humans and can be used in a high-throughput fashion. 
Establishment of a nematode Caenorhabditis elegans as a model for genetic study 
in 1960s has opened up possibilities to employ this animal in different biological 
arenas including that of bacterial pathogenesis. A well-understanding of its genetics 
and physiological aspects contribute to its widespread utilization. Another advantage 
of using this worm is the possibility to perform high-throughput operations in a whole-
body system when automated instruments are at hand. Despite of its simplicity, this 
worm shares similarities to mammalian signaling cascades in innate immunity when 
responding to pathogen invasion. The PMK-1 p38 MAPK cassette, which is related 
to the Toll-Like Receptor cascade signal in mammals, is important for activation 
of antimicrobial genes in C. elegans, in the absence of NFκB and independent of 
TOL-1 signaling [86]. This fact, together with susceptibility of the nematode to human 
pathogens, has led to a widespread use of C. elegans as an infection model. The 
experiment is carried out by simply feeding the worm with the pathogen of interest.
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Pseudomonas aeruginosa – Caenorhabditis elegans 
pathogenesis assays
Extensive studies of C. elegans as P. aeruginosa infection model have resulted 
in four distinct assays that are carried out in slightly different growth media and 
incubation condition. Lethality of the animal in each assay depends on a different 
subset of virulence factors, which are also important in causing infection in mammals 
(summarized in Table 1). The known C. elegans infection assays are as follow: (i) 
Slow-killing assay. In this assay, minimal growth media (nematode growth media, 
NGM) is used. A functioning quorum sensing system is essential in causing intestinal 
colonization, resulting in the nematodes’ death over a period of days [33]. (ii) Fast-
killing assay. In a high-osmolarity Peptone Glucose Sorbitol (PGS) media, the worms 
are killed by phenazine intoxication within several hours [90]. (iii) Lethal paralysis 
assay. Upon growth in a Brain Heart Infusion (BHI) media, P. aeruginosa produces 
hydrogen cyanide, a neurotoxin that causes lethal paralysis of the worm within hours 
[212]. (iv) Red death assay. In this setup, depletion of phosphate in NGM media causes 
activation of lethal phenotype of P. aeruginosa that eventually kills the nematodes. 
Phosphate scarceness activates three signaling systems in P. aeruginosa, they are: 
phosphate signaling PhoB, quorum sensing (particularly MvfR-PQS system) and 
pyoverdine-dependent iron acquisition. Death of the animals are characterized by 
accumulation of a red-colored PQS+Fe3+ complex in the intestine of C. elegans [94].  
In addition to the four agar-based assays mentioned above, recently a novel high-
throughput liquid-based pathogenesis assay has been developed [95]. In this novel 
assay called Liquid-Killing, pyoverdine siderophore plays an important role in 
inducing a hypoxic response followed by death of the worms [95]. Cellular oxygen 
and iron homeostasis in C. elegans is regulated by HIF-1 (hypoxia inducing 
factor), a transcription factor that upregulates genes expression for iron uptake and 
downregulates ones responsible for iron storage. During iron sufficiency, an iron-
dependent prolyl hydroxylase family EGL-9 hydroxylates HIF-1, makes it a target for 
proteasomal degradation. Conversely, depletion if iron causes EGL-9 to be inactive 
and thus stabilized HIF-1. This system ensures sufficient iron for the animal to survive 
during iron scarcity [213]. In Liquid-Killing assay, restriction of iron concentration 
causes a fierce battle to sequester iron for both the host and pathogen. Pyoverdine acts 
as a strong iron chelator that is toxic to the animal. In addition, P. aeruginosa seems 
to disrupt iron homeostasis in C. elegans by promoting HIF-1 destabilization that 
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resulted in a hypoxic response and death. Pyoverdine also regulates the production 
of PrpL protease, that might involve in degradation of iron-storage protein from the 
host [95]. As pyoverdine is also indispensable for P. aeruginosa virulence in mice, it 
would be intriguing to see if pyoverdine-mediated cell hypoxia might also be relevant 
in human infection.
Table 1. Resemblance of P. aeruginosa pathogenesis in C. elegans with infection in mammals
Assay Comparison with infection in mammals Ref.
Slow-killing 
(agar-based)
Slow-killing mechanism is based on infection-like process, including 
establishment and proliferation of pathogen in intestine along with 





Phenazine-1-carboxylic acid that is toxic under acidic condition 
might play a role in infection of CF patients, or during inflammation 





Hydrogen cyanide production (cyanogenesis) in P. aeruginosa 
during lung infection in CF patient is a complex network involving 
quorum sensing, GacA and RsmA regulation. Cyanogenesis also 
suggested as a mechanism of P. aeruginosa dominance and per-




This assay mimics P. aeruginosa infection during intestinal phos-




This assay possibly mimics condition in CF patient where oxygen 
gradient is observed in a thick mucus, inducing hypoxic response 
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Cystic fibrosis
Cystic fibrosis (CF) is the most common inherited genetic disorder in Caucasian 
population. CFTR gene mutation causes excess mucus production and altered mucosal 
immunity. P. aeruginosa pulmonary infection in CF patients mostly develops into 
a chronic, recalcitrant infection that makes antibiotic treatment inefficient [214]. 
The CFTR gene is only present in vertebrates, hence, it is not possible to mimic CF 
condition in C. elegans by making CFTR knockouts. However, with combination of 
killing assays for C. elegans as described here, preliminary efficacy study of novel 
therapies against P. aeruginosa infections can be performed. For examples, as has 
been shown for interference with quorum sensing-dependent virulence factors [33]. 
Concluding remarks
Discrete responses of C. elegans in reaction to P. aeruginosa in different pathogenesis 
assays, demonstrate its excellent feature as a model to study host-pathogen interactions. 
As each assay is probing a different subset of virulence factors, they can complement 
each other to unravel and better understand the exact virulence mechanisms. In addition, 
a combination of C. elegans assays can be used to study pathogenesis inhibition by 
novel antibacterial therapies urgently needed to combat antibiotic resistance. Non-
conventional drug targets, such as the quorum sensing pathway, can now be studied 
by observation of pathogen attenuation under specific assay conditions with the read 
out based on the survival of the worms [33]. The high-throughput nature of the C. 
elegans assays render these into invaluable preliminary methods to screen compound 
libraries in a relatively short time. The selected compounds can subsequently be tested 
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Abstract
Virulence pathways in Gram-negative pathogenic bacteria are regulated by quorum-
sensing mechanisms, through the production and sensing of N-acylhomoserine lactone 
(AHL) signal molecules. Enzymatic degradation of AHLs leading to attenuation 
of virulence (quorum quenching) could pave the way for the development of new 
antibacterials. Penicillin V acylases (PVAs) belong to the Ntn hydrolase superfamily, 
together with AHL acylases. PVAs are exploited widely in the pharmaceutical industry, 
but their role in the natural physiology of their native microbes is not clearly understood. 
This report details the characterization of AHL degradation activity by homotetrameric 
PVAs from two Gram-negative plant pathogenic bacteria, Pectobacterium atrosepticum 
(PaPVA) and Agrobacterium tumefaciens (AtPVA). Both the PVAs exhibited substrate 
specificity for degrading long chain AHLs. Exogenous addition of these enzymes into 
Pseudomonas aeruginosa greatly diminished the production of elastase and pyocyanin, 
biofilm formation and increased the survival rate in an insect model of acute infection. 
Subtle structural differences in the PVA active site that regulate specificity for acyl 
chain length have been characterized, which could reflect the evolution of AHL-
degrading acylases in relation to the environment of the bacteria that produce them 
and also provide strategies for enzyme engineering. The potential for using these 
enzymes as therapeutic agents in clinical applications and a few ideas about their 
possible significance in microbial physiology have also been discussed.
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Introduction
Penicillin acylases are microbial enzymes that cleave the amide bond of natural 
penicillins [25], finding industrial application in the manufacture of the pharmaceutical 
intermediate 6-aminopenicillanic acid (6-APA). Penicillin acylases can show substrate 
preference for benzyl penicillin (Pen G, PGAs) or phenoxymethyl penicillin (Pen 
V, PVAs). Although both enzymes belong to the Ntn hydrolase superfamily [216], 
they differ in their catalytic N-terminal nucleophile residue (PGA-ser, PVA-cys) 
and their subunit composition. While PGAs are heterodimeric enzymes, PVAs [26] 
are homotetramers and are evolutionarily related to bile salt hydrolases (BSHs) that 
deconjugate bile salts in the mammalian gut [217] forming the cholylglycine hydrolase 
(CGH) group. A recent study [218] has explored the phylogenetic clustering of CGHs 
from Gram-positive and Gram-negative bacteria into two different groups.
Quorum sensing (QS) allows the bacteria to perceive their population density [219] 
through the secretion of auto-inducer signal molecules and modulate gene expression 
to trigger specific metabolic pathways. QS has been linked to bioluminescence, 
bacterial virulence and swarming motility among other physiological processes 
[220]. Bacterial pathogens including Pseudomonas aeruginosa, Vibrio cholerae 
and Acinetobacter baumanii use QS to regulate virulence genes and formation of 
biofilms, thereby increasing their persistence [221]. Gram-negative proteobacteria use 
autoinducers N-acylhomoserine lactones (AHLs) [222,223], with a homoserine lactone 
ring linked via an amide bond to an acyl side chain (C4-C18) which may be saturated 
or unsaturated, or with a hydroxy, oxo or no substituent on the carbon at the 3-position 
of the N-linked acyl chain. Synthesized AHLs diffuse into neighbouring cells, where 
they modulate gene expression through binding to the LuxR family of regulators. 
While Pectobacterium carotovorum and Agrobacterium tumefaciens produce 3-oxo-
C6 and 3-oxo-C8-HSLs, respectively [224], P. aeruginosa utilizes C4 and 3-oxo-C12-
HSLs as signals for auto-induction. Bacteria in mixed-species communities have also 
been known to respond to structurally related non-cognate AHLs produced by other 
bacteria [225].  
The disruption of AHL-directed signaling (termed “quorum quenching”, QQ) through 
inhibition or enzymatic degradation is an attractive strategy for controlling bacterial 
pathogenesis and biofilm formation [175]. Enzymes that degrade AHL include 
lactonases (ring cleavage) and acylases (amide bond cleavage), which have been 
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characterized from a variety of bacteria. An exhaustive list has been provided by 
Grandclément and colleagues [226]. Penicillin acylases are known to share similar 
structural fold and mechanistic features with AHL acylases, and the probability 
of substrate cross-reactivity has been suggested earlier [227].  Although recent 
studies have demonstrated activity of Kluyvera citrophila PGA [29] and aliphatic 
penicillin acylase from Streptomyces lavendulae [228] on AHLs, both these enzymes 
are ser-Ntn hydrolases with heterodimeric structure. A new AHL acylase from P. 
aeruginosa (HacB) [28] cleaves Pen V to a small extent; however, AHL degradation 
by PVA enzymes or any other cys-Ntn hydrolase has not been explored in detail so 
far. Moreover, although the concrete role of PVAs in microbial physiology is not yet 
understood, studies have shown possible links to quorum sensing and pathogenesis in 
bacteria with respect to function and regulation of PVA and BSH [229,230]. 
In earlier reports, we have characterized the unique biochemical [231] and structural 
[232] features of a highly active PVA from the Gram-negative Pectobacterium 
atrosepticum (PaPVA), with maximum specific activity (430 µmolmin-1mg-1) among 
reported PVAs. The present study describes the characterization of PVA from another 
related plant pathogen A. tumefaciens (AtPVA, 62% sequence identity with PaPVA) 
and elucidates the subtle structural differences between the enzymes. Further, we 
report the promiscuous deacylation of AHLs by these PVAs, and explore the structural 
interactions involved in AHL binding.  The application of PVA enzymes also led to 
reduction in QS-regulated biofilm formation in P. aeruginosa PAO1 culture and the 
attenuation of P. aeruginosa virulence in Galleria mellonella infection models, making 
them attractive options for novel QQ-based therapeutic formulations.
Materials and Methods
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are listed in Table 1. E. coli DH5a 
and BL21 star strains were maintained on Luria-Bertani (LB) medium supplemented 
on appropriate antibiotics and cultured at 37°C. Antibiotics were added (100 µg/ml 
ampicillin, 35 µg/ml kanamycin or 10 µg/ml tetracycline) as required. 
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Preparation of AtPVA and PaPVA
The pva gene from A. tumefaciens (GenBank GI:159185562) was cloned in 
pET22b vector between NdeI and XhoI restriction sites using the primers AtuF 
(gcttgacatatgtgcacgcgtttcgtttatatag) and AtuR (ctgaatctcgagaagcccgagaaacttgaaag), 
and expressed in E. coli BL21 star cells with a C-terminal His-tag. The enzyme was 
purified to homogeneity using a HIS Select Ni2+ affinity column (Sigma) and ENrichTM 
650 (BioRad) size exclusion column. The protein was dialyzed against 10 mM Tris-Cl 
buffer pH 7.4 containing 100 mM NaCl and 1mM DTT and stored in aliquots at -20°C. 
PaPVA was purified from recombinant E. coli as described earlier [231].
PVA enzyme activity assay
Pen V hydrolysis activity was estimated by studying the formation of Schiff’s conjugate 
with the product 6-APA and p-dimethyl amino benzaldehyde [233]. One unit (IU) of 
enzyme activity was defined as the amount of enzyme producing 1 µmol 6-APA in 
1 min.
Biochemical characterization of AtPVA
The Pen V hydrolysis activity was assayed at different pH (4-9) and temperatures (20-
70°C) to ascertain the optimum conditions. AtPVA stability was studied by incubating 
the protein in 10 mM Tris-Cl buffer pH 7.4 for 2 h at different temperatures between 
30-90°C and assaying for PVA activity at 45°C after different time intervals. Effect of 
pH on enzyme stability was studied by incubating the protein in 100 mM buffers of 
different pH (1-11) for 4 h at 25°C and assaying the residual activity. Kinetic parameters 
were determined by assaying the enzyme activity with increasing concentrations (5-240 
mM) of penicillin V (potassium salt, Sigma) as substrate. The data were fitted using 
non-linear regression as detailed for PaPVA earlier [231].
Crystallization trials were set up with AtPVA (15 mg ml-1) using the sitting drop 
vapour diffusion technique. The protein crystallized in the 0.1M HEPES pH 7.5 and 
12% PEG 3350 condition of the PEG Rx crystallization screen (Hampton Research, 
USA). The crystals were frozen in liquid nitrogen with 25% (w/v) 2, 5-hexanediol as 
cryoprotectant.  Diffraction data were collected at 2.8 Å resolution at the SSRL-BL12-2 
beamline at the Stanford Synchrotron Light Source (USA). Investigation and scaling 
of the diffraction data was performed using XDS [234] and SCALA [235]. The AtPVA 
structural model was built using molecular replacement on Phaser ver. 2.5.6 [236] 
and Autobuild (Phenix), with the refined structure of PaPVA (PDB ID: 4WL2) as the 
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template. Further model building and refinement was done using Coot and Refmac5 
(CCP4 software suite) respectively. AtPVA crystallized in P212121 space group with a 
single tetramer per asymmetric unit (Table S1, Online Resource 1). 
Table 1. Bacterial strains and plasmids used in this study









gF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA
Promega
BL21 star
F- ompT hsdSB (rB - mB -) gal dcm rne131 
(DE3) Promega
pSB536 AHL biosensor, Ampr Swift et al. 1997
pSB401 AHL biosensor, Tetr Swift et al. 1997
pSB1075 AHL biosensor, Ampr Winson et al. 1998
P. aeruginosa 
PAO1 Laboratory strain University of Nottingham
Plasmids
pET22b(+) Cloning vector, Ampr Novagen
pET28b(+) Cloning vector, Kmr Novagen
pET22b(+)-AtPVA pET22b(+) containing gene coding for PVA from A. tumefaciens This study
pET28b(+)-PaPVA pET28b(+) containing gene coding for PVA from P. atrosepticum Avinash et al. 2015
aATCC: American Type Culture Collection
bDSM: Deutsche Sammlung von Mikroorganismen, Germany
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Bioluminescence assay for detection of AHL degradation
AHL degradation activity was monitored by employing biosensors that exhibit 
luminescence in the presence of specific AHLs [225]. Quenching of luminescence 
levels can be used as an indication of AHL hydrolysis by the acylase enzymes [237]. 
0.5 µL of 5 mM AHL stock solution in DMSO was spotted to a flat-bottom µClear 
white microplate (Greiner Bio-One) and dissolved in 50 µL reaction mixture containing 
5 µg enzyme in 100 mM NaCl, 1 mM DTT and 25 mM Tris HCl buffer pH 7.4 (for 
AtPVA) or 20 mM sodium acetate buffer pH 5.2 (for PaPVA). After 4 h incubation 
at 25°C, the enzyme was heat inactivated (80°C for 15 min), and an equal volume of 
modified PBS (137 mM NaCl, 2.7 mM KCl, 100 mM Na2HPO4, 1.8 mM KH2PO4) 
was added to each well, followed by 100 µl of 1:100 diluted overnight biosensor. 
Luminescence of the biosensors was measured at 30°C during a 12 h time-course 
using FLUOstar Omega (BMG Labtech) as described previously [33]. Control reactions 
were performed in the same manner using heat-inactivated enzyme. E. coli (pSB536) 
was used to analyze C4-HSL degradation, E. coli (pSB401) for C6- to C8-HSL (Swift 
et al. 1997), and E. coli (pSB1075) for C10- to (3-OH- and 3-oxo-) C12-HSL [225]. To 
determine the enzyme activity on AHLs, the ratio of luminescence unit to biosensor 
growth in OD600 (relative luminescence unit, RLU) from active enzymes was compared 
to those from inactive enzymes.
HPLC analysis 
To confirm the deacylase activity of PVA enzyme on long chain AHLs, the reaction 
with C10-HSL was analyzed by HPLC [238]. The enzymes (25 µg in 3ml of same buffer 
as the bioluminescence assay) were incubated with 0.4 mM C10-HSL for 4 h at 25°C 
(heat-inactivated enzyme was used as a control). Samples of 750 µl from time 0 and 
4 h were processed for detection of residual substrate, HSL and decanoic acid [28].  
For detection of the substrate, residual C10-HSL in the reaction mixture was extracted 
twice with an equal volume of acidified ethyl acetate. The free HSL released during 
the reaction was dansylated with an equal volume of 2.5 mg ml-1 dansyl chloride 
(in acetone) and incubated overnight at 37°C [174]. After SpeedVac evaporation, the 
sample was neutralized with 50 µl of 0.2 M HCl and diluted with acetonitrile. Decanoic 
acid in the sample was extracted thrice with an equal volume of hexane followed by 
drying under a nitrogen stream and derivatization with 4-bromomethoxy-7-methyl 
coumarin (BrMMC) reagent was performed as described previously [239].  
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HPLC was carried out in a Shimadzu LC-10AT VP system using a Phenomenex Luna 
C18 reverse-phase column (250 x 4.60 mm, 5 µm) coupled with a SPD-M10AVP PDA 
detector. The column was washed with 5% acetonitrile in water (solvent A), and the 
sample was eluted in a linear gradient to 100% acetonitrile (solvent B). C10-HSL was 
detected at 219 nm, dansylated HSL at 267 nm, and BrMMC-derivatized decanoic 
acid at 328 nm [238]. Reaction control of reference substrate and products showed that 
the dansylation and BrMMC derivatization was specific to HSL and decanoic acid, 
respectively (data not shown).  
Kinetics of AHL degradation by PVAs
The kinetic behavior of AtPVA and PaPVA on 3-oxo-C12-HSL was determined by 
an end-point assay using ortho-phthalaldehyde (OPA) derivatization of the HSL 
product. Eight different concentrations of 3-oxo-C12-HSL in which the substrate was 
completely soluble (0.01-0.25 mM) were prepared from DMSO stock. The reaction 
mixture consisted of 100 mM NaCl, 1 mM DTT and 25 mM sodium phosphate 
buffer pH 7.4 (for AtPVA) or 20 mM sodium acetate buffer pH 5.2 (for PaPVA). The 
DMSO concentration was kept at 0.8% for each reaction. Enzyme (2 µg AtPVA or 
0.5 µg PaPVA) was added into the 1 ml reaction mixture; a 90 µL sample was taken 
immediately and thereafter regularly at 1 min intervals. The enzyme was inactivated 
with 10 µL of 1M NaOH; this step did not interfere with the subsequent derivatization. 
After removal of enzyme by centrifugation, 50 µL was transferred into a black Fluotrac 
microplate (Greiner Bio-One) and mixed with 50 µL OPA reagent (Sigma-Aldrich), 
followed by 20 min incubation at 25°C. Fluorescence was measured on a FLUOstar 
Omega, BMG Labtech with an excitation at 355 nm and emission at 460 nm. A standard 
curve using 0-0.25 mM HSL standard prepared in reaction mixture showed a straight 
line that can be fitted to the following equation: y = 77290x + 490.5 (R2=0.9996). 
Initial velocity was limited in the range of 15% substrate conversion and calculated 
from the standard curve. The enzyme kinetics model was analyzed by fitting the v/[S] 
curves in GraphPad Prism software.
Docking of AHLs to PaPVA and AtPVA
The 3D structures of C6-HSL, C10-HSL and 3-oxo-C12-HSL used in the docking study 
were obtained from PubChem compound database. Partial atomic charges of each 
ligand atom were determined from OPLS_2005 all-atom force field using LigPrep. 
Grid based ligand docking program Glide was used for docking these ligands in the 
binding site of PaPVA and AtPVA. The binding site was defined as a grid box of 
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dimension 26x26x26 Å, centered on the Cys1 residue. Receptor grid generation was 
followed by ligand docking where the ligands were docked flexibly using Glide’s extra 
precision. Free energy of binding was roughly estimated by using an empirical scoring 
function called GlideScore, which includes electrostatic, van der Waals interaction and 
other terms for rewarding or penalizing interactions that are known to influence ligand 
binding. All structural figures were prepared using PyMol or CCP4MG.  
Disruption of quorum sensing in Pseudomonas aeruginosa  
PAO1 by PVAs
Purified AtPVA (0.08 mg ml-1) or PaPVA (0.4 mg ml-1) was added to a 1:100 diluted 
overnight culture of P. aeruginosa PAO1 in 100 ml LB. Samples were taken at 6 and 
24 h post inoculation, centrifuged for 5 min and supernatant was stored at -20°C until 
further analysis. 
(i) AHLs measurement. The levels of 3-oxo-C12-HSL and C4-HSL were measured 
by bioluminescence assay using biosensor E. coli pSB1075 and pSB536 respectively 
[225,240]. Cell-free supernatant was filtered through a 0.2 µm pore filter, and 20 µL 
of the sample was mixed with 180 µL of 1:100 diluted overnight biosensor culture. 
Light production was monitored at 30°C for 12 h.  
(ii) Elastase assay. Cell-free supernatant (100 µL) was added to 900 µL of elastase 
buffer (100 mM Tris HCl pH 7.5; 1 mM CaCl2) containing 20 mg of Elastin Congo 
Red (ECR, Sigma Aldrich) [241]. After 2h at 37°C, elastase activity of the supernatant 
was measured as A495/A600.   
(iii) Pyocyanin assay. Cell-free supernatant (5 ml) was extracted with 3 ml chloroform 
and re-extracted with 1 ml of 0.2 M HCl [242]. After centrifugation, the absorbance 
of HCl layer was measured at 520 nm. Production of pyocyanin (µg ml-1 culture) was 
calculated as (A520/A600) ×17.072.
(iv) Biofilm formation assay. The static biofilm assay was performed in a round-
bottom polystyrene 96-well plate (Greiner Bio-One) using a method by Merritt and 
colleagues [243] with modification. 0.5 mg ml-1 AtPVA or 0.66 mg ml-1 PaPVA was 
added to an overnight culture of P. aeruginosa PAO1 (0.01OD) in M9 medium (47.7 
mM Na2HPO4.7H2O; 22 mM KH2PO4; 8.5 mM NaCl; 18.7 mM NH4Cl; 2 mM MgSO4; 
0.1 mM CaCl2; 0.01 mM glucose). A minimum of 20 wells per treatment were used 
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with an aliquot of 110 µL in each well. Biomass quantification was performed using a 
crystal violet method [244] after 18 h at 30°C. 
(v) Galleria mellonella killing assay. Larvae of G. mellonella were obtained from Frits 
Kuiper (Groningen, The Netherlands) and kept in a dark container at 15°C. Animals of 
2.5-3 cm size were selected for the assay, with a minimum of 15 animals per treatment. 
An overnight culture of P. aeruginosa PAO1 was diluted 1:100 in LB medium, grown 
into an early logarithmic phase (A600 0.3-0.4), and the CFU count was determined from 
a standard curve of CFUs/ A600. The cells were then washed with sterile 10 mM MgSO4 
and diluted into 103 CFU/mL. Afterwards, 100 µL of enzyme (0.5 mg ml-1 AtPVA or 
0.66 mg ml-1 PaPVA) or reaction buffer was added to 900 µL of bacteria and incubated 
at 30°C for 1 hour. An insulin pen (HumaPen Luxura; Lilly Nederland) was used to 
inject 10 µL of the culture to the last proleg of the larvae. Animals injected with 10 mM 
MgSO4 served as a control for physical trauma. Infection development was followed 
for 24 hours at 30°C [124,245]. The animals were considered dead when not reacting 
to touch or have turned black.
Accession code: 
The structural coordinates for AtPVA have been deposited in the PDB under the 
accession codes 5J9R.
Results 
Biochemical characterization of AtPVA
AtPVA was expressed as a tetramer of molecular mass 148 kDa; the enzyme exhibited 
a specific activity of 205 µmolmin-1mg-1with high specificity for Pen V over bile salts 
and other β-lactam antibiotics (Figure S1, Supplementary material). Maximum Pen 
V hydrolysis was observed at 45°C in optimum pH 6 - 7 (Figure 1). AtPVA was stable 
in the pH range 5-8, while PaPVA [231] was more stable in acidic pH (3-6). There 
was also a drastic reduction in AtPVA activity and loss of tertiary structure at 60°C 
(Figure 1). 
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Figure 1. AtPVA (a) pH and (b) temperature optima, stability at increasing (c) pH (after 4 h) and (d) 
temperature. Maximum activity was taken as 100%.
AtPVA was observed to exhibit complex kinetic behaviour similar to PaPVA, showing 
positive cooperativity and substrate inhibition with Pen V and modulation of PVA 
activity in the presence of bile salts (Figure 2a).  The major difference between AtPVA 
and PaPVA lies in the extent of substrate inhibition; AtPVA showed a Ki of 47.2 mM, 
compared to 163.1 mM for PaPVA. Near complete reduction of AtPVA activity was 
observed at 240 mM Pen V, while PaPVA still had considerable activity (20% of Vmax) 
at the same concentration [231]. Drastic reduction in Pen V hydrolysis with AtPVA 
was also observed in the presence of high GDCA (glycodeoxycholate, a bile salt) 
concentration (Figure 2b). 
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Figure 2. (a) v/[S] plot of AtPVA with Pen V as substrate. Kinetic parameters are given in inset. (b) 
Relative PVA activity in the presence of increasing concentrations of GDCA. Pen V concentration 
was kept constant at 50 mM.
Structural analysis of AtPVA
The structural features of AtPVA closely resemble the PaPVA structure (PDB ID 
4WL2) with a few subtle differences. Although the AtPVA tetramer (Figure 3) 
possesses a similar non-planar orientation and distance between subunits as PaPVA 
[232], the angle between the opposite subunits (169.6°) was closer to the planar shape 
of the PVA from Bacillus sphaericus (171°) than PaPVA (158°). AtPVA shares many 
similar active site residues with PaPVA including the nucleophilic N-terminal cysteine 
(C1), and the presence of two Trp residues (W21, W80) in the active site participating 
in substrate binding. Superposition of the two structures revealed that AtPVA (and 
other PVAs) lack the 5-residue insertion in the loop region (61-74) near the active site 
in contrast to PaPVA [231]. It is possible that the length of this loop might play a role 
in modulating the substrate inhibition in PVAs from Gram-negative bacteria. Finally, 
AtPVA and BtBSH (BSH from Gram-negative Bacteroides thetaiotamicron, PDB ID 
3HBC) also lack a solvent-exposed loop covering the region 228-239 that is present 
in PaPVA.
AHL degradation by PVAs
The ability of PVAs from Gram-negative bacteria (PaPVA and AtPVA) to hydrolyze 
AHL signals was evaluated to explore their possible association with quorum sensing. 
Incubation (4 h) of long chain AHLs with pure PVA enzymes showed reduction in 
bioluminescence compared to the heat-inactivated control, indicating AHL degradation. 
Activity of PaPVA was restricted to C10 and C12-HSL. AtPVA was active on a broader 
substrate spectrum (C6 to C12-HSL), although significant quenching was observed with 
the long chain AHLs, with moderate activity on C6 and C8-HSLs (Table 2). Both 
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enzymes were observed to be distinctly more active on straight chain AHLs, with 
only moderate quenching in case of oxo- or hydroxy- substituted AHLs. The activity 
of the PVA enzymes on long chain AHLs was further confirmed by monitoring the 
degradation of C10-HSL using HPLC (Figure 4).
Figure 3. (a) Tetramer structure of AtPVA. Subunits are shown in different colours. (b) Superposition 
of monomer structures of AtPVA and PaPVA. The loop extensions in PaPVA are shown in green (res-
idue numbering according to PaPVA). N-terminal cysteine (stick representation) is shown in yellow.
Kinetics of AHL degradation
For kinetic analysis, 3-oxo-C12-HSL was chosen as a representative substrate as it is a 
highly studied signal produced by P. aeruginosa and has significant clinical relevance 
[246,247]. PaPVA (18.9 µmolmin-1mg-1) exhibited 4-fold higher activity over AtPVA 
(4 µmolmin-1mg-1) with 0.2 mM 3-oxo-C12HSL as substrate, similar to the trend for 
Pen V as substrate [231]. 
AtPVA and PaPVA showed sigmoid v/[S] curves with increasing concentrations of 
3-oxo-C12-HSL, exhibiting a better fit for allosteric behaviour. However, saturation 
could not be achieved for both the enzymes as the low solubility of 3-oxo-C12-HSL in 
aqueous buffer did not permit rate measurements at concentrations higher than 0.25 
mM. A reasonable estimate of kinetic parameters calculated by applying initial values 
as constraints to the allosteric sigmoidal equation revealed similar K0.5 values but a 
significantly higher Vmax for PaPVA (Figure 5).  Apparent kcat/Km values for PaPVA 
(13.5x104 M-1s-1) and AtPVA (2.68x104 M-1s-1) were comparable to the available value 
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Table 2. Specificity of purified AtPVA and PaPVA for different AHL substrates. Remaining AHLs after 
degradation assay were detected by suitable Lux-based biosensor at 30°C for 12h. Bioluminescence 
(%RLU) is expressed relative to heat-inactivated enzyme (taken as 100%). Results are displayed as 
Mean ± SD from three independent experiments.
AHL substrate AtPVA PaPVA
C4-HSL 116.3 ± 12.3 119.6 ± 19.3
C6-HSL 81.3 ± 17.9 116.3 ± 19.6
3-oxo-C6-HSL 82.2 ± 6.3 112.4 ± 26.1
C7-HSL 112.1 ± 9.20 127.1 ± 4.7
C8-HSL 64.9 ± 8.2 100.4 ± 4.5
3-oxo-C8-HSL 90.2 ± 15.3 119.1 ± 12.0
C10-HSL 6.6 ± 1.0 8.1 ± 4.6
3-oxo-C10-HSL 45.0 ± 9.5 53.4 ± 7.44
C12-HSL 6.1 ± 1.5 5.2 ± 0.9
3-oxo-C12-HSL 66.6 ± 10.2 63.7 ± 10.2
3-OH-C12-HSL 39.5 ± 8.1 28.9 ± 7.8
Figure 4. HPLC analysis of residual C10-HSL and released HSL and decanoic acid, for AtPVA (upper 
panels) and PaPVA (lower panels) after 4h incubation with C10-HSL at 250C. Reduction of C10-HSL 
levels was corroborated with the occurrence of free HSL and decanoic acid, confirming the acylase 
activity of PVAs on C10-HSL.
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Figure 5. v/[S] curves for (a) AtPVA and (b) PaPVA showing sigmoid kinetics with 3-oxo-C12-HSL as 
substrate. Kinetic parameters are given in inset.
 
Binding of long chain AHLs to AtPVA and PaPVA
Docking studies were performed to understand the structural interactions responsible 
for the selective activity of PVAs on long chain AHLs. The mode of binding was almost 
identical in both PVAs, with the AHLs (C6-HSL, C10-HSL and 3-oxo-C12-HSL) binding 
to the active site with similar amide bond orientation and favourable binding energy 
(Figure S2, Supplementary material). However, the extent of interaction of enzyme 
residues with the substrate molecule seemed to increase with the increase in length of 
acyl chain of the AHL molecule.
The lactone ring was housed in the same pocket where the β-lactam moiety was 
bound in the case of Pen V [232] with an Asn residue (N250 in AtPVA or N271 in 
PaPVA) involved in hydrogen bonding with the NH group of the amide bond. The 
AHL acyl chain fits into a hydrophobic pocket lined primarily by the two Trp residues 
in the active site (W23, W87 in AtPVA and W21, W80 in PaPVA respectively) and 
residues from loop 2 and loop3 surrounding the active site (Figure 6). It appears that 
longer hydrophobic chains in C10-HSL and 3-oxo-C12-HSL enable greater number 
of hydrophobic interactions with the enzyme. The loop residues (Y61, L137, A138 
in AtPVA and F63, M69, L146 and A147 in PaPVA respectively) form additional 
interactions with the hydrophobic acyl chain in these substrates, probably enhancing 
the strength of binding and favourably orienting the AHL molecule in the active site. 
Better binding affinity values (estimated as glidescores) and smaller nucleophilic attack 
distances from the N-terminal catalytic cysteine (C1) to the carbonyl carbon of the 
substrate were also observed in C10-HSL and 3-oxo-C12-HSL over C6-HSL (Table 3). 
The presence of a (oxo- or hydroxy-) substituent did not effect a significant change 
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in binding orientation, although a reduction in activity was observed (Table 3). It is 
possible that a change in polarity due to the presence of a 3’ substituent might have 
caused a binding impediment. A preference for unsubstituted AHLs has also been 
observed in AHL acylases from Shewanella sp. [249] and Acinetobacter sp. [250]. 
Table 3. Properties of different AHL substrates and results of docking with AtPVA and PaPVA struc-
tures (AlogP = hydrophobicity, SA = surface area, Nadist = Nucleophilic attack distance between 
SH group of cys1 and carbonyl carbon atom of AHL).
Ligand 
(AHL)








AtPVA PaPVA AtPVA PaPVA
C6 199.3 1.133 55.4 6 1 3 -6.01 -6.46 5.15 5.19
C10 255.4 2.958 55.4 10 1 3 -6.12 -6.22 4.04 4.70
3-oxo-
C12
297.4 2.729 72.5 12 1 4 -6.98 -7.21 3.80 4.76
Figure 6. Mode of binding of 3-oxo-C12-HSL in the binding site pocket of (upper) AtPVA and 
(lower) PaPVA. The hydrophobic pocket in which the alkyl side chain fits is shown as mesh.
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Quorum quenching in P. aeruginosa by PVAs 
Exogenous addition of the PVAs into P. aeruginosa PAO1 culture was followed by 
measurement of AHL levels and monitoring of QS-regulated virulence factors and 
biofilm formation, to study their quorum quenching activity. Decrease in 3-oxo-C12-
HSL levels was apparent 6h post incubation (Figure 7a), but the accumulation of 
C4-HSL was unaffected (data not shown). This result corroborates the finding that 
both PVAs hydrolyze only long chain AHLs. 
Elastase and pyocyanin levels were also negatively influenced at 6 h after acylase 
addition (early stationary phase) (Figure 7b). Interestingly, AtPVA almost completely 
blocked the production and pyocyanin and elastolytic activity even at 5-fold lower 
concentration than PaPVA, despite PaPVA exhibiting higher activity on AHLs in 
vitro. This might be explained by a probable loss in enzyme (PaPVA) activity at pH 
7 required for P. aeruginosa growth, or proteolytic degradation of the enzymes in 
bacterial culture. Although there was comparable decrease in 3-oxo-C12-HSL levels 
in both cases after 6 h, the insufficient stability of PaPVA might have caused a delay 
in AHL degradation, giving the bacteria time to activate the QS circuit. Decrease in 
QQ-mediated attenuation of virulence over time has been observed earlier in the case 
of AhlM from Streptomyces sp. [27]. 
PVA-mediated AHL degradation also led to a moderate reduction in biofilm formation 
by P. aeruginosa (Figure 7c). Weakening of biofilm structure in P. aeruginosa has 
been linked to the disruption of the 3-oxo-C12-HSL regulated lasI/R QS system [251]. 
In addition, the therapeutic effects of PVAs in attenuation of P. aeruginosa virulence 
could be ascertained by studies on G. mellonella larvae. Simplicity of use and a positive 
correlation between P. aeruginosa virulence patterns in insects and mice make G. 
mellonella an attractive alternative infection model for anti-virulence experiments 
[125,252]. In the present study, preincubation of P. aeruginosa culture (10 cfu) with 
PVAs was observed to increase the survival rates of G. mellonella larvae after 24 
h from only 10.3 ± 7.2% in untreated infection to 73 ± 5% (AtPVA) or 53.7 ± 11% 
(PaPVA) (Figure 7d). Control injection with only MgSO4 only did not affect the 
survival of the larvae. Here too as in the in vitro assay, AtPVA turned out to be more 
efficient in attenuating virulence. Regardless, these results establish the potential 
efficacy of PVAs as QQ therapeutic agents.
4
70
Chapter 4 | Quorum quenching activity of Penicillin V acylases
Figure 7. Influence of AtPVA or PaPVA on P. aeruginosa PAO1 culture: (a) 3-oxo-C12-HSL level, (b) 
Elastolytic activity and pyocyanin production 6 h after exogenous addition of enzyme, (c) Biofilm for-
mation, (d) Survival rate in G. mellonella 24h after infection with P. aeruginosa PAO1. Larvae injected 
with MgSO4 were taken as control. Error bars indicate standard deviation.
Discussion
Enzymes active on AHLs hold great potential for application as QQ agents in clinical 
therapy as they can reduce virulence without affecting the growth of the bacteria, 
thereby diminishing the chance for emergence of resistant strains. Apart from the many 
AHL acylases and lactonases characterized so far, it has recently come to light that 
other related enzymes can promiscuously degrade the AHL signals as well, effecting 
QQ albeit at a lower rate. Examples include mammalian paraoxanases [175], porcine 
acylase [253] and PGA from Kluyvera citrophila (KcPGA) [29]. Although PVAs and 
PGAs come under the same functional ambit, they show significant differences in 
sequence and structural composition. While AHL acylases are generally homologous 
to heterodimeric PGAs and share similar active sites including an N-terminal catalytic 
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serine, bacterial PVAs are homotetrameric and evolutionarily related to BSHs with 
cysteine at the N-terminal. The heterodimeric acylase from Streptomyces avendulae 
(SlPVA) active on aliphatic penicillins and Pen V has been recently hinted to degrade 
AHLs [228], but it shares significant sequence and structural homology with the ser-
Ntn hydrolases. In the present study, the ability of cys-Ntn PVAs from Gram-negative 
bacteria to degrade long chain AHLs and attenuate QS-mediated virulence in P. 
aeruginosa has been described for the first time. Both the organisms employed in this 
study are also well-known plant pathogens that produce AHLs and employed as model 
systems to study AHL-based QS mechanisms [237]. The AiiB [254] and BlcC/AttM 
[255,256] lactonases from A. tumefaciens have been implicated in QQ; however, no 
acylase active on AHLs has been reported so far from these bacteria.  
Acylases active on AHLs have been observed to vary in their substrate specificities, 
and separate into different phylogenetic clusters [250]. Enzymes of the AAC group 
(including AAC from Shewanella sp., PvdQ from P. aeruginosa, AhlM from 
Streptomyces sp. and AiiD from Ralstonia sp.) degrade only long chain AHLs, while 
some members of the penicillin G acylase group (including QuiP and HacB from 
P. aeruginosa, and AiiC from Anabena sp.) group can act on both long and short 
chain AHLs. A newly characterized AHL acylase AmiE of the amidase family [250] 
possesses an activity preference for long chain unsubstituted AHLs similar to PVAs. 
However, the PVA enzymes shared little sequence similarity (<15%) with any of the 
known acylases active on AHLs (Figure S3, Supplementary material). In addition, 
both the PVAs explored in this study did not act on the AHL signals secreted by the 
bacteria that produce these enzymes – 3-oxo-C8-HSL of A. tumefaciens and 3-oxo-C6-
HSL of P. atrosepticum. It would be however, interesting to study whether the substrate 
spectrum of penicillin acylases would include the non-canonical aryl HSLs [257] as 
well, given that penicillins also possess aryl side chains.  
Although a structural complex of PVAs with any AHL could not be crystallized 
productively, it seems highly probable that the catalytic mechanism proceeds similar 
to other Ntn hydrolases (through a nucleophilic attack by the N-terminal residue on 
amide bond followed by formation of a tetrahedral intermediate). Docking analysis 
showed that the AHLs bind to PVA enzymes at the same site as Pen V, with the acyl 
chain housed in a hydrophobic pocket lined by Trp residues and loop 2 and 3 while 
the lactone ring interacts with residues from loop 4. Accommodation of the AHL 
acyl chains in the active site hydrophobic pocket has been illustrated in the AHL 
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acylase PvdQ [21] and KcPGA [29], while the S. lavendulae acylase also contains a 
long hydrophobic pocket to bind aliphatic penicillins that can accommodate AHLs. 
The size of the hydrophobic pocket and the conformational variations of a few critical 
residues in the binding site have been suggested to modulate the activity of different 
PGAs on AHLs [258]. Moreover, it has been demonstrated in PvdQ that mutagenesis 
of two residues (Lα146W, Fβ24Y) in the active site could change the size of the 
hydrophobic binding pocket thus effecting a change in substrate specificity from long 
chain to medium chain AHLs [248].  
PVAs occur in a diverse range of bacteria and some fungi [230], and are usually 
expressed constitutively. It has been demonstrated in V. cholerae [229] that the PVA 
expression is reduced during the induction of virulence genes by the AHL-based 
AphA/HapR QS system and expressed more at high cell densities. Moreover, long 
chain AHLs have been known to antagonize QS in organisms that use C6-C8 HSLs 
as signals, including Chromobacterium violaceum [259] and Aeromonas hydrophila 
[240]. It is therefore possible that the PVAs could be employed in the environment to 
gain a competitive advantage in a mixed species community [260], while not interfering 
with the bacterium’s own QS system. Further genomic and knockout analyses of PVA 
producing strains could help shed some light on the relevance of their QQ ability in 
microbial physiology. Nevertheless, the recent additions of many novel acylases to 
the list of AHL-degrading enzymes seem to go hand in hand with the complexity of 
AHL-based signaling mechanisms in Gram-negative bacteria. 
Importantly, the knowledge of AHL-hydrolysis activity of penicillin acylases adds 
them to the list of QQ enzymes that can be developed for clinical applications. PVA 
enzyme formulations could have great potential for the biocontrol of P. aeruginosa 
pulmonary infection in cystic fibrosis patients. A dry powder formulation of the 
enzyme could not only be directly delivered into the lungs, but also increases its shelf 
life [261]. With their broad spectrum activity, PVAs can also help attenuate virulence 
in Acinetobacter baumanii [244] and co-infections by other pathogens whose QS 
mechanisms are at least partly dependent on long chain AHLs. QQ enzymes have 
also been applied to disrupt bacterial biofilms on silicone surfaces [262]. Sustained 
QQ activity can be ensured for clinical application by enhancing protein stability (via 
directed evolution) and the use of stabilizing excipients. It is also advantageous that 
many penicillin acylases have been already optimized for industrial use with methods 
for their production on large scale; this could help in reducing development times for 
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their clinical application in QQ systems. However, their activity levels and specificity 
for AHL acyl chain length should also be studied to direct their application to specific 
pathogens. With the recent expansion in the volume of information about QS systems in 
pathogenic bacteria, the development of a battery of enzymes acting on a broad range 
of AHLs would definitely prove beneficial in tackling bacterial virulence. In addition 
to potential clinical applications, this result also encourages the further exploration of 
possible link between QQ and the natural role of PVAs for the bacteria.
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Supplementary materials
Table S1. X-ray diffraction data collection and structure model refinement of AtPVA. Values in pa-
rentheses represent outer shell.
X-ray diffraction and data collection
X-ray source (wavelength) INDUS –II (1.98 Å)
Space group P 212121
Resolution range 39.55-2.8 Å
Unit cell parameters (Å) a=50.66, b= 134.77, c = 215.07
Molecules per asymmetric unit 1 tetramer
Matthews coefficient (Å3Da-1) 2.48
Solvent content (%) 50.44%
Total no. of reflections 259813 (37088)
No. of unique reflections 37299 (5327)
Multiplicity 7.0 (7.0)
Completeness (%) 99.9 (99.9)
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Figure S1. (a) Determination of native molecular weight of AtPVA on ENrichTM 650 (BioRad) size 
exclusion column, showing tetrameric organization. Standard curve obtained using molecular weight 
markers (Biorad): Thyroglobin (670 Kda), IgG (158 KDa), ovalbumin (44 KDa), myoglobin (17 KDa) and 
vitamin B12 (1350 Da). (b) MALDI-TOF spectrum of AtPVA showing monomer molecular weight. (c) 
Relative activity of AtPVA towards various beta-lactam substrates and bile salts. Activity on Penicillin 
V was taken as 100%. 6-APA production was assayed using pDAB method and bile salt hydrolysis 
was assayed using ninhydrin method.
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Figure S2. Ligand interaction diagrams (4Å cut-off) of C6-HSL, C10-HSL and 3-oxo-C12-HSL re-
spectively with AtPVA (a-c) and PaPVA (d-f). [Colour scheme: green – hydrophobic residues, red 
– acidic residues, blue – basic residues, cyan – polar residues, solid arrows – backbone hydrogen 
bonds, dotted arrows – side chain hydrogen bonds].
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Figure S3. Neighbor-joining phylogenetic tree of acylases active on AHLs. Numbers represent 
percentage bootstrap values based on 1000 replications.
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Abstract
Pseudomonas aeruginosa is the predominant pathogen in pulmonary infections 
associated with cystic fibrosis. Quorum sensing (QS) systems regulate the production 
of virulence factors and play an important role in the establishment of successful P. 
aeruginosa infections. Inhibition of the QS system (termed quorum quenching) renders 
the bacteria avirulent thus serving as an alternative approach in the development of 
novel antibiotics. Quorum quenching in Gram negative bacteria can be achieved 
by preventing the accumulation of N-acyl homoserine lactone (AHL) signaling 
molecule via enzymatic degradation. Previous work by us has shown that PvdQ 
acylase hydrolyzes AHL signaling molecules irreversibly, thereby inhibiting QS in P. 
aeruginosa in vitro and in a Caenorhabditis elegans model of P. aeruginosa infection. 
The aim of the present study is to assess the therapeutic efficacy of intranasally instilled 
PvdQ acylase in a mouse model of pulmonary P. aeruginosa infection. First, we 
evaluated the deposition pattern of intranasally administered fluorochrome-tagged 
PvdQ (PvdQ-VT) in mice at different stages of pulmonary infection by in vivo imaging 
studies. Following intranasal instillation, PvdQ-VT could be traced in all lung lobes 
with 42 ± 7.5 % of the delivered dose being deposited at 0 hour post bacterial-infection, 
and 34 ± 5.2 % at 72 hours post bacterial-infection. We then treated mice with PvdQ 
during lethal P. aeruginosa pulmonary infection and that resulted in a five-fold 
reduction of lung bacterial load and a prolonged survival of the infected animals with 
the median survival time of 57 hours in comparison to 42 hours for the PBS-treated 
group. In a sublethal P. aeruginosa pulmonary infection, PvdQ treatment resulted in 
less lung inflammation as well as decrease of CXCL2 and TNF-α levels at 24 hours 
post-bacterial infection by 15% and 20%, respectively. In conclusion, our study has 
shown therapeutic efficacy of PvdQ acylase as a quorum quenching agent during P. 
aeruginosa infection.
81
Chapter 5 | PvdQ attenuates P. aeruginosa virulence in pulmonary infection model
Introduction
Pseudomonas aeruginosa is an opportunistic Gram negative bacterium that is mainly 
associated with hospital-acquired infections and known as the major pathogen in 
cystic fibrosis (CF) patients [263]. Nearly all pulmonary P. aeruginosa infections in 
CF patients will develop into chronic, persistent infections that require aggressive 
antibiotic treatments [13]. The intrinsic traits of this bacterium coupled with complex 
adaptive behaviors such as biofilm formation make it resilient to many antibiotic 
treatments [264]. All of these elements propelled P. aeruginosa into a significant 
multidrug-resistant pathogen worldwide. 
In numerous pathogens, production of bacterial virulence determinants is tightly 
regulated in a cell density-dependent manner, aided by a quorum sensing (QS) signaling 
system [265]. By detecting the accumulation of signal molecules, each individual cell 
is capable of sensing the population density and subsequently responds by producing 
an arsenal of virulence factors when a critical population mass is reached [36]. The 
most studied signaling molecules in Gram-negative bacteria are N-acyl homoserine 
lactones (AHLs) [266]. The AHLs are produced by AHL-synthases (e.g. LuxI-type 
family) and sensed by transcriptional regulators (LuxR-type family) [265]. The core 
of QS in P. aeruginosa consists of two LuxRI-based signaling systems that work in a 
hierarchal fashion, namely LasRI and RhlRI with 3-oxo-C12-HSL and C4-HSL as their 
respective cognate AHL [14]. Deletion of either the AHL synthases or AHL receptors 
resulted in a downregulation of QS-regulated virulence factors, such as rhamnolipids, 
elastase protease, pyocyanin siderophore and biofilm formation [267,268]. These QS 
mutants are less pathogenic in animal models in comparison to the wild-type [269,270], 
revealing the importance of this system for establishing successful infections. These 
findings opened up a possibility of attacking QS system as a new antivirulence drug 
therapy.  
QS inhibition (termed quorum quenching, QQ) can be performed by employing 
small molecule inhibitors to block the AHL productions or to avoid the interaction 
between AHLs and the response regulators. Bioactive compounds isolated from natural 
sources, or ones that are synthetized chemically, have shown therapeutic efficacy as 
QS inhibitors both in vitro and in vivo [181,187,188,204,271]. However, some well-
known small molecules QS inhibitors (QSIs), such as patulin and furanones, are toxic 
for mammals [272,273] diminishing their potential for use humans. Another obvious 
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approach for QS inhibition is by preventing accumulation of signal molecules by means 
of enzymatic degradation [166]. So far, three classes of enzymes have been identified 
that are known to inactivate AHLs, namely (i) AHL-lactonases (that cleave the ester 
bond in the homoserine lactone (HSL) ring moiety [170,274]), (ii) AHL-acylases (that 
irreversibly hydrolyze the amide bond between the acyl chain and HSL [164]), and 
the least studied (iii) AHL-oxidoreductases (that modify the 3-oxo-substituents of the 
AHLs [22]). 
Numerous AHL-inactivating enzymes (QQ enzymes) were characterized, but only 
lactonase has been tested for its efficacy in mammalian models of pulmonary infection 
[275,276]. Due to the large size of the enzyme molecules, the only possible route 
of administration is via the upper respiratory tract. Combining the procedures of 
establishing the infection and delivering the drug via the upper respiratory tract is 
challenging to be performed in small animals. Therefore, the recent study on the 
administration of an AHL-lactonase was done in rats using intubation of trachea. It 
successfully reduced mortality in the rat model of pneumonia [276]. However, there 
is yet no study that employs a non-invasive drug administration method that closely 
mimics the actual procedure in human. 
The purpose of our study was to determine the efficacy of one of the other AHL-
inactivating enzymes, an AHL-acylase that was instilled intranasally in a mouse 
model of pulmonary P. aeruginosa infection. Our enzyme of interest is PvdQ acylase, 
a periplasmic enzyme from P. aeruginosa that is suggested to be involved in the 
maturation of pyoverdine siderophore [32]. Beside this function, PvdQ is a well-studied 
AHL-hydrolyzing enzyme, with specificity to long chain AHLs [21,31]. PvdQ, either 
overexpressed in, or exogenously supplemented to P. aeruginosa, could significantly 
attenuate the virulence production, both in vitro [31], and in vivo in a Caenorhabditis 
elegans model [33]. In this report, we show results of PvdQ acylase deposition in the 
respiratory tract after intranasal administration and its efficacy in lethal and sublethal 
models of pulmonary P. aeruginosa infection.
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Materials and Methods
Bacterial strains and growing condition
Enzymatic hydrolysis of long chain AHL was monitored by employing a reporter 
strain E. coli pSB1075 (AmpR) [225]. Determination of PvdQ inhibition strength was 
performed by reporter strains P. aeruginosa PlasB::lux [277] and PrhlA::lux (TetR) 
(this study). P. aeruginosa PAO1 was obtained from Barbara Iglewski (University of 
Rochester Medical Center, Rochester, NY) [31]. The overnight cultures of the biosensors 
were prepared by inoculating a loop of frozen glycerol stock in Luria Bertani (LB) 
medium, followed by incubation at 370C, 200 rpm. For the animal experiments, P. 
aeruginosa PAO1 from a frozen glycerol stock was grown in Pseudomonas isolation 
agar (PIA) selection medium (BD Difco™) overnight at 370C. A single colony was 
used to inoculate a 100 mL LB medium in a 250 mL erlenmeyer flask, at 370C, 200 
rpm for 18 hours. When necessary, 100 µL/mL tetracycline or 50 µL/mL ampicillin 
was added to the media. 
Preparation of PvdQ
Production and purification of PvdQ
PvdQ was produced and purified as reported previously [21], with modifications. E. coli 
DH10B harboring pMCT_pvdQ was grown in 2xTY medium with chloramphenicol 
supplementation (50 µg/mL) for 30 hours at 300C, 200 rpm. The harvested cells were 
sonicated in a three times volume of lysis buffer (50 mM Tris Cl pH 8.8; 2 mM EDTA), 
followed by centrifugation at 17.000 rpm for 1 hour. The clear lysate was applied to an 
anion exchange HiTrap Q-sepharose column and the flowthrough containing PvdQ was 
collected. After adjusting the ammonium sulfate concentration to 750 mM, the solution 
containing PvdQ was applied to a phenyl sepharose column. PvdQ eluted at the end 
of the 1000 to 0 mM ammonium sulfate gradient. The buffer was exchanged into 50 
mM sodium phosphate pH 6.5 and the sample was applied to a HiTrap Q-sepharose 
column. The collected flowthrough was subsequently concentrated and applied to a 
gel filtration superdex 16/60 75. A major peak containing PvdQ was collected, snap 
frozen and stored at -800C until further use. All protein chromatography columns were 
obtained from GE Healthcare Life Sciences. 
Endotoxin removal from the purified PvdQ
For animal experiments, endotoxin contamination in purified PvdQ was eliminated 
using a Pierce™ High Capacity Endotoxin Removal Resin (Thermo Scientific) 
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following the manufacturer’s manual. To adjust the PvdQ concentration, an endotoxin-
free PBS buffer (Millipore, Merck) was used. The endotoxin content of purified PvdQ 
was analyzed with the LAL test at the University Medical Center Groningen, the 
Netherlands. 
Fluorochrome labeling of PvdQ 
For the purpose of the PvdQ deposition study in mice, PvdQ was labelled with 
VivoTag 680 XL Fluorochrome (Perkin Elmers). 0.5 mg PvdQ (1 mg/mL) was labelled 
according to the manufacturer’s manual. The calculated degree of labelling was 2, 
indicating that in average 2 dye molecules were coupled to one molecule of PvdQ.
In vitro quorum quenching activity of PvdQ
Enzymatic activity of PvdQ in hydrolyzing 3-oxo-C12-HSL
The enzymatic activity of PvdQ in deacylating 3-oxo-C12-HSL (Cayman Chemical) 
was validated using a bioassay procedure as previously described [28]. E. coli JM109 
(pSB1075) biosensor that emits luminescence in the presence of long-chain AHLs 
was employed to detect the remaining 3-oxo-C12-HSL. Briefly, 2 µL of 0.5 mg/mL 
3-oxo-C12-HSL in acetonitrile was spotted onto a flat-bottom µClear white microplate 
(Greiner Bio-One) and incubated at the room temperature until the acetonitrile 
evaporated. The remaining AHL was solubilized in 100 µL PBS buffer pH 7.4 
containing 5 µg of PvdQ. A control reaction was prepared in identical conditions using 
heat-inactivated PvdQ. After 4 hours at 300C with slow agitation, 100 µL of the 100 
times diluted overnight biosensor was added to each well. The emitted luminescence 
and the bacterial growth (OD600) were monitored in a FLUOstar Omega platereader 
(BMG Labtech).
Quorum quenching activity of PvdQ in P. aeruginosa reporter strains
The following assays were performed to determine the quorum sensing inhibition 
activity of PvdQ by employing P. aeruginosa biosensors. P. aeruginosa PrhlA::lux 
and PlasB::lux each containing a chromosomal insertion of a luciferase gene under 
the control of a rhlA rhamnolipid promoter or a lasB elastase promoter, respectively 
[277]. Twofold serial dilutions of PvdQ in PBS (100 µL) were made in a flat-bottom 
µClear white microplate (Greiner Bio-One), covering PvdQ concentration of 0-16 
µM. Overnight cultures of the biosensors were diluted 100 times in LB, and 100 µL 
was added to the wells containing PvdQ. The emitted luminescence and the bacterial 
growth (OD600) were monitored in a FLUOstar Omega platereader (BMG Labtech).
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Epithelial cell viability assay
The effect of PvdQ on the cell viability was assessed in the lung epithelial cell lines 
A549 and H460. Serial twofold dilutions of PvdQ with a maximum concentration 
of 10 µM were added to 105 cells, followed by incubation at 370C for 48 hours. The 
level of cell proliferation was determined by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS salt, Promega) 
proliferation assay according to the manufacturer’s manual.
Preparation of the agarose-embedded bacteria
One day prior to infection of animals, P. aeruginosa PAO1 was embedded in agarose 
as explained elsewhere [278,279], with modifications. Cell pellets from 100 mL 
overnight culture of P. aeruginosa PAO1 were washed twice with a sterile PBS, and 
were resuspended in 5 mL LB. A volume of 1 mL bacterial suspension was added 
to 10 mL 1.5% sterilized, pre-warmed (48-500C) agarose (Type I Low EEO, Sigma-
Aldrich) and mixed thoroughly. To prepare sterile agarose beads, a sterile LB medium 
was added to the agarose solution. The mixture was pipetted dropwise into the center 
of stirred vegetable oil (200 mL) that was equilibrated at ~500C. The stirring was kept 
at 1500 rpm for 6 minutes at ~500C. Afterwards, the emulsion was stirred slowly at 
40C for 20 minutes, followed by incubation on ice for 20 minutes. 100 mL oil in the 
top layer was discarded, and the remaining agarose beads were washed with PBS, 
followed by centrifugation in a swinging bucket rotor at 2700 x g, 40C for 15 minutes. 
The beads were subsequently washed one time with 0.5% sodium deoxycholic acid 
(SDC, Sigma-Aldrich) in PBS, one time with 0.25% SDC, and 4 times with PBS. After 
the last wash, PBS was added to the agar beads in a ratio of 2:1. The agarose beads 
slurry was stored at 40C prior to use the following day. A homogenized aliquot of the 
agarose beads was serially diluted and plated onto PIA medium, followed by incubation 
at 370C for 24 hours. Based on the counted colony forming unit (CFU) on PIA plates, 
the original agarose beads slurry was adjusted with PBS to 1.25 x 107 CFU/mL (lethal 
dose) or 6.25 x 106 CFU/mL (sublethal dose) and 40 µL of the bacterial preparation 
was administered per animal.
Animal experiments
Animal experiments were conducted in accordance with the Dutch Animal Protection 
Act and were approved by the Netherlands National Committee for the protection of 
animals used for scientific purposes (DEC6692, AVD105002017854). The experiments 
were performed in a BSL-2 area in the Central Animal Facility (CDP) of the University 
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Medical Center Groningen (UMCG). Female BALB/c mice aged 11-12 weeks old 
with a minimum weight of 20 grams (at the start of experiment) were purchased from 
Charles River, France. Groups of 4-6 mice were housed in individual ventilator cages 
with unrestricted access to food and water. Infected animals were placed in cages with 
warming pads at the bottom of the cage.
Infection procedure and intranasal PvdQ administration
The procedure for developing pulmonary infection in our study was a combination 
between intratracheal instillation of bacteria at the start of the experiment, and a daily 
intranasal delivery of the drug.
Intratracheal instillation of bacteria
Sterile agarose beads or agarose beads laden with P. aeruginosa PAO1 were instilled 
into the lungs via nonsurgical intratracheal administration [280,281]. Mice were 
anesthetized by isoflurane inhalation and the depth of anaesthesia was checked by the 
foot reflex towards pinching. Mice were then placed vertically by the upper teeth on 
an intubation stand, with continuous anaesthesia through a nose cone. Cold light was 
placed in front of the throat and the tongue was retracted to the side using forceps. 
When the trachea was visualized, a disposable sterile intravenous G20 catheter (BD 
Insyte-W) with an adjusted length was inserted into the trachea. To confirm that the 
catheter was indeed inside the trachea, a ventilator (Harvard Minivent) was connected. 
Correct catheter placement will show the chest, but not the abdomen, moving in 
synch with the ventilator’s programmed rate. Afterwards, 40 µL of agarose beads 
were carefully administered into the catheter, followed by blowing 200-400 µL of 
air into the catheter to ensure that all beads were delivered into the lungs. While the 
animal was still under anaesthesia, a transponder microchip (IPTT-300, BMDS) for 
temperature measurement was implanted subcutaneously. This transponder allows 
body temperature measurement with a portable reader device (DAS-7006s, BMDS) 
by scanning the mice without direct contact. The mice were weighed daily and their 
general appearance (body temperature, coat condition, behaviour and locomotion) was 
monitored 2-3 times a day. At designated time points, the mice were anesthetized with 
isoflurane and euthanized by cardiac exsanguination. Blood, bronchoalveolar lavage 
fluid, kidney, spleen, and lungs were collected aseptically from the animals.
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Intranasal PvdQ administration
Mice were lightly anesthetized with isoflurane, and held in a ~600 inclined supine 
position. Subsequently, 50 µL PvdQ was instilled dropwise onto the nose of the 
anesthetized animal. The control group (PBS-treated) received an intranasal 
administration of 50 µL PBS.
Study design
The in vivo study consisted of three parts: Study 1. Mouse tolerance of PvdQ; Study 
2. In vivo imaging to monitor deposition of intranasally administered PvdQ; Study 3. 
An efficacy study of PvdQ in a mouse pulmonary infection model. 
Study 1. Mouse tolerance of the intranasally administered PvdQ
To determine tolerance of PvdQ, groups of mice were intratracheally challenged with 
sterile agarose beads and received a daily intranasal administration of PvdQ (25 ng/g 
and 250 ng/g body weight) or PBS. Animals from each group was sacrificed at 24, 48 
or 72 hours after the first intranasal administration for analysis of immune responses 
or inflammation. Experiments were performed in duplicate, totaling to 4 animals per 
group.
Study 2. In vivo imaging to monitor deposition of intranasally administered PvdQ
As PvdQ is a protein, special attention was given to proper delivery to the location 
of infection, i.e. the lungs. Deposition of intranasally administered PvdQ in airways 
of mice was examined by employing a VivoTag 680XL-labelled PvdQ (PvdQ-VT). 
Groups of animals were infected with a sublethal dose of P. aeruginosa PAO1 and 
received 50 µL of 1 mg/mL PvdQ-VT intranasally at 0 and 72 hours post bacterial 
inoculation. The animals were allowed to recover for 5 minutes after PvdQ-VT 
administration, followed by in vivo imaging as previously described [282]. First, the 
animal was placed in a Fluorescence Molecular Tomography (FMT, PerkinElmer, 
Waltham, USA) that permits localization of PvdQ-VT in a three-dimensional visual 
of the animal. The fluorescence was measured at an excitation wavelength of 660 
nm and an emission wavelength of 680 nm. Next, the animal was sacrificed and the 
isolated lungs were placed on a petri dish, followed by visualization in the In Vivo 
Imaging System (IVIS® Spectrum, PerkinElmer, Waltham, USA). The fluorescence 
was measured at an excitation wavelength of 675 nm and an emission wavelength of 
720 nm. The acquired data from FMT and IVIS were analyzed by TrueQuant™ v3.1 
software and Living Image® Software v3.2, respectively. The relative deposition of 
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PvdQ-VT in a certain region of interest was calculated by dividing the fluorescence 
intensity in the region of interest by intensity of the total area times 100%. Experiments 
were performed in duplicate, totaling to 6 animals per group.
Study 3. Efficacy of PvdQ in a mouse pulmonary infection model
The efficacy of PvdQ as a quorum sensing inhibitor was assessed in a lethal (n=6 per 
group) and a sublethal pulmonary infections with P. aeruginosa PAO1. Groups of 
infected animals received a daily intranasal administration of PvdQ (25 ng/g and 250 
ng/g body weight) starting immediately after bacterial inoculation. At 24 and 48 hours, 
mice were sacrificed for quantitative analysis of bacteriology, immune responses and 
histopathological analysis, unless otherwise stated. Efficacy test in the lethal infection 
was performed as one experiment (n=6 per group), while experiments for the sublethal 
infection were performed in triplicate, totaling to 22-23 animals per group.
Analysis of animal samples
Bronchoalveolar lavage
For bronchoalveolar lavage (BAL), the lungs were flushed three times with a total 
volume of 2 mL PBS supplemented with protease inhibitor (cOmplete™, EDTA-
free Protease Inhibitor Cocktail, Roche). Cytospin preparations from 100 µL of 
unprocessed BAL fluid sample were stained with May Grünwald and Giemsa staining 
for differential cell counts. Levels of TNF-α and CXCL2 in the cell-free supernatant of 
BAL fluid (600 rpm slow acceleration, room temperature for 5 minutes) were measured 
by ELISA in accordance to the manufacturer’s instructions (Duoset, R&D systems). 
Quantitative Bacteriology
Isolated lungs were homogenized in 5 mL PBS using a mechanical homogenizer 
(IKA-RW15 potter system). Blood, BAL fluid and serial dilution of lung homogenates 
were plated on the selective media Pseudomonas Isolation Agar (PIA) for quantitative 
bacteriology.  
Histopathology
Lungs were inflated with cryocompound (Klinipath) and fixed in 4% formaldehyde 
(Sigma-Aldrich) overnight. Afterwards, the lobes were separated and trimmed prior to 
paraffin-embedding (Ruehl-Fehlert et al., 2004). Sections of 3-4 µm were stained with 
haematoxylin and eosin (Sigma-Aldrich). 10-15 areas of the lung sections were scored 
blinded for peribronchial infiltrates and alveolar involvement at a 40x magnification 
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using an adapted histological scoring system (Table 1) (Bayes et al., 2016) that was 
originally mentioned in Dubin et al. (Dubin and Kolls, 2007).
Table 1. Histological scoring system for lung inflammation in infected animals
Score Peribronchial infiltrate Alveolar involvement
0 None None
1 Low (infiltrate ≤ 4 cells thick) Low (<25% examined lung with increased cellularity/thickening)
2 Medium (infiltrate 5-10 cells thick) Medium (25-50% examined lung with in-creased cellularity/thickening)
3 High (25-50% visualized lumen) High (>50% examined lung with increased cellularity/thickening)
4 Diffuse (>50% visualized lumen)
Statistical analysis
Comparisons between two groups were carried out using Mann Whitney U (non-
parametric data). Survival graph was created using the method of Kaplan-Meier, and 
the comparison of survival between groups was analyzed by the χ2 test. Statistical 
analysis was performed using Graphpad Prism version 5 or SPSS statistics version 25. 
A probability value (P) ≤ 0.05 was considered statistically significant. 
Results
In vitro study of PvdQ
Purified PvdQ is active and quenches the virulence of P. aeruginosa biosensors in a 
dose-dependent manner
PvdQ was purified with a yield of 30 mg L-1 of cell culture. The protein was >95% pure 
judged from SDS PAGE with a Coomassie blue staining (Figure S1, Supplementary 
material). Purified PvdQ for animal experiments underwent an endotoxin removal step, 
resulting in a final endotoxin level of 1.6 EU/mg PvdQ, well below the recommended 
limit for endotoxin in preclinical research [283]. The endotoxin removal procedure 
did not affect the AHL-hydrolyzing activity of PvdQ (Figure S2, Supplementary 
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material), as shown by the equal degradation of 3-oxo-C12-HSL substrate in both 
enzymatic reactions.   
Effectivity of PvdQ in attenuating virulence of P. aeruginosa was monitored by 
employing biosensors with a chromosomal integration of a luciferase gene controlled 
by the QS-regulated lasB promoter or rhlA promoter. Emitted luminescence reflects 
activation of the quorum sensing system, thus the amount of produced light is inversely 
proportional to the inhibitory strength of PvdQ. The chosen PvdQ doses did not affect 
growth of the biosensors. Dose-response curves were created by plotting the response 
of the biosensors as a relative luminescence unit per cell density (Figure 1). The IC50 
value could not be calculated since complete signal abolishment was not reached. 
We could not test a higher concentration of PvdQ to reach a greater signal reduction, 
because PvdQ precipitates at concentrations above 4 mg/mL. 
Figure 1. Dose-response curve of PvdQ acylase. Biosensors (a) P. aeruginosa rhlA::lux and (b) P. 
aeruginosa lasB::lux were incubated with various concentration of PvdQ, as follows: 16 µM (l), 8 
µM (n), 4 µM (p), 2 µM (q), 1 µM (¿), µµM (¡), 0.25 µM (£) and 0 µM (Í).
Purified PvdQ does not affect the viability of epithelial cell lines
The toxicity of PvdQ to mammalian cells was assessed in vitro, using A549 and 
H460 human epithelial cell lines. Incubation of cells with up to 10 µM PvdQ for 
48 hours did not affect the number of viable cells in comparison to control without 
PvdQ treatment (Figure S3), suggesting that PvdQ exhibits minimal to no cytotoxicity 
towards epithelial cells.
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Validation of the animal model and PvdQ administration procedure
The mouse infection model
In principle, the severity of infection in the model depends on the bacterial inoculation 
dose and the stress level experienced by the animals. In our procedure, the infected 
animals were receiving a daily administration of PvdQ via intranasal route. Based on 
pilot experiments, we found that an inoculation dose lower than 105 CFU/lungs resulted 
in no development of infection, whereas an inoculation dose of 106 CFU/lungs resulted 
in a severe infection. For the present study we therefore adjusted the inoculation dose to 
2.5x105 CFU/lungs as a sublethal dose and to twice that amount (5x105 CFU/lungs) as 
a lethal dose. Due to the high discomfort in the lethal infection, the PvdQ distribution 
study was only performed in the sublethal infection model, while the efficacy of PvdQ 
was investigated in both levels of infections.
Study 1. Mouse tolerance of intranasally administered PvdQ
Our studies with mammalian epithelial showed that PvdQ was not toxic to these 
cells in vitro. Based on these results we performed the first part of an in vivo study to 
further ensure safety of intranasally administered PvdQ in mice. Tolerance of non-
infected mice to intranasally administered PvdQ was determined with 2 doses of PvdQ 
(25 ng/g and 250 ng/g per animal). Both doses did not induce breathing difficulties, 
inactivity, poor posture or a drop of body temperature. Mild fluctuations of body 
weight were observed, with an average of 4% increase or decrease from the initial body 
weight, which was comparable to the control group receiving sterile beads and a daily 
intranasal PBS administration. Lungs harvested at 24, 48 and 72 hours after the first 
PvdQ administration showed no macroscopic injury. Histological examination of lungs 
72 hours after PvdQ administration showed no inflammatory lesions or abnormalities 
(data not shown). 
Study 2. In vivo imaging to monitor the deposition of intranasally administered 
PvdQ
A fluorochrome-tagged PvdQ (PvdQ-VT) was used to ascertain the deposition of 
the intranasally administered PvdQ-VT in mouse lung tissue. To determine whether 
infection influences enzyme deposition, PvdQ-VT was intranasally administered to 
infected animals at different stages of infection (0 and 72 hours post-infection) followed 
by in vivo imaging analyses. The Fluorescence Molecular Tomography (FMT) allows 
a three-dimensional visualization of the whole animal and the typical result is shown 
in Figure 2a. PvdQ-VT could be traced along the respiratory tract of the animals and 
5
92
Chapter 5 | PvdQ attenuates P. aeruginosa virulence in pulmonary infection model
Figure 2. Typical imaging results of animals after intranasal administration of PBS (control, left 
panel) or PvdQ-VT at different stages of infection (middle and right panels). (a) Results from FMT; 
(b) Results from IVIS. Upper panels show intact lungs, while lower panels show the separated lobes 
in the following order (starting on top going clockwise): trachea (T), left lung (LL), post-caval lobe 
(PL), inferior lobe (IL), middle lobe (ML) and superior lobe (SL). 
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42±7.5 % of the delivered dose was deposited in the lungs at 0 hour post-infection. 
At 72 hours post-infection, a slightly lower lung deposition was observed (34 ± 5.2 
%, n.s. compared to 0 hour post-infection), and the majority of PvdQ-VT was found 
in the upper respiratory tract and the head. Afterwards, the lungs were isolated for a 
more thorough visualization in the In Vivo Imaging System (IVIS) and typical data 
are shown in Figure 2b. PvdQ-VT can be found in all lung lobes with a nearly equal 
distribution between the right lobes (combined, 47 ± 10.7 %) and the left lobe (53 ± 
10.7 %) at 0 hour post-infection. However, at 72 hours post-infection, the distribution 
was shifted with the left lobe containing slightly more (60 ± 8.8 %) than the right 
lobes (40 ± 8.7%).
Efficacy of PvdQ in a mouse model of pulmonary infection 
Study 3. (i) Treatment with PvdQ results in a longer survival time and higher 
bacterial clearance during lethal pulmonary infection 
Having established a pulmonary infection model and the safety of the PvdQ treatment, 
the next step was to investigate efficacy of PvdQ treatment in this infection model. 
Treatment of lethally infected animals with PvdQ (25 ng/g) resulted in a five-fold lower 
bacterial load for the PvdQ-treated groups than for the PBS-treated group at the end 
of experiment (P = 0.0465, Figure 3a). Furthermore, the PvdQ treatment significantly 
prolonged the survival time, with a median survival time of 57 hours as compared to 42 
hours in the PBS-treated animals (P = 0.004, Figure 3b). The same extent of efficacy 
was observed with the treatment of 250 ng/g PvdQ (data not shown).
Figure 3. Effects of PvdQ treatment in a lethal P. aeruginosa infection mouse model (n=6 animals). 
(a) PvdQ treatment results in a lower load of P. aeruginosa in infected animals as compared to 
PBS-treatment. The bacterial count was obtained 42-60 hours post-bacterial infection. The box 
and whiskers respectively represent 25th to 75th percentiles, and range of the data. The horizontal 
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Study 3. (ii) PvdQ treatment results in less lung inflammation in a model of sub-
lethal pulmonary infection 
Inoculation with a sublethal bacterial dose resulted in a moderately severe infection, 
with no mortality as a consequence. Using this model, the efficacy of PvdQ treatment 
was assessed within 48 hours post-infection by performing multiple analyses, including 
quantitative bacteriology, analyses of immune responses and histopathological analysis. 
No significant differences were observed in bacterial load between the PvdQ-treated 
group and the PBS-treated group at 24 or 48 hours post bacterial-infection (Figure 
S4). No bacteria were found in the blood, spleen or kidney, indicating that the infection 
was restricted to the lungs. 
Figure 4. Lung histology scores of lungs of mice treated with PBS (●) or PvdQ (n) at 24 hours and 
48 hours post bacterial-infection in a model of sublethal pulmonary infection with P. aeruginosa. 
Three animals were sacrificed from each group at each time point. The graph represents mean and 
standard deviation. 
Histopathological analysis of lung tissue showed milder inflammation in the PvdQ-
treated group than in the PBS-treated group 24 and 48 hours post-infection (Figure 
4). Lung tissue of mice treated with PBS showed a higher level of lung injury with 
diffuse inflammation and swollen alveolar walls, while mice treated with PvdQ showed 
only small restricted lesions and hardly any alveolar involvement (Figure 5). In line 
with this finding, the levels of CXCL2 and TNF-α in BAL fluid of PvdQ-treated mice 
were significantly lower compared to PBS-treated mice at 24 hours post-infection. 
At 48 hours post-infection the levels of immune response indicators were similar 
between both groups and almost back to the levels found in non-infected animals 
(Figure 6). The total number of inflammatory cells in BAL fluid of PvdQ and PBS-
treated animals was higher as compared to non-infected animals (Figure S5.A), but 
no differences were seen between PBS- and PvdQ-treated animals. In addition, the 
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number of neutrophils in BAL fluid was assessed, but again no differences were seen 
between PBS and PvdQ treatment (Figure S5.B). The same extent of efficacy was 
observed with the treatment of 250 ng/g PvdQ (data not shown).
Figure 5. Histological examination of lung tissue of animals infected by sublethal P. aeruginosa 
doseand treated with either PBS or PvdQ at 48 hours post-bacterial infection. Upper panels rep-
resent images of H&E stainings at 20x magnification, and the areas marked with rectangular are 
shown in 200x magnification in the lower panels. 
Figure 6. Amounts of A. CXCL2 and B. TNF-α in cell-free BAL fluid from the infected animals 
treated with PBS (black bars) or PvdQ (white bars). The level of both CXCL2 and TNF-α of PvdQ 
treatment group was lower in comparison to the PBS-treated group at 24 hours post-infection. 
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Discussion
P. aeruginosa infection is a growing problem in the healthcare, as well as being the 
predominant pathogen in pulmonary infections of cystic fibrosis patients. Multiple 
factors are contributing to the tenacity of P. aeruginosa as a human pathogen, including 
its remarkable adaptability that allows this bacterium to establish a successful infection 
and to escape antibiotic treatments. In the wake of the antibiotic resistance problem, 
relatively much attention has been given to the study of quorum sensing inhibitors 
(QSIs) as novel antibacterial candidates [19,164,166]. They fall into the category 
of antivirulence drugs that generate less selective pressure for evoking resistance 
in comparison to conventional antibiotics. AHL-hydrolyzing enzymes prevent 
accumulation of AHLs and the QQ effects by some of these enzymes are evident in 
infection models. Nevertheless, the number of the documented studies in mammals 
is relatively small, given the abundance of the characterized QQ enzymes. The first 
study in a pulmonary infection model was conducted by Migiyama and colleagues, 
showing that a P. aeruginosa strain overexpressing AiiM lactonase is less virulent than 
the wild-type [275]. This finding was followed by a report from Hraiech and colleagues 
who employed a purified SsoPox-I lactonase as a therapeutic agent in a lethal P. 
aeruginosa pulmonary infection model in rats [276]. The purified SsoPox-I lactonase 
was administered through the intubation of the exposed trachea and could reduce the 
mortality of the infected animals. Although these studies excellently demonstrated 
the therapeutic value of AHL-hydrolyzing enzymes, there is yet no study using a non-
invasive administration route of the enzymes that closely mimics the possible drug 
administration route in human. In the present study, we have shown that PvdQ is well-
tolerated by human lung epithelial cell lines, indicating that PvdQ has minimal or no 
cytotoxic effects on human cells. Furthermore, intranasally administered PvdQ acylase 
is well tolerated and distributes well in lung tissue of mice, even during infection. 
Most importantly, intranasally administered PvdQ acylase alleviates P. aeruginosa 
pulmonary infection in mice, which may lead to faster resolution of the infection. 
Prior studies have confirmed that supplementation of PvdQ to cultures of P. aeruginosa 
inhibits accumulation of 3-oxo-C12-HSL and in turn blocks production of elastase and 
pyocyanin [31]. Furthermore, PvdQ showed a therapeutic effect in a C. elegans model 
of P. aeruginosa infection [33]. In order to test the preclinical efficacy of PvdQ in a 
more relevant animal model, we developed a mouse model combining the P. aeruginosa 
pulmonary infection with an administration procedure that can be translated to the 
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human situation. A pulmonary infection model is very challenging to be developed 
in mouse [279], even more so when the infection is combined with a topical drug 
administration method. Lung-targeted delivery systems of large molecules in animal 
can be performed via pulmonary inhalation by different procedures, such as passive 
inhalation of aerosolized drugs (whole body, head-only or nose-only exposure system), 
direct intratracheal administration or intranasal administration [284]. Arguably, among 
these methods, a nose-only aerosol system would be of highest resemblance to that of 
in human, such as the inhalation of aerosolized DNAse Pulmozyme® for cystic fibrosis 
patients. However, the major drawback of this method is the requirement of highly 
accurate instruments, an ample amount of drugs, and a long exposure time (30-45 
minutes) that could subject the infected animals to high level of stress. Intranasal 
delivery is one of the most common, and the least intrusive method for this purpose 
[284,285], hence it was chosen as the drug administration procedure in our experiment. 
Despite its simplicity, the downside of this intranasal delivery is the difficulty in 
controlling the dose deposition efficiency, because the drugs have to travel all the way 
through the upper respiratory tract before finally reaching the lungs. 
Lung deposition efficiency from intranasal administration of fluorochrome-tagged 
PvdQ (PvdQ-VT) at 0 hour post bacterial-inoculation is in concordance to the study of 
Eyles and colleagues. They observed 48±12.1% of radiolabeled 7-µm-diameter polymer 
microspheres in the healthy mouse lungs after an intranasal challenge [286]. In our 
study, the reduced lung deposition efficiency at the later stage of infection might be 
a repercussion of lung function deterioration caused by bacterial infection, such as a 
decrease of the inspired air volume as seen in other studies [287,288]. At 72 hours 
post-bacterial infection, a shift of deposition towards the left lobe was observed. This 
finding is presumably related to the structural changes experienced by each lobe. 
However, to explain specific regional functions of the lungs, further research with 
a more elaborate function-related physiology study (e.g. determination of airspace 
diameters) is required.   
The efficacy of PvdQ was assessed in mouse models with different levels of infection 
lethality. PvdQ administered via an intranasal route during lethal infection resulted in 
a lower bacterial load in the lungs, demonstrating a role of PvdQ in promoting bacterial 
clearance (Figure 3). Since the delivered PvdQ is a sub-MIC dose that did not affect 
bacterial growth in vitro and in a C. elegans infection model, we strongly believe that 
PvdQ does not clear the infection itself but is helping the immune system by disarming 
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the bacteria in the mouse infection model. As a result of the lowered bacterial load, 
survival time of PvdQ treatment group was increased, in agreement with other murine 
studies of AHL-lactonases AiiM [275] and SsoPox-I [276]. In addition, our results also 
corroborate with the findings from animal studies of small molecule QSIs, such as 
furanone, patulin and garlic extracts [188,198,204]. However, some of these QSIs such 
as patulin and furanone are known to be toxic for mammals [272,273]. In addition, the 
small molecule QSIs having intracellular targets are prone to development of resistance 
via upregulated efflux pumps [289]. The median survival after PvdQ treatment is longer 
than shown for the group of animals receiving a deferred SsoPox-I lactonase treatment 
(45 hours) in the study of Hraiech and colleagues [276]. Direct comparisons with the 
group receiving an immediate treatment is not possible because the median survival 
cannot be calculated from their data as they stopped their observation after 50 hours 
post-bacterial infection. The fact that our mice eventually were still dying even though 
the bacterial load is lower, may be related to an overwhelming inflammatory response. 
The high bacterial load may induce an excess of inflammatory responses that cannot 
be counteracted by PvdQ disarming virulence factors anymore.  
In order to perform an extensive analysis of immune responses, we extended our study 
with a more thorough examination during a sublethal infection. The experimental 
setup was similar to that of the lethal infection, but with a smaller bacterial inoculum. 
Consequently, the sublethal infection was milder and the defense mechanisms 
themselves could clear the infection, resulting in a 1000-fold lower bacterial CFU 
in comparison to the lethal infection. The treatment with PvdQ in the sublethal P. 
aeruginosa infection did not lead to a lower bacterial count in comparison to the PBS-
treated group (Figure S4) but resulted in less lung inflammation (Figure 4 and Figure 
5) as well as lower levels of CXCL2 and TNF-α (Figure 6) suggesting that virulence 
has been suppressed. High levels of proinflammatory cytokines are observed during 
bacterial infection in CF patients, including IL-8 (a human analogue of CXCL2 in 
mouse) and TNF-α [290]. The high levels of IL-8 and TNF-α in the sputum positively 
correlate with clinical symptoms of deterioration in CF patients and antibiotic treatment 
resulted in lower levels of both cytokines [291,292]. Numerous bacterial virulence 
factors are known to activate innate immune responses, while others are responsible for 
tissue damage during infection. This includes 3-oxo-C12-HSL that is not only a potent 
chemoattractant of neutrophils [293] but also can induce an inflammatory response 
by macrophages [294,295]. Many QS-regulated virulence determinants are known 
for their tissue destructive properties, among them is elastase that hydrolyses protein 
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elastin of lung tissue [13]. Our observations in the sublethal infection model indicate 
that PvdQ treatment may reduce lung inflammation by preventing the accumulation 
of 3-oxo-C12-HSL and thereby diminishing the production of virulence factors that 
contribute to lung injury. We observed no difference in the number of inflammatory 
cells in BAL fluid from the PBS treatment group, even though a considerably higher 
amount of cells was found at the epithelial tissue of the PBS-treated group (Figure 5). 
Extracellular factors of P. aeruginosa such as 3-oxo-C12-HSL [48], rhamnolipid [296] 
and pyocyanin [297] potentially induced apoptosis of the neutrophils that migrated 
to the alveolar space, reducing the number of cells in BAL fluid. The dose of 25 ng/g 
is presumably sufficient to fully hydrolyze extracellular AHLs in the lungs. Hence, 
increasing the PvdQ dose further did not improve the therapeutic efficacy in both 
lethal and sublethal infections. 
Taken together, our study shows that the intranasally administered PvdQ acylase can 
act as a therapeutic QQ enzyme to attenuate P. aeruginosa in a mouse pulmonary 
infection model. The inhibition of P. aeruginosa virulence clearly contributed to 
bacterial clearance and an improved condition of the lungs. Hence, PvdQ by itself can 
be a potential candidate as a part of the treatment of pulmonary infection. Increasing 
the shelf-life of PvdQ is achievable by formulating it into a dry powder that is suitable 
for inhalation [261]. Another interesting approach is to employ PvdQ in the combination 
therapy to increase the efficacy of conventional antibiotics. Therefore, in the future 
studies, expanding the therapeutic application of PvdQ would be of high interest.
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Supplementary materials
Figure S1. Purified PvdQ on a SDS PAGE gel. The first lane shows the protein ladder (Prestained 
Pageruler, Thermo Fisher). PvdQ appears as two subunits: the small subunit alpha and the large 
subunit beta (indicated with the arrows).
Figure S2. Bioactivity assay of PvdQ acylase in hydrolyzing 3-oxo-C12-HSL substrate, before (PvdQ) 
and after endotoxin removal treatment (PvdQ-ET). The emitted light is proportional to the presence 
of 3-oxo-C12-HSL. Heat-inactivated PvdQ is used in the control reaction. The result is presented as 
a mean of 6 individual wells and standard deviation (SD).
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Figure S3. Viability of human epithelial cell lines A549 (white bars) and H460 (black bars) after 48 
hours incubation with PvdQ. Cell viability is shown as percentage value relative to the control (0 µM 
of PvdQ). 
Figure S4. Bacterial loads in lungs of mice treated with PBS or PvdQ 24 hours (grey bars) and 48 
hours (white bars) post-bacterial infection in a model of sublethal pulmonary infection of P. aeru-
ginosa. Seven animals were sacrificed from each group at each time point. The box and whiskers 
respectively represent 25th to 75th percentiles, and range of the data. The horizontal lines represent 
the median.
Figure S5. BAL fluid analysis from animals treated with PBS or PvdQ 24 hours (grey bars) and 48 
hours (white bars) post-bacterial infection in a model of sublethal pulmonary infection of P. aerugino-
sa. A. Total cell counts, and B. Polymorphonuclear leukocytes (PMNs, neutrophils) and Mononuclear 
leukocytes (MNs) cells in BAL fluid. Three animals were sacrificed from each group at every time 
point. The bars represent mean and standard deviation. 
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Abstract
N-acylhomoserine lactone (AHL)-acylase (also known as amidase or amidohydrolase) 
is a class of enzyme that belongs to the Ntn-hydrolase superfamily. As the name 
implies, AHL-acylases are capable of hydrolysing AHLs, the most studied signalling 
molecules for quorum sensing in Gram-negative bacteria. Enzymatic degradation of 
AHLs can be beneficial in attenuating bacterial virulence, which can be exploited as a 
novel approach to fight infection of human pathogens, phytopathogens or aquaculture-
related contaminations. Numerous acylases from both prokaryotic and eukaryotic 
sources have been characterized and tested for the interference of quorum sensing-
regulated functions. The existence of AHL-acylases in a multitude of organisms from 
various ecological niches, raises the question of what the physiological roles of AHL-
acylases actually are. In this review, we attempt to bring together recent studies to 
extend our understanding of the biological functions of these enzymes in nature.
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Introduction
Quorum sensing (QS) is a cell-to-cell communication that allows bacteria to 
synchronize collective behaviour in a population density-dependent manner. This 
unique social interaction is often related to the regulation of highly complex structures 
and goods that are metabolically too expensive, if not impossible, to be produced by an 
individual cell [298]. In Gram-negative bacteria, QS depending on N-acylhomoserine 
lactones (AHLs) autoinducers is the most well-known communication system. The 
typical core system consists of the production and secretion of autoinducers, followed 
by a signal recognition by transcriptional regulators that subsequently regulate 
expression of QS-related genes, including those of autoinducer synthases (Figure 
1). Variations of this system exist in diverse Gram-negative bacterial models [266]. 
The autoinducer synthases (LuxI homologs) and the transcriptional regulators (LuxR 
homologs) often can synthesize and perceive multiple AHLs, respectively [299]. 
Figure 1. Typical N-acylhomoserine lactone-dependent QS core circuit in Gram-negative bacte-
ria. The LuxI synthase homologs produce AHLs, the signaling molecules consist of a homoserine 
lactone ring linked via an amide bond to an acyl chain with a variety of chain lengths and substitu-
tions. AHLs are recognized by LuxR homologs, the transcriptional regulators that are composed of 
two domains: An N-terminal domain that binds to AHL, and a C-terminal domain that recognizes 
a specific DNA sequence called lux box. Following binding to the AHL, the regulator proteins will 
undergo dimerization prior to transcriptional activation. This in turn affects the expression level of 
several genes regulated by QS including the AHL synthase, allowing an up regulation or a down 
regulation depending on the bacterial model. The protein structures in this figure are represented 
by LasI (PDB file: 1RO5) and LasR (PDB file: 3IX3).
6
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QS not only matters for communication within one species but is also important for 
making connections with a bigger social network that involves other bacterial species 
(interspecies) and organisms from different kingdoms (interkingdom), because they 
reside alongside each other or are in symbiosis in nature. There is growing evidence 
that cross-communication involving QS is existing in highly complex communities 
constituting multiple organisms. For instance, the lungs of cystic fibrosis patients are 
often colonialized by multiple pathogens. The predominant pathogen Pseudomonas 
aeruginosa produces 3-oxo-C12-HSL that not only regulates QS in another pathogen 
[300], but also shows immunomodulatory activities towards the host. In a dose-
dependent manner, 3-oxo-C12-HSL directly elicits the production of a neutrophil-
attracting chemokine, interleukin 8 (IL-8), in human lung fibroblasts and epithelial 
cell lines [301,302]. However, longer exposure to higher concentrations of 3-oxo-
C12-HSL can promote an adverse effect by accelerating apoptosis in neutrophils 
and macrophages (Li et al., 2004; Tateda et al., 2003; Telford et al., 1998). On the 
other hand, interkingdom mutualism is also common, one well-known example is an 
interaction between legumes family with its symbionts, the nitrogen-fixating bacteria 
called rhizobia. AHL-dependent QS systems in several members of Rhizobiaceae 
have been found to influence the symbiotic interactions [303,304]. An AHL from 
Sinorhizobium meliloti, 3O14-HSL, benefits the bacteria by inducing an increase in 
the nodulation of the model legume Medicago truncatula [305]. Hence, mutation of 
the lux homolog locus of S. meliloti leads to a decrease and delay of nitrogen-fixation 
nodules production, demonstrating a role of QS in establishing the symbiosis [306].  
Numerous molecules in nature can disarm QS by blocking different steps of the 
signalling pathway, in an interference called quorum quenching (QQ). An obvious 
possibility for this purpose is by inhibiting the accumulation of signalling molecules 
by enzymatic inactivation of AHLs. Three classes of enzymes are categorized as AHLs 
QQ enzymes, namely: (i) acylase (also known as amidase or aminohydrolase) that 
hydrolases the amide bond between the acyl chain and the homoserine lactone ring; (ii) 
lactonase that opens the homoserine lactone ring; and (iii) oxidoreductase that modifies 
the AHLs by oxidizing or reducing the acyl chain without degrading the AHLs (Figure 
2). With respect to the demand for new antibiotics due to the alarming emergence of 
drug-resistance strains, it is understandable why the majority of QQ researches are 
heavily devoted to  exploit QQ agents to fight infections [19,164,226,307]. In many 
pathogens, QS plays a crucial role in the regulation of virulence factors production that 
often determine the success of establishing an infection in the host. Hence, blocking 
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QS renders the bacteria less virulent, and is seen as a prospective strategy to develop 
novel therapies that will provoke less pressure for resistance. On the other side, taking 
into account the widespread occurrence of QQ enzymes in numerous organisms, the 
fundamental knowledge of the physiological function of these molecules is intriguing 
and has to be addressed. 
This review aims to bring together the recent publications relating to the biological 
functions of the QQ enzymes, focusing to the AHL-acylases. The possible roles 
of AHL-acylases with and without relation to QS modulation are being discussed, 
including a comparison with the known functions of other classes of QQ enzymes.
Figure 2. AHL-deactivating enzymes: Three classes of enzymes are categorized as AHLs QQ en-
zymes, namely: (i) acylase (also known as amidase or aminohydrolase) that hydrolases the amide 
bond between the acyl chain and the homoserine lactone ring (blue); (ii) lactonase that opens the 
homoserine lactone ring (green); and (iii) oxidoreductase that modifies the AHLs by oxidizing or 
reducing the acyl chain without degrading the AHLs (orange).
Quorum quenching acylases 
N-terminal nucleophile hydrolase superfamily
Most of the known bacterial AHL-acylases are members of the N-terminal nucleophile 
(Ntn)-hydrolase, a superfamily of enzymes that was coined by Brannigan et al. [24]. 
This group consists of diverse enzymes that recognize different kinds of substrates, 
but share common properties such as an autocatalytic activation, the presence of 
an N-terminal catalytic nucleophile (Threonine, Serine or Cysteine) and cleavage 
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of amide bonds [216]. Members of this superfamily amongst others are glutamine 
amidotransferase [308], aspartylglucosaminidase (AGA) [309], the 20S proteasome 
[310], and penicillin acylase [311]. The latter is one of the most prominent and best 
characterized representatives of the Ntn-Hydrolases. For decades, this enzyme is 
in focus of the scientific community as well as biotech companies [25]. It catalyses 
the deacylation of β-lactam antibiotics, producing 6-aminopenicillanic acid, a base 
intermediate for many semi-synthetic antibiotics [312]. Penicillin acylases are classified 
based on their substrate specificity, as penicillin G acylase (PGA) and penicillin V 
acylase (PVA), with benzylpenicillin and phenoxymethylpenicillin as their preferential 
substrate, respectively [313].
The sequence similarity within the Ntn-hydrolase family is very low and the enzymes 
within this family exhibit quaternary structures ranging from heterodimers (PGAs), 
homotetramers (PVAs) to the complex 4 homoheptameric rings forming the 20 S 
proteasome [29,30,314]. However, a conservation of their tertiary fold structure is 
strongly pointing towards their evolutionary relationship [312]. The active sites and 
core structures of the enzymes are located in typically comparable locations [216]. 
For example, the N-terminal nucleophile is nested in a characteristic αββα-fold, and 
highly conserved within the Ntn-Hydrolases superfamily [24,216]. This structure is 
providing the capacity for a nucleophilic attack and also enables the autocatalytic 
procession of the pro-enzyme [312]. 
Ntn-Hydrolases are synthesized as inactive precursor proteins that have to pass through 
a maturation process to be functional, as it was initially observed in PGA [315]. The 
precursor protein is composed of a signal peptide, an α-subunit and linker, and a 
β-subunit [311]. During the maturation process, which is postulated to take place in 
the periplasm or during the translocation over the membrane, the N-terminal residue of 
the beta subunit is autoproteolysed, separating the α- from the β-subunit and exposing 
the N-terminal nucleophilic residue to the solvent [316]. This is followed by a series of 
processing steps where the pro-region is sequentially removed from the C-Terminus 
of the α-subunit [317]. However, the protein localization might not be essential for the 
proteins maturation and functionality, since the pac gene in E. coli without a signal 
sequence was found to be actively expressed in the cytosol [318]. The linker or pro-
peptide is masking the active site, including the nucleophilic residue [312]. Comparison 
between the precursor and the mature protein, showed an extreme similarity of 
both structures, suggesting no major conformational changes occurred during the 
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maturation process. Whereas it could be shown that the pro-peptide is crucial for the 
correct folding of the protein [317], it also brings together residues important for the 
autoproteolysis. In case of the AHL-acylase PvdQ, it could be shown that in the vicinity 
of the N-terminal nucleophile, a hydrophobic pocket is gated off from the solvent by 
a Phe(β24). This pocket is too small to fit the acyl chain of its ligand 3-oxo-C12-HSL. 
Upon binding, the pocket opens providing enough space for the binding [21].
The members of the protein family share the same amide bond hydrolysis mechanism. 
Initially the nucleophilic oxygen or sulfur of the nucleophile (Thr, Ser, Cys) donates 
its proton to its own alpha amino group. Subsequently the nucleophilic attack on the 
carbonyl carbon of the substrate is launched, resulting in a tetrahedral intermediate, 
which in turn is stabilized by residues of the oxyanion hole [319]. Afterwards the 
α-amino group of the nucleophile donates its proton to the nitrogen of the scissile 
peptide bond, leading to a covalent bond with part of the substrate and the leaving 
amino product is released. In the second phase of the catalytic process, the acyl-enzyme 
complex will be cleaved in a deacylation step, returning the N-terminal nucleophile to 
its initial state. This is done by the hydroxyl group of a water molecule which attacks 
the carbonyl group of the acyl-enzyme complex [320].
AHL-acylases
The first enzymatic activity that involved deacylation of AHL was observed in 
Variovorax paradoxus VAI-C, in which this strain was found to be capable of 
assimilating AHL as a sole nitrogen and energy source [321]. This observation was 
soon followed by the isolation and characterization of the AiiD acylase from Ralstonia 
sp. that shared similarities with Ntn-hydrolases, such as aculeacin A acylase (AAC) and 
cephalosporin acylases [174]. This finding stimulated the succeeding experiments of 
testing the ability of different enzymes from the Ntn-hydrolase family for hydrolysing 
AHLs. Gene PA2385 from P. aeruginosa was initially identified as β-lactam acylase 
based on sequence similarities with glutaryl acylase from Pseudomonas SY-77. The 
gene which is also referred as pvdq, displays all the characteristics of the Ntn-hydrolase 
superfamily such as the characteristic αββα-fold (Figure 3b) and it is synthesized as 
a precursor protein which undergoes an autocatalytic maturation step. PvdQ acylase is 
actively hydrolysing long-chain AHLs, but has no activity towards β-lactam compounds 
such as cephalosporin and penicillin [31]. On the other hand, the glutaryl acylase SY-77 
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Figure 3. Juxtaposition of two representative members of the Ntn-hydrolase superfamily: PvdQ 
from Pseudomonas aeruginosa (left column) and PaPVA from Pectobacterium atrosepticum (right 
column). A) Cross-section of each enzyme showing the overview of the active sites with 3-oxo-C12-
HSL as a substrate according to ligand docking data. The predicted binding pockets are colored in 
blue. B) Structural comparison between the heterodimeric PvdQ (composed of subunit α and β) and 
the homotetrameric PaPVA shows the presence of the characteristic αββα-fold, that are depicted 
in yellow ribbon. C) Close-Up of the active centers of PvdQ (serine as the active nucleophile) and 
PaPVA (cysteine as the active nucleophile). These enzymes share a striking resemblance in the 
active sites, showed here by the presence of the oxyanion hole that is crucial for the stabilization of 
the tetrahedral intermediate (PvdQ: Valβ70, Asnβ269 and Hisβ23; PaPVA: Asn183 and Trp87). In 
addition, two tryptophan residues are thought to be important for the appropriate orientation of the 
substrate by providing a hydrophobic pocket for the acyl chain (PvdQ: Trpβ162 and Trpβ187; PaPVA: 
Trp23 and Trp87). Ligand docking was performed in Discovery Studio 3.0 (Accelrys, USA) for PvdQ, 
and Glide’s extra precision for PaPVA [30]. All structural figures were prepared in Pymol NRG studio.
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The similar mode of action of AHL-acylase and penicillin acylases, leads to the idea 
of cross-reactivity between these enzymes [227], and recent studies have confirmed 
this idea. KcPGA from Kluyvera citrophila was found to be active on AHLs with 
6-8 carbons with or without 3-oxo modification [29]. Two PVAs from Gram-negative 
bacteria, namely AtPVA (from Agrobacterium tumefaciens) and PaPVA (from 
Pectobacterium atrosepticum) were found to be active on medium to long chain 
AHLs [30]. PVA and PGA differ in sequence, structural composition and N-terminal 
nucleophile residue. Similar to PvdQ, bacterial PGAs are generally heterodimeric with 
a serine as the Ntn residue, while bacterial PVAs are homotetrameric with cysteine 
as the Ntn residue. In silico docking showed a suitable fit of long-chain AHLs in the 
crystal structure of AtPVA and PaPVA [30]. On the other side, AhlM, an extracellular 
AHL-acylase from Streptomyces sp. was found to be able of cleaving penicillin G (Park 
et al., 2005). PA0305 from P. aeruginosa encodes HacB, an AHL-acylase that shows 
low activity towards penicillin V and penicillin G [28]. As mentioned in the previous 
section, despite of having low sequence similarity, the members of this superfamily 
share a comparable structure of the active site. Using PvdQ and PaPVA as AHL-
acylase models that can degrade long-chain AHLs, the similarity of the orientation of 
the substrate to the N-terminal nucleophile and the acyl side chain binding pocket in 
both structures is obvious (Figure 3).
To date, many enzymes have been characterized and found to possess AHL-deacylating 
activity (Table 1). It is important to note that some enzymes in this list are produced by 
organisms lacking a AHL-dependent QS system (Gram-positive bacteria and eukarya). 
Phylogenetic analysis of the known bacterial AHL-acylases shows 4 major groups, they 
are: aculeacin A acylase (AAC), PGA, PVA, and AmiE amidase family [335], with the 
exception of AiiO and AibP acylases that do not belong to any of these groups (Figure 
4). We believe that this list is only a small portion of the abundant number of AHL-
acylases that are waiting to be revealed. It is noteworthy to mention that kinetic data 
on AHLs are scarce due to the low solubility of most substrates. Nevertheless, recently 
quite some valid numbers have been reported and catalytic efficiencies in the order 
of 1-10 x104 per mole/min have been reported (e.g HacB: 7.8 x104 M-1s-1[28], which 
equals the best efficiencies reported on β-lactams (e.g. KcPGA: 3.4 x104 M-1s-1, [29]. 
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Table.1: Widespread of AHL-acylases. 
Source AHL-acylase Substrates Refs.
Prokarya
Acinetobacter sp. Ooi24 AmiE 3-oxo-C10-HSL [250]
Agrobacterium tumefaciens AtPVA (3-oxo-)C6 – C12-HSL [30]
Anabaena sp. PCC7120 AiiC (3-oxo-)C4 – C14-HSL [226]
Brucella melitensis AibP C12-HSL, 3-oxo-C12-HSL [322]
Comamonas sp. strain D1 n.i. (3-oxo-)C4 – C16-HSL [323]
Deinococcus radiodurans QqaR (3-oxo-)C8 – C14-HSL [277]
Kluyvera citrophila KcPGA (3-oxo-)C6 – C8-HSL [29]
Ochrobactrum sp. A44 AiiO (3-oxo-)C4 – C14-HSL [324]
Pectobacterium atrosepticum PaPVA C10-HSL ; C12-HSL [30]
Pseudomonas aeruginosa PvdQ (3-oxo-)C10 – C14-HSL [31]
QuiP (3-oxo-)C7 – C14-HSL [28,325]
HacB C6 – C14-HSL [28]
Pseudomonas syringae strain 
B728a
HacA C8-HSL; C10-HSL; C12-HSL [326]
HacB (3-oxo-)C6 – C12-HSL [326]
Ralstonia mannitolytica str. SDV n.i. 3-oxo-C10-HSL [327]
Ralstonia solanacearum GMI1000 Aac C7-HSL; C8-HSL, 3-oxo-C8-
HSL; C10-HSL
[328]
Ralstonia sp. XJ12B AiiD 3-oxo-C8-HSL, 3-oxo-C10-HSL; 
3-oxo-C12-HSL
[174]
Rhodococcus erythropolis W2* n.i. C4-HSL, (3-oxo-)C6-HSL, C7-
HSL, (3-oxo-)C8-HSL, C10-HSL
[329]





Shewanella sp. strain MIB015 Aac C8-HSL; C10-HSL; C12-HSL [249]






Tenacibaculum maritimum strain 
NCIMB2154(T)
n.i. C10-HSL [331]
Variovorax paradoxus VAI-C n.i. C4-HSL, (3-oxo-)C6-HSL, 
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Source AHL-acylase Substrates Refs.
Eukarya




Sus sp. (porcine kidney) pAcy1 C4-HSL; C8-HSL** [253]
n.i. not identified, SP: putative signal peptides 
* Type of QQ enzymes production is strain-specific. R. erythropolis W2 produces acylase, lac-
tonase and oxidase, while in R. erythropolis strains LS31 and PI33, only lactonase activity was 
observed [333].
**Last et al. indicated that pAcy1 shows no hydrolysing activity towards C6-HSL but towards 
C6-homoserine [334]
With the exception of Ochrobactrum sp. A44 AiiO, which has been classified as an αβ-hydrolase 
with a catalytic triad, all the other characterized bacterial enzymes belong to the Ntn-hydrolase 
family.
Figure 4. Phylogenetic tree from the known protein sequences of bacterial AHL-acylases. The 
phylogenetic tree was constructed using the neighbor-joining method with the ClustalW (MEGA 
program, ver.7). Number represents Bootstraps values based on 1000 replications.
 
What are the potential physiological roles of AHL-acylases? 
After two decades since the earliest finding of AHL-acylase and the myriad of 
discoveries of novel acylases later on, the actual physiological roles of these enzymes 
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are still obscure. With respect to their AHL-hydrolysing ability, these enzymes are 
speculated to be involved in the degradation of AHLs signalling molecules in nature. 
When a certain enzyme fulfilled this proposed activity, it may lead to either of the 
following consequences: (i) AHL-degradation for fine tuning the endogenous QS 
system, (ii) AHL-degradation for modulating the QS system of other bacterial species, 
or even the microbiota where the acylases producers reside, (iii) AHL-degradation as 
a mechanism to use AHLs for nutrient sources, or to escape the toxicity of AHLs. 
Nonetheless, it is also possible that the natural substrates for certain acylases are not 
AHLs, and these enzymes are involved in biological systems unrelated to QS. In this 




P. aeruginosa is a multihost pathogen that can be found in various environments and 
is mainly known as an opportunistic pathogen in immunocompromised patients and 
cystic fibrosis patients. The core QS system of this bacteria consists of the hierarchical 
LasRI and RhlRI systems, with 3-oxo-C12-HSL and C4-HSL as their cognate AHL, 
respectively [336]. Next to the QS system, four Ntn-hydrolase homologs are present 
in Pseudomonas aeruginosa PAO1: namely pvdQ (PA2385), quiP (PA1032), hacB 
(PA0305) and PA1893, in which the first three have been characterized as AHL-
acylases [28,31,325], while PA1893 is known to be part of QS-regulons ( Schuster 
et al., 2003; Wagner et al., 2003). These enzymes efficiently hydrolyse long-chain 
AHLs, including the native 3-oxo-C12-HSL of P. aeruginosa. When grown in a rich 
medium, P. aeruginosa strains with constitutive expression of these acylases show a 
decreased level of 3-oxo-C12-HSL in the supernatant. The production of QS-regulated 
virulence factors elastase and pyocyanin was diminished in the strain overproducing 
HacB. In the strain overproducing PvdQ, reduction of elastase, pyocyanin and PQS 
levels was observed [28,31]. Vice versa, disruption of the acylase genes resulted in 
higher accumulation of AHL. A ΔhacB single mutant and a ΔpvdQ, ΔhacB, ΔquiP 
triple mutant accumulated 3-oxo-C12-HSL to a higher level  compared to ΔpvdQ, 
ΔquiP double mutant that produced 3-oxo-C12-HSL in the same level as wild type 
[28]. This observation indicates that in rich medium, HacB might be working as the 
main acylase in controlling long-chain AHL accumulation. The other explanation 
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is that PvdQ and QuiP are produced only when a particular environmental cue(s) is 
present, as described below. 
The pvdQ gene lies in the pyoverdine operon, which is responsible for biosynthesis of 
the main siderophore of P. aeruginosa. PvdQ works in one of the final maturation step 
of pyoverdine in the periplasmic space, in particular by removing myristoleic acid from 
the precursor PvdIq, generating ferribactin [32]. The crystal structure of PvdQ reveals 
a large hydrophobic binding pocket that serves its function to cleave a long-chain fatty 
acid [21]. Pyoverdine is only produced in iron-limiting conditions, the environmental 
cue for pyoverdine biosynthesis gene to be expressed. However, it is important to note 
that a pvdQ deletion strain grown in iron-limiting media did not only show a defect in 
pyoverdine production, but also accumulated higher concentrations of 3-oxo-C12-HSL 
compared to wild-type [337], supporting the indication of a dual function for PvdQ 
in P. aeruginosa. Among the described acylases, QuiP is crucial in assimilation of 
long-chain AHLs as carbon source [325]. A ΔquiP deletion mutant showed a growth 
defect when utilizing AHLs as carbon source. Microarray analysis from cultivating the 
bacteria in a medium with C10-HSL as a sole carbon source, showed an up-regulation 
of quiP and PA1893, but did not affect pvdQ and hacB expressions. Taken together, 
this observation hints to the possibility that QuiP functions in AHL-scavenging [227].
Brucella melitensis is a Gram-negative infectious agent of Brucelliosis, a zoonotic 
disease that is transmitted via unpasteurized dairy products or direct contact with 
the infected animals [338]. The bacterium possesses LuxR homologs, namely VjbR 
and BabR that are known as global regulators for virulence factors production and 
stress response [339]. A low concentration of C12-HSL (and possibly 3O-C12-HSL) 
was detected in vitro, while the synthase(s) currently have not been characterized yet 
[340]. The QS system works in a non-classical manner, in which the produced C12-HSL 
negatively influences the production of virulence factor, specifically the expression of 
flagellar genes. 
Using an elegant AHL-sensitive reporter system [271] that allows observation of C12-
HSL accumulation at a single bacterium level, the study revealed another hint of this 
QS regulatory mechanism [322]. The intracellular accumulation of C12-HSL in vitro 
was reduced at the end of logarithmic phase when the population density was the 
highest. It means that the accumulation of C12-HSL in this bacterium does not reflect 
the increase of population density, unlike the majority of the known QS system. This 
6
116
Chapter 6 | Physiological functions of AHL-acylases
phenomenon is suspected to be mediated by a QQ enzyme named AibP acylase. This 
enzyme has a conserved region at the predicted α and β subunit as it is a member of 
the Ntn-hydrolase superfamily. In the wild type strain, the peak of aibP expression 
coincides with the decrease of intracellular C12-HSL level. In agreement with this 
observation, disruption of the aibP gene resulted in the tenfold higher C12-HSL 
accumulation both in vitro and during macrophage infection. In the ΔaibP mutant, 
a decrease of flagellar genes expression was observed to the same level as C12-HSL 
addition to the wild type strain. These observations show that the modulation of C12-
HSL concentration by AibP acylase favours virulence factors production. 
Modulating a multispecies community
Highly complex microbial assemblies called microbial granules or granular sludge 
are emerging as effective methods for wastewater treatment [341]. Granular sludge 
consists of aggregates of numerous microorganisms formed by self-immobilization. 
Complete waste degradation is achieved by complicated interactions between these 
multispecies populations and their cumulative actions. Nowadays, granular sludge 
is cultivated in aerobic conditions, a procedure that overcomes drawbacks from its 
predecessor that strictly grew in anaerobic systems [342,343]. In comparison to the 
conventional activated sludge, aerobic granules are stronger, denser, showing better 
settling abilities, and more resilience to shock loadings [344]. Its compact structure 
offers protection to the granules, and permit them to perform biodegradation of toxic 
wastes, such as phenols [345,346]. 
The majority of aerobic granules are produced in sequential batch reactors (SBR) seeded 
by activated sludge [341,347]. The microbial granulation cycle is divided into several 
phases with defined structural characteristics that can be monitored microscopically. 
By utilizing a sequencing batch reactor (SBR) seeded by floccular sludge, Tan and 
colleagues revealed the involvement of AHL-dependent QS that is modulated by QQ 
during the granulation cycle [348,349]. In the first study, short to medium-chain AHLs 
predominated by 3-oxo-C8-HSL, were found to have accumulated during granules 
formation. Conversely, the dispersion of mature granules coincided with the decrease 
of the AHL accumulation below detection level [348]. This observation is in agreement 
with previous finding that AHLs and autoinducer-2 (AI-2, a signalling molecule in 
Gram-positive bacteria) are important in maintaining the structural integrity of aerobic 
granules [350]. Supplementation of exogenous AHLs induced aggregation of floccular 
biomass, suggesting the importance role of AHL level in the formation of granules. 
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16S rDNA analysis from this microbial community, showed a presence of both AHL-
producing organisms (from α, β, and ɣ Proteobacteria) and QQ organisms (from phyla 
Proteobacteria, Actinobacteria, Bacteriodetes and Firmicutes), wherein some are 
both AHL-producers and AHL-degraders [349]. Based on isolation studies, floccular 
sludge communities were predominantly QQ organisms (60%), in which more than 35 
organisms were in the top 50 most abundant community members. Among these QQ 
organisms, the previously known genera that produce AHL-acylase or AHL-lactonase 
were isolated, such as Variovorax, Bacillus, Ochrobacterium and Rhodococcus. 
Almost all QS-proficient organisms in floccular sludge were capable of producing long-
chain AHLs and these AHLs were also the preferred substrates for all QQ organisms. 
Hence, only short to medium-chain AHLs were detected at low concentration at this 
phase. It is important to note that AHLs degradation in this complex community is 
attributed to the QQ activity rather than spontaneous hydrolysis. Interestingly, the 
microbial consortia during granules formation were dominated by AHL-producing 
organisms, explaining the increase of AHL accumulation at this stage [349]. It is 
currently unknown whether this alteration of community members was triggered by 
the granulation process, or that the granule assembly was more favourable for AHL-
producing bacteria. Nevertheless, this observation demonstrated the important role of 
AHLs signal fine tuning to direct community behaviour. This modulation of AHLs is 
might also occur in natural environments where complex and dynamic multispecies 
communities exist.
Modulating interkingdom interactions
Biofouling is an accumulation of microorganisms, algae, plants or animals on wetted 
artificial surfaces, causing serious problems in marine industry and underwater 
structures. The most common macroalga associated with biofouling is from the genus 
Ulva. Asexual reproduction of Ulva involves a release of motile zoospores from mature 
algae, followed by a quest for new suitable surfaces to settle. Once a zoospore locates 
an appropriate site, it produces adhesive-containing vesicles to support its permanent 
attachment, and subsequently grows into the mature organism [351]. The settlement 
itself depends on multiple environmental cues, including the presence of bacterial 
biofilms [352]. AHLs released by the biofilms attract the zoospores and induce calcium 
influx that relates to the modulation of flagellar movement resulting in a decrease in 
swimming rate [353]. The zoospores can detect a wide range of AHLs, preferably with 
acyl chains longer than six carbons [354].
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Further investigation of bacterial communities and AHL modulation in situ was 
performed by Tait and colleagues [330]. Samples of intertidal rock-pools colonized 
by Ulva were collected from Wembury beach, UK. LC/MS-MS analysis from the 
dichloromethane extract of the pebbles showed a presence of AHLs, including 
C8-HSL and C10-HSL. These AHLs are believed to be produced by some members 
of the bacterial community colonizing the rocks, confirmed by metagenomic 
analysis and laboratory cultures. Among these species were the previously unknown 
Sulfitobacter (α-Proteobacteria family), as well as Glaciecola and Marinobacteria 
(Alteromonadaceae family). An identified isolate of Shewanella sp. is both an AHL-
producing (3OC4-HSL, 3-oxo-C10-HSL and 3-oxo-C12-HSL) and AHL-degrading strain 
(lactonase and acylase activity to medium until long chain AHLs). In vitro experiments 
of unispecies biofilms with variation in biofilm density, showed a preference of the 
zoospores to settle on the biofilm with the highest AHL concentration. QQ enzymes 
in Shewanella sp. modulate its AHL concentration, hence affecting the zoospores 
settlement. Interestingly, this effect was also shown in the multispecies biofilm of 
Vibrio and Sulfitobacter, in which the co-culturing with Shewanella sp. reduces the 
zoospores settlement. These observations suggest that the presence of AHL-degrading 
species plays a role in AHL turnover within a microbial community, which in turn 
influences interkingdom interaction, as seen with the Ulva zoospores settlement.  
The abovementioned examples of Ulva with marine bacteria, and plants with their 
rhizhobia symbionts confirm that plants are capable of recognizing AHLs. However, 
there is a lack of knowledge of how plants perceive these AHLs. Using young seedlings 
of plant model Arabidopsis thaliana and Medicago truncatula, Palmer and colleagues 
show a biphasic effect of AHLs in primary root growth of the plants in a concentration-
dependent manner [332]. Low concentrations of AHLs induce primary root growth via 
transpiration that induces nutrient uptake, and in contrast, higher concentrations induce 
an adverse effect of growth inhibition, due to ethylene production. The response was 
more pronounced for the AHLs with acyl chain of 12 carbons or longer. Interestingly, 
exposure to L-homoserine (HS), but not to a long-chain acyl tail, elicited a comparable 
response as an exposure to C12 to C14-HSLs. This result indicated the occurrence 
of AHLs deacetylation to release L-homoserine lactone (HSL), which is further 
hydrolysed into HS, a signal that is recognized by the plants. An enzyme called fatty 
acid amide hydrolase (FAAH) produced by diverse plants and animals species was 
suggested to be responsible for this function [332,355]. FAAH is a serine hydrolase 
that belongs to the amidase signature family. This enzyme  is part of a system that 
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regulates the endogenous concentration of N-acylethanolamines, a fatty acid derivatives 
group important in an array of physiological and behavioural functions [356]. Purified 
FAAH from A. thaliana (AtFAAH) cleaved the same type of AHLs that are modulating 
the growth in planta. The hypothesis was further confirmed by a ΔAtFAAH deletion 
mutant that was shown to be less sensitive to the exposure of AHLs. It is clear that the 
presence of FAAH is important in perceiving AHLs in the plant models; however, the 
study implies that FAAH does not discriminate AHLs from good and bad bacteria 
(biologically relevant concentrations of 3-oxo-C14-HSL from S. meliloti and 3-oxo-
C12-HSL from pathogen P. aeruginosa, are both inducing root growth). Furthermore, 
as noted by the authors, further experiments are needed to confirm the role of FAAH 
at different age of the plants, since the expression of this enzyme is lower in the roots 
of mature plants.
AHL turnover mechanism
In order to serve as a “signal”, the signalling molecules not only have to be produced 
and accumulated at a certain moment, but they also have to be abolished when the 
signalling is no longer required. Hence, AHLs turnover mechanisms should be existing 
as a way to avoid the build-up of these molecules and allow a proper utilization of 
the signalling molecules in reflecting the population density or as an environmental 
cue. AHLs are known to undergo a non-enzymic lactonolysis at high pH and at 
increased temperature, in which the AHLs with longer acyl chains are more stable 
[357]. Nevertheless, enzymatic degradation of AHL in nature is also believed to occur 
and has been speculated as one of the natural roles of QQ enzymes.  
The rhizhosphere is home for a rich diversity of microorganisms, including those that 
are capable of degrading AHLs. Bulk soil samples are able to biologically mineralize 
AHL with high efficiency, in which the degradation products most probably are utilized 
to form biomass by the microorganisms (Wang and Leadbetter, 2005). In fact, the first 
bacterium with AHL-acylase activity (V. paradoxus VAI-C) was isolated from turf 
soil (Leadbetter and Greenberg, 2000). This bacterium is able to utilize AHLs, HS, 
and HSL as sole nitrogen sources, but only the first two substrates can be utilized as a 
carbon source. The AHLs metabolism pathway is still unknown, but the deacylation of 
AHL is believed to be the first step to release the acyl chain, which can be processed 
further. Another bacterium that was isolated from the same enrichment culture, 
Arthrobacter strain VAI-A, showed an aberrant growth in defined media with 3-oxo-
C6-HSL, but metabolized a substrate with an opened lactone ring 3OC6-HS (as carbon 
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and nitrogen source) and HSL (as nitrogen source) (Flagan et al., 2003). Interestingly, a 
co-culture of V. parodoxus with Arthrobacter VAI-A in a defined medium with 3-oxo-
C6-HSL as a sole carbon and nitrogen source significantly increased the growth rates 
compared to monocultures in the same medium composition. The nutrient symbiosis 
between these bacteria was not fully understood, but it is speculated that the remaining 
carbon from the utilized HSL is used as an energy source for Arthrobacter VAI-A. 
An enrichment culture of a different soil sample revealed other strains of Arthrobacter 
species (strain HSL-1, HSL2 and HSL-3), and Burkholderia strain HSL-4 that can 
utilize HSL as a sole carbon and nitrogen source (Yang et al., 2006). As predicted, 
the AHL dependent growth rates were stimulated during the co-culture between 
these HSL-degrading strains and AHL-acylase producer Ralstonia mannitolytica 
strain SDV. These observations indicate the presence of AHL-degrading and AHL-
mineralizing consortia in the soil, explaining why accumulation of AHLs is scarcely 
found in the soil. 
Escaping AHLs-mediated toxicity
The AHLs not only function as signalling molecules, but also show a potent antibacterial 
activity [358]. AHLs with an oxo group substitution at the third carbon (3O-AHLs) in 
aqueous environment can undergo spontaneous hydrolysis into acylhomoserines and 
tetramic acids [358]. The latter compounds display strong antibacterial activity towards 
Gram-positive bacteria but are tolerated by Gram-negative bacteria. In addition, 
these compounds bind iron with an affinity that is comparable to the pyoverdine 
siderophore of P. aeruginosa. The strains of Bacillus cereus producing β-lactamase 
and B. thuringiensis producing AiiA lactonase showed resistance towards 3-oxo-AHLs. 
The AHL-degrading activities of these enzymes presumably protects the bacteria 
from 3-oxo-C12-HSL and prevents the conversion into tetramic acid derivative [358]. 
In another study, a B. thuringiensis mutant defective in AiiA production displayed a 
decreased survival rate in a mixed culture with Erwinia carotovora on the pepper root 
[359]. The plant pathogen E. carotovora is also known to utilize AHL-dependent QS 
to regulate the exoenzyme production and the biosynthesis of antibiotic carbapenem 
[6]. By producing AiiA, not only B. thuringiensis could avoid the toxicity of AHLs and 
its tetramic acid derivatives, but it also inhibits QS of its competitor. With the same 
rationale, it is tempting to propose that the extracellular AHL-acylases such as AhlM 
from Streptomyces might also confer the same advantages to the producing bacteria. 
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In Gram-positive bacteria which are not using AHLs as signalling molecules, these 
AHL-hydrolysing enzymes could give a competitive advantage in bacterial warfare. 
Concluding remarks
The earliest discovery of AHL-degrading enzymes was immediately followed by 
postulations about their role in AHL turnover and QS modulation in nature. Despite of 
the inquisitiveness, research to explore the fundamental basis of why QQ enzymes exist 
was outcompeted by the enthusiasm of potential therapeutic and industrial applications 
of these enzymes. Nevertheless, toils in this area have been conducted to unveil some 
in vivo physiological functions of the QQ enzymes. AHL degradation is indispensable 
to prevent a signal build-up and to allow a real-time monitoring of de novo AHLs 
synthesis to reflect the population density. In the context of multispecies interactions, 
it is becoming apparent that signal fine tuning and quenching is as important as signal 
transmittance itself. A notable observation of a highly complex community showed 
that both QS and QQ play important roles in directing the community behaviour, or 
indirectly modulating the behaviour of other organism whose fate is depending on 
AHLs cues. Within a highly complex community, AHL degradation is counted as a 
cumulative function of populations rather than individuals, hence the performances 
of multiple AHL-hydrolysing enzymes are often intertwined. 
AHLs are more than merely communication signals; these molecules are 
multifunctional and can exert detrimental effects to other organisms. It is unsurprising 
that AHL-degrading enzymes are regarded as a part of the arsenal during bacterial 
warfare, given the bestowed benefit to the producing organisms. This advantage is not 
limited to bacteria only as mammalian paraoxonases (AHL-lactonases) can inactivate 
AHLs. These enzymes are considered to be defence mechanisms against bacterial 
pathogenesis [360–362]. However, considering the prevalence and the efficiency of 
the AHL-degrading enzymes, one might ask how the AHL-dependent QS systems are 
still successfully operated, in spite of the vulnerability of extracellular AHLs. Docking 
simulations of both PvdQ and PaPVA demonstrate that AHLs fit perfectly in the 
binding pocket of the respective enzymes raising questions not about the design of the 
enzymes but the design of the signaling molecules itself. It is important to emphasize 
that AHLs do not represent the only autoinducers playing a signaling role in QS of 
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Gram-negative bacteria. For instance, P. aeruginosa uses in addition to 3-oxo-C12-HSL 
and C4-HSL, a 2-heptyl-3-hydroxy-4-quinolone (PQS). 
Enzymes are classified based on enzymatic activities they possess or are predicted to 
be a member of a certain class based on a homology analysis or presence of particular 
motifs. The classification system is robust and practical to easily point out certain 
activities an enzyme could catalyse. However, in many cases, enzymatic nomenclature 
could be a source of confusion when determining the native physiological role of the 
enzymes. This confusion applies to the names penicillin and cephalosporin acylase. The 
products of these enzymes, 6-APA and 7-ACA are more toxic to the enzyme producer 
than the substrates penicillin and cephalosporin C. Therefore, it is difficult to imagine 
a physiological function for these enzymes in potentiating β-lactams. A natural role in 
degrading AHL is better conceivable. On the other hand, considering the variability of 
individual enzyme characteristics and the multitude of producers, it is too pretentious 
to assign AHLs as the native substrate for all here-mentioned AHL-acylases. Some 
of the well-studied enzymes showed a broad range of substrate specificities, and it 
is challenging to point out which one is the natural substrate. The AHL-degrading 
activity could be complementary to the main function of the enzyme. For example, 
during iron-limiting conditions, PvdQ acylase in P. aeruginosa was observed to play 
a dual role: pyoverdine biosynthesis and regulating AHL concentration. This double 
function is also evident in BlcC lactonase (formerly AttM) produced by the plant 
tumour-inducing pathogen Agrobacterium tumefaciens. The BlcC lactonase controls 
the accumulation of endogenous 3-oxo-C8-HSL at the onset of tumour progression, 
and is also involved in the production of gamma-hydroxybutyrate (GHB) from gamma-
butyrolactone (GLB) [363,364]. 
Hitherto, the gained knowledge of QQ enzymes (AHL-acylases in this review) is only 
the tip of the iceberg. There are still countless unidentified enzymes and mechanisms 
awaiting to be discovered. 
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Table S1. List of abbreviated molecules 
Abbreviation AHLs IUPAC
C4-HSL N-butanoyl-L-homoserine lactone N-(Tetrahydro-2-oxo-3-furanyl)-butana-
mide
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Quorum sensing (QS) systems enable bacteria to coordinate their population 
behavior in order to achieve greater impacts that are challenging, if not impossible, 
to be accomplished by individuals. By detecting signaling molecules (autoinducer) 
accumulation as a function of population density, each cell subsequently regulates the 
expression of a particular set of genes. Growing interest in this field is greatly related to 
the fact that QS regulates virulence factor production in many pathogenic bacteria. By 
using QS system to take a census of population, bacteria launch an arsenal of virulence 
determinants as a unified attack when population density reaches a critical mass: a 
tactic to overwhelm the host organism. The knowledge of the QS system in pathogenic 
bacteria opens up a possibility to use this system as a target for antibacterial drugs. 
Conventional antibiotics kill susceptible bacteria by targeting their essential systems 
(DNA replication, protein synthesis, cell wall synthesis), and at the same time giving a 
strong selective pressure to allow the emergence of resistance bacteria. These infections 
in worst cases are untreatable by any prescribed antibiotic [365]. Therefore, finding 
novel antibiotics or preserving effectiveness of current antibiotics are among major 
challenges faced by modern medicine. Interference of QS system (termed as quorum 
quenching, QQ) leads to attenuation of bacterial virulence, resulting in milder infections 
in animal models [148,204,269,275]. Compounds with such working mechanisms are 
often described as antivirulences. With an alarming rise of antibiotic-resistant bacteria, 
every promising strategy to alleviate bacterial infections is a great contribution in drug 
development research.
The research presented in this thesis has focused on studying enzymatic degradation of 
N-acylhomoserine lactone (AHL) signaling molecule for QS inhibition in Gram-negative 
bacteria, particularly in Pseudomonas aeruginosa. The employed enzymes belong to 
the AHL-acylase class that cleaves the amide bond of AHLs, resulted in irreversible 
degradation of the molecules. We identified and characterized AHL-hydrolyzing 
activities from two bacterial Penicillin V acylases (PVAs) and re-purposed them as QQ 
enzymes for P. aeruginosa. Further, we assessed the efficacy of another AHL-acylase, 
named PvdQ, as a treatment in a mouse model of P. aeruginosa pulmonary infection. 
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Quorum sensing regulatory network – Understanding bacterial 
pathogenesis
 
An introduction to the classical LuxRI QS system in Gram-negative bacteria, as well 
as QS inhibition mechanisms with focus to QQ enzymes are presented Chapter 1. 
This chapter also provides information about the highlighted pathogen in this thesis, P. 
aeruginosa. This bacterium is an infamous opportunistic human pathogen that is mainly 
associated with hospital-acquired infections and lung infection in cystic fibrosis patients. 
The QS system in P. aeruginosa is one of the most well-studied to date. Hence, P. 
aeruginosa is often used as a model for QS system in Gram-negative bacteria. An 
overview of its complex QS regulatory network is given in the first part of Chapter 
2. The core of QS in P. aeruginosa consists of two LuxRI homologs named Las and 
Rhl systems, with 3-oxo-C12-HSL and C4-HSL as their respective cognate signaling 
molecules [13]. The QS system is further modulated by several regulators that are 
activated by different cues, such as nutrition availability or growth phase. Interference 
of QS can be achieved by using QS inhibitors (QSIs) to block the signaling molecule 
synthesis or to inhibit the signal recognition by the transcriptional activator protein. 
Another obvious approach is by preventing the accumulation of signaling molecules 
with enzymatic inactivation. The example of such QQ agents from both natural and 
synthetic sources are also discussed in this chapter. 
Understanding P. aeruginosa pathogenesis and developing the infection treatment 
require a knowledge of host-pathogen interactions. The best model to mimic human 
diseases is indeed humans themselves, but it is ethically prohibited to perform 
experiments on humans without preliminary tests in animal models. Non-human 
mammals, especially murine, are the preferred animal models for studying human 
diseases due to their physiological relatedness. Growing awareness of animals’ lives 
created strict rules that regulate experiments with vertebrates in general. Including 
in these rules is a requirement to provide positive evidence in a simpler infection 
model such as in invertebrates, when the appropriate models exist. Chapter 2 provides 
an exhaustive list of infection models for P. aeruginosa ranging from cell lines, 
invertebrates, to mammals. Simple animal models such as the nematode Caenorhabditis 
elegans and the larvae of great wax moth Galleria mellonella are gaining popularity 
as models of infection. A closer look to the infection assays for the nematode C. 
elegans to study P. aeruginosa pathogenicity is described in more detail in Chapter 
7
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3. The pathogenesis of P. aeruginosa in evolutionary distant hosts revealed conserved 
virulence factors that are required for causing infections in many host systems, such as 
LasR of QS system [91,136] and GacA response regulator of the GAC two-component 
system [69,125,153]. Such positive correlations in different models are also evident 
in efficacy studies of several QQ agent [161,179,204]. These observations strengthen 
the credibility of non-mammalian hosts as a preliminary screening step in studying 
bacterial pathogenesis and in the development of infection treatments. 
PVAs: from semisynthetic antibiotic production to quorum 
quenching
Penicillin acylases catalyze deacylation of natural penicillin to yield an active 
intermediate 6-aminopenicillanic acid (6-APA), an important core for the production of 
semisynthetic β-lactam antibiotics [25]. Based on their substrate preferences, penicillin 
acylases can be classified into Penicillin G acylases (Pen G, PGAs) or Penicillin V 
acylases (Pen V, PVAs). They are different in nucleophilic residues (serine for PGAs, 
and cysteine for PVAs) and in their subunit composition (PGAs are heterodimeric, while 
PVAs are homotetramers) [26]. Penicillin acylases and AHL-acylases belong to the 
Ntn hydrolase superfamily. Hence, they share similar structural fold and mechanistic 
features, and substrate cross-reactivity between these enzymes has been suggested 
[27–29,227].
The promiscuous deacylation of AHLs by two novel PVAs is discussed in Chapter 4. 
These PVAs belong to plant pathogens, namely Agrobacterium tumefasciens (AtPVA) 
and Pectobacterium atrosepticum (PaPVA). The corresponding pva genes were isolated, 
cloned and overexpressed in E. coli. The PVAs share 62% sequence identity, similar 
structural features and exhibited high specificity for Penicillin V. The ability of these 
PVAs in hydrolyzing AHLs was first determined by utilizing biosensors that produce 
luminescence in the presence of specific AHLs. Activity of PaPVA was restricted 
to C10 to C12-HSL, while AtPVa showed a broader range of substrate spectrum (C6 to 
C12-HSL) with highest activity on the long-chain AHLs. The release of HSL and acyl 
chain following the AHL deacylation activity was confirmed by HPLC. Subsequently, 
kinetics study with 3-oxo-C12-HSL as a substrate was performed for both enzymes. 
Apparent kcat/Km values for PaPVA (13.5 × 104 M−1 s−1) and AtPVA (2.68 × 104 M−1 
s−1) are comparable to the available values for HacB acylase [28] and 10-fold higher 
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than PvdQ acylase [248]. To understand the substrate preference of these enzymes, 
we performed docking studies. An almost identical substrate binding in both PVAs 
was observed. The enzymes preference of longer chain AHLs seemed to be caused 
by greater interactions between the residues in the hydrophobic pocket with the long-
chain AHLs. Having confirmed the AHL-hydrolyzing activity, we then assessed the 
QQ activity in P. aeruginosa PAO1. The exogenous addition of these enzymes into P. 
aeruginosa PAO1 culture not only reduced the production of 3-oxo-C12-HSL signaling 
molecule, but also greatly diminished the production of QS-regulated virulence factors 
(elastase, pyocyanin, and biofilm formation). Efficacy of the PVAs was further observed 
in rescuing G. mellonella larvae upon P. aeruginosa PAO1 infection. Survival rates 
were dramatically higher with the PVA treatments (70% for AtPVA; 50% for PaPVA) 
in comparison to the untreated infection (10%). The findings of this study therefore 
underline the potential of PVAs as therapeutic enzymes and motivate to further explore 
the possible link between AHL-hydrolyzing activity with the natural role of PVAs. 
Efficacy of PvdQ acylase in a mouse model of P. aeruginosa 
pulmonary infection 
Among many characterized AHL-degrading enzymes, up to now only two studies in 
murine pulmonary infection model are documented [275,276]. Both involve AHL-
lactonases that cleave the lactone ring of the AHL. The only possible administration 
route for therapeutic enzymes to reach the lungs is via the upper respiratory tract. 
Combining the procedures of establishing the infection and delivering the drug via 
the upper respiratory tract is challenging to be performed in small animals. Therefore, 
the recent study on the administration of an AHL-lactonase was done in rats using 
intubation of trachea. The treatment successfully reduced mortality in the rat model 
of pneumonia [276]. 
Our study group have been studying an acylase called PvdQ, a periplasmic enzyme 
from P. aeruginosa that is suggested to be involved in the maturation of pyoverdine 
siderophore [32]. PvdQ is also an AHL-acylase with specificity to long chain AHLs. 
Previous studies by our group show that PvdQ, either overexpressed in or exogenously 
supplemented to P. aeruginosa, could significantly attenuate the virulence production, 
both in vitro [31], and in a C. elegans model [33]. Based on these data, we conducted 
an efficacy study of intranasally administered PvdQ acylase in a mouse model of P. 
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aeruginosa pulmonary infection, that is presented in Chapter 5. We aimed to employ 
a non-invasive drug administration method that closely mimics the actual procedure 
in human. We first developed the lung infection model, by inoculating mice with P. 
aeruginosa -laden agarose microbeads. In principle, the severity of infection in the 
model depends on the bacterial inoculation dose and the stress level experienced by the 
animals. We found an inoculation dose of 2.5x105 CFU/lungs as a sublethal dose and 
to twice that amount (5x105 CFU/lungs) as a lethal dose. Using this infection model, 
we evaluated the deposition pattern of intranasally administered fluorochrome-tagged 
PvdQ (PvdQ-VT) in mice at different stages of pulmonary infection. In vivo imaging 
studies following intranasal instillation showed that PvdQ-VT could be traced in all lung 
lobes with 42 ± 7.5 % of the delivered dose being deposited at 0 hour post bacterial-
infection, and 34 ± 5.2 % at 72 hours post bacterial-infection. The distribution of PvdQ-
VT was observed to be shifted to the left lobe at 72 hour post bacterial infection. An 
explanation for this finding is presumably related to the structural changes experienced 
by each lobe, although further research is required to confirm the hypothesis (e.g. 
determination of airspace diameters). We then treated mice with PvdQ during lethal P. 
aeruginosa pulmonary infection. This treatment resulted in a five-fold reduction of lung 
bacterial load and prolonged survival of the infected animals with the median survival 
time of 57 hours in comparison to 42 hours for the PBS-treated group. In a sublethal 
P. aeruginosa pulmonary infection, PvdQ treatment resulted in less lung inflammation 
based on the histology severity scoring and decrease of CXCL2 and TNF-α levels at 24 
hours post-bacterial infection by 15% and 20%, respectively. The results of this study 
confirmed the ability of PvdQ to be a quorum quencher of P. aeruginosa infection in 
a relevant animal model, and further extended the previous observation in C. elegans. 
Physiological function of AHL-acylases
Great interest in expanding the potential of QQ enzymes for therapeutic and industrial 
applications outcompeted the eagerness to explore fundamental basis of why QQ 
enzymes exist. After two decades since the earliest finding of AHL-acylase and myriad 
of novel acylases discoveries later, the majority of their actual physiological roles are 
still obscure. With respect to their AHL-hydrolyzing activities, they are speculated to 
be involved in the degradation of AHLs signaling molecules in nature. Nevertheless, 
it is also possible that the natural substrates for certain acylases are not AHLs, and 
they are involved in biological systems unrelated to QS. Chapter 6 summarizes 
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findings related to physiological functions of QQ enzymes in nature. Studies from 
different AHL-acylases reveal their role in modulating different level of interactions: 
intraspecies (within one species), interspecies (between two or more bacterial species) 
or interkingdom (between a bacterial species and an organism from different Kingdom 
of life). The examples of interactions in which AHL-acylases participate in are quite 
diverse: QS-dependent virulence in P. aeruginosa [28,31,337], regulation of granulation 
cycle in a multispecies granular sludge [348,349], and the settlement of zoospores 
of the marine macroalga Ulva [330,354]. Acylase-producing bacteria are conceivably 
belonging to microbial consortia that are involved in the AHL turnover in nature. For 
instance, in soil bacteria that degrade and/or mineralize AHLs are present and these 
bacteria use AHLs as a nutrient source [327,366]. Nevertheless, the hitherto known 
functions might be only the tip of the iceberg and there are still countless unidentified 
enzymes and mechanisms awaiting to be discovered.
Conclusion and future perspectives
Bacteria are intelligent organisms with a fascinating adaptability to environmental 
stimuli, such as acquiring mechanisms to escape antibiotic attack. This situation 
encumbered us with a challenging task to find ideal substitutes for antibiotics. We 
have shown that inducing communication breakdown in pathogenic bacteria by means 
of QS inhibition can be employed as a potential antibacterial therapy that provokes less 
pressure for resistance. Although QQ compounds do not kill bacteria, they can delay the 
infection process and give more time to the immune system to clear the infections. The 
studies presented here confirmed the potential of AHL-acylases as novel antibacterial 
candidates. The ability of AtPVA and PaPVA in hydrolyzing AHLs could shift the 
application of these enzymes from the production of semisynthetic antibiotics to work 
as antibacterial enzymes themselves. The efficacy of PvdQ acylase in a mouse infection 
model illustrates the possible use of QQ enzyme for the treatment of bacterial infections. 
This study serves as a proof of concept for therapeutic application of PvdQ acylase in 
attenuating P. aeruginosa infection in a relevant lung infection model. QQ enzymes 
that attack extracellular targets might give less selective pressure in comparison to 
small molecule QSIs, which inhibit intracellular targets and therefore are prone to 
development of resistance via upregulated efflux pumps [289]. Although AHL-acylase 
alone can be used as an antibacterial drug, the effect can be magnified by a combination 
therapy with the existing antibiotics [158]. 
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Quorum sensing (QS) systemen stellen bacteriën in staat hun populatie gedrag te 
coördineren. Daarmee kunnen groepen van bacteriën uitdagingen trotseren, die 
individuele cellen niet aankunnen. Door het detecteren van signaal moleculen 
(autoinducers), die ophopen als een functie van de populatie dichtheid, reguleert elke cel 
vervolgens de expressie van een bepaalde set van genen. De groeiende belangstelling 
voor dit onderzoeksveld is sterk gerelateerd aan het feit dat QS de productie van 
virulentiefactoren in veel pathogene bacteriën reguleert. By using QS system to take 
a census of population, bacteria launch an arsenal of virulence determinants as a 
unified attack when population density reaches a critical mass: a tactic to overwhelm 
the host organism. Bacteriën maken gebruik van het QS-systeem voor het monitoren 
van de populatiedichtheid om dan vervolgens -als een kritische massa is bereikt- 
een collectieve aanval met een arsenaal aan virulentie factoren uit te voeren: een 
tactiek om het gastheerorganisme te overweldigen. Kennis betreffende het QS-systeem 
van pathogene bacteriën geeft de mogelijkheid om dit systeem te gebruiken als een 
doelwit voor nieuwe antibacteriële geneesmiddelen. Conventionele antibiotica doden 
gevoelige bacteriën door zich te richten op hun essentiële systemen (DNA-replicatie, 
eiwitsynthese, celwand synthese) en geven tegelijkertijd een sterke selectieve druk, 
die het ontstaan  van resistentie bacteriën mogelijk maakt. Multiresistentie bacteriën 
dreigen onbehandelbaar te worden [365]. Daarom is het vinden van nieuwe antibiotica 
een van de grootste uitdagingen voor de moderne geneeskunde. Compounds with such 
working mechanisms are often described as antivirulences. Interferentie met QS-
systeem (aangeduid als quorum quenching, QQ) leidt tot het afzwakken van bacteriële 
virulentie, resulterend in mildere infecties in diermodellen [148,204,269,275]. 
Verbindingen met een dergelijk werkingsmechanisme worden vaak beschreven als 
antivirulens. Met de alarmerende opmars van antibioticaresistente bacteriën, is elke 
veelbelovende strategie om bacteriële infecties te onderdrukken een grote bijdrage in 
onderzoek naar geneesmiddelen ontwikkeling.
Het onderzoek gepresenteerd in dit proefschrift is gericht op het bestuderen van 
enzymatische afbraak van N-acylhomoserine lacton (AHL) signaalmoleculen voor QS-
remming in Gram-negatieve bacteriën, in het bijzonder in Pseudomonas aeruginosa. 
De gebruikte enzymen behoren tot de klasse AHL-acylases, die de amide binding 
van AHL’s knippen, wat resulteert in een onomkeerbare afbraak van de moleculen. 
We identificeerden en karakteriseerden de AHL-hydrolyserende activiteiten van twee 
bacteriële Penicilline V acylases (PVA’s) en gaven deze een nieuwe toepassing als QQ-
enzymen voor P. aeruginosa. Verder toonden we van een ander AHL-acylase, genaamd 
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PvdQ, de werkzaamheid aan voor het behandelen van P. aeruginosa longinfecties in 
een muismodel.
Het quorum sensing coördinatie netwerk – Begrip van 
bacteriële pathogenese
Een inleiding tot het klassieke LuxRI QS-systeem in Gram-negatieve bacteriën, 
evenals QS-remmingsmechanismen met focus op QQ-enzymen, worden besproken 
in hoofdstuk 1. Dit hoofdstuk geeft ook informatie over de centraal staande pathogeen 
van dit proefschrift, P. aeruginosa. Deze bacterie is een beruchte opportunistische 
menselijke ziekteverwekker die vooral wordt geassocieerd met ziekenhuisinfecties en 
longinfecties bij patiënten met taaislijmziekte.
Het QS-systeem in P. aeruginosa is een van de best bestudeerde tot nu toe. Vandaar 
dat P. aeruginosa vaak wordt gebruikt als een model voor het QS-systeem in Gram-
negatieve bacteriën. Een overzicht van het complexe QS-reguleringsnetwerk wordt 
beschreven in het eerste deel van hoofdstuk 2. De kern van QS in P. aeruginosa bestaat 
uit twee LuxRI-homologen genaamd Las en Rhl, met 3-oxo-C12-HSL en C4-HSL 
als hun respectievelijke bijbehorende signaleringsmoleculen [13]. Het QS-systeem 
wordt verder gemoduleerd door verschillende regulatoren die worden geactiveerd 
door verschillende signalen, zoals beschikbaarheid van voedingstoffen of groeifase. 
Interferentie van QS kan worden bereikt door QS-remmers (QSI’s) te gebruiken om 
de synthese van het signaalmolecuul te blokkeren of om de signaalherkenning door 
het transcriptieactivator-eiwit te remmen. Een andere voor de hand liggende aanpak is 
het voorkomen van de accumulatie van signaalmoleculen door enzymatische afbraak. 
Voorbeelden van dergelijke QQ-middelen uit zowel natuurlijke als synthetische 
bronnen wordt ook in dit hoofdstuk besproken.
Begrip van in de P. aeruginosa pathogenese en de ontwikkeling van een behandeling 
tegen infectie vereist kennis van gastheer-pathogeen interacties. Het beste model 
voor het nabootsen van menselijke ziekten is inderdaad de mens zelf, maar het is 
ethisch verboden om experimenten op mensen uit te voeren zonder voorafgaande 
testen in diermodellen. Niet-menselijke zoogdieren, in het bijzonder muizen, zijn de 
diermodellen die de voorkeur hebben voor het bestuderen van menselijke ziektes 
vanwege hun fysiologische verwantschap. Toenemende bewustwording van het leven 
8
136
Chapter 8 | Samenvatting, algemene discussies en toekomstperspectieven
van dieren leidde tot strikte regels voor experimenten met gewervelde dieren in het 
algemeen. Een van de voorwaarde is allereerst het aantonen van de positieve werking 
in een eenvoudiger infectiemodel zoals in ongewervelden, voor zover deze geschikte 
modellen beschikbaar zijn. 
Eenvoudige diermodellen zoals de nematode Caenorhabditis elegans en de larven van 
de grote wasmot Galleria mellonella winnen aan populariteit als infectiemodellen. Een 
nadere blik op de infectie experimenten met de nematode C. elegans voor het bestuderen 
van P. aeruginosa pathogeniciteit wordt in hoofdstuk 3 beschreven. Such positive 
correlations in different models are also evident in efficacy studies of several QQ 
agent [161,179,204]. These observations strengthen the credibility of non-mammalian 
hosts as a preliminary screening step in studying bacterial pathogenesis and in the 
development of infection treatments. Een studie van de pathogenese van P. aeruginosa 
in evolutionair niet-verwante gastheren onthulde geconserveerde virulentiefactoren die 
nodig zijn voor het veroorzaken van infecties, zoals LasR van QS-systeem [91,136] 
en GacA-respons regulator van het GAC twee componentensysteem [69,25,153]. 
Dergelijke positieve correlaties in verschillende modellen zijn ook waarneembaar in 
het onderzoek naar effectiviteit van verschillende QQ-agentia [161,179,204]. Deze 
observaties versterken de geloofwaardigheid van niet-zoogdiergastheren als een eerste 
screeningstap bij het bestuderen van bacteriële pathogenese en bij het ontwikkelen van 
infectiebehandelingen. 
PVA’s: van semisynthetische antibiotica productie tot quorum 
quenching 
Penicilline acylases katalyseren de deacylering van natuurlijk penicilline, dat leidt 
tot de vorming van een  actief tussenproduct 6-aminopenicillaanzuur (6-APA), een 
belangrijke bouwsteen voor de productie van semisynthetische β-lactam antibiotica 
[25]. Op basis van hun substraat voorkeuren kunnen penicilline-acylases worden 
geclassificeerd in Penicilline G acylases (Pen G, PGA’s) of Penicilline V acylases 
(Pen V, PVA’s). Ze verschillen in nucleofiele residuen (serine voor PGA’s en cysteïne 
voor PVA’s) en in hun subunit samenstelling (PGA’s zijn heterodimeren en PVA’s 
homotetrameren) [26]. Penicilline acylases en AHL-acylases behoren tot de Ntn 
hydrolase superfamilie. Daarom zijn ze vergelijkbaar in vouwing, structuur en 
mechanisme [27-29,227].
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De promiscue deacylering van AHL’s door twee nieuwe PVA’s wordt besproken in 
hoofdstuk 4. Deze PVA’s behoren tot plant pathogenen, namelijk Agrobacterium 
tumefasciens (AtPVA) en Pectobacterium atrosepticum (PaPVA). De overeenkomstige 
pva genen werden geïsoleerd, gekloneerd en tot overexpressie gebracht in E. coli. 
De PVA’s delen 62% sequentie-identiteit, vergelijkbare structurele kenmerken en 
vertonen een hoge specificiteit voor Penicilline V. Het hydrolyserend vermogen van 
deze PVA’s van AHL’s werd eerst bepaald door gebruik te maken van biosensoren, 
die in de aanwezigheid van specifieke AHL’s luminescentie produceren. De activiteit 
van PaPVA bleek beperkt tot C10 tot C12-HSL, terwijl AtPVa een breder spectrum 
van substraatherkenning (C6 tot C12-HSL) vertoonde met de hoogste activiteit op de 
langketenige AHL’s. De vorming van HSL en acylketen na de AHL-deacylerings 
activiteit werd bevestigd met HPLC. Vervolgens werd voor beide enzymen een 
kinetisch onderzoek uitgevoerd met 3-oxo-C12-HSL als een substraat. Schijnbare 
kcat/Km waarden voor PaPVA (13,5 x 104 M-1 s-1) en AtPVA (2,68 x 104 M-1 s-1) zijn 
vergelijkbaar met de gepubliceerde waarden voor HacB-acylase [28] en is 10-voudig 
hoger dan voor PvdQ acylase [248]. Om de substraatvoorkeur van deze enzymen te 
begrijpen, hebben we docking studies uitgevoerd. Een bijna identieke substraatbinding 
werd in beide PVA’s waargenomen. De voorkeur van enzymen voor AHL’s met 
langere keten is mogelijk het gevolg van nauwer interacties tussen de residuen in 
de hydrofobe pocket met de AHL’s met lange keten. Nadat de AHL-hydrolyserende 
activiteit was bevestigd, evalueerden we vervolgens de QQ-activiteit in P. aeruginosa 
PAO1. Exogene toevoeging van deze enzymen aan een P. aeruginosa PAO1-kweek 
verminderde niet alleen de productie van 3-oxo-C12-HSL-signaal moleculen, maar 
verminderde ook aanzienlijk de productie van QS-gereguleerde virulentiefactoren 
(elastase, pyocyanine en biofilm vorming).  De werkzaamheid van de PVA’s werd 
verder bevestigd bij het beschermen van G. mellonella larven na P. aeruginosa PAO1-
infectie. Overlevingspercentages waren aanzienlijk hoger met de PVA-behandelingen 
(70% voor AtPVA, 50% voor PaPVA) in vergelijking tot de onbehandelde infectie 
(10%). De bevindingen van dit onderzoek onderstrepen daarom het potentieel van 
PVA’s als therapeutische enzymen en motiveren om het mogelijke verband tussen 
AHL-hydrolyserende activiteit en de natuurlijke rol van PVA’s verder te onderzoeken.
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Werkzaamheid van PvdQ-acylase in een muizenmodel met P. 
aeruginosa longinfectie 
Van de vele gekarakteriseerde AHL-afbrekende enzymen zijn tot nu toe slechts twee 
studies van het pulmonaire infectiemodel in de muis gedocumenteerd [275,276]. Beide 
hebben betrekking op AHL-lactonasen, die de lactonring van de AHL splitsen. De 
enige mogelijke toedieningsroute voor therapeutische enzymen naar de longen, is via 
de bovenste luchtwegen. Het combineren van de procedures voor het induceren van 
een longinfectie en het toediening van het medicijn via de bovenste luchtwegen is een 
uitdaging bij kleine dieren. Daarom is de recente studie over de toediening van een 
AHL-lactonase uitgevoerd bij ratten met behulp van intubatie van de luchtpijp. De 
behandeling verminderde met succes de mortaliteit in het rattenmodel [276].
Onze onderzoeksgroep bestudeerde een acylase genaamd PvdQ, een periplasmatisch 
enzym van P. aeruginosa waarvan wordt gesuggereerd dat het betrokken is bij de 
vorming van het siderofoor pyoverdine [32]. PvdQ is ook een AHL-acylase met 
specificiteit voor langketenige AHL’s. Eerdere studies van onze groep laten zien dat 
PvdQ, ofwel overexpresseerd in of exogeen toegevoegd aan P. aeruginosa, de virulentie 
significant kon verzwakken, zowel in vitro [31], als in een C. elegans model [33]. Op 
basis van deze gegevens hebben we een werkzaamheid onderzoek uitgevoerd van 
intranasaal toegediend PvdQ-acylase in een muismodel na P. aeruginosa longinfectie, 
dat wordt gepresenteerd in hoofdstuk 5. We streefden naar een niet-invasieve medicatie 
toedieningsmethode, die een realistische kopie is van de werkelijke procedure bij de 
mens. We hebben eerst het longinfectiemodel ontwikkeld door muizen te inoculeren 
met agarose micro bolletjes gevuld met P. aeruginosa. In principe hangt de ernst van 
de infectie in het model af van de bacteriële inoculatiedosis en het stressniveau, dat 
de dieren ervaren. We vonden een inoculatie dosis van 2,5x105 CFU / longen als een 
sub-letale dosis en tot tweemaal die hoeveelheid (5x105 CFU / longen) als een letale 
dosis. We evalueerde het intranasaal depositie traject in het muis infectie model met 
behulp van PvdQ gekoppeld aan een fluorochroom (PvdQ-VT) in verschillende stadia 
van longinfectie. In vivo scanning studies na intranasale toediening toonden aan dat 
PvdQ-VT kon worden getraceerd in alle long lobben waarbij 42 ± 7% van de gegeven 
dosis aanwezig was op 0 uur na bacteriële infectie en 34 ± 5% op 72 uur na bacteriële 
infectie. De verdeling van PvdQ-VT verschoof 72 uur na de bacteriële infectie naar 
de linker lob. Een verklaring voor deze bevinding is vermoedelijk gerelateerd aan 
de structurele veranderingen van elke lob, hoewel verder onderzoek nodig is om de 
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hypothese te bevestigen (bijvoorbeeld bepaling van grootte van luchtholte). Vervolgens 
behandelden we muizen met een normaliter dodelijke P. aeruginosa longinfectie én 
PvdQ. Deze behandeling resulteerde in een vijfvoudige reductie van long bacteriële 
belasting en verlengde de overleving van de geïnfecteerde dieren tot een gemiddelde 
overlevingsperiode van 57 uur in vergelijking met 42 uur voor de met PBS behandelde 
groep. In a sublethal P. aeruginosa pulmonary infection, PvdQ treatment resulted in 
less lung inflammation based on the histology severity scoring and decrease of CXCL2 
and TNF-α levels at 24 hours post-bacterial infection by 15% and 20%, respectively. 
The results of this study confirmed the ability of PvdQ to be a quorum quencher of P. 
aeruginosa infection in a relevant animal model, and further extended the previous 
observation in C. elegans. In een sub-letale P. aeruginosa longinfectie resulteerde de 
PvdQ-behandeling in minder longontsteking op basis van de histologische scores en 
een verlaging van de CXCL2- en TNF-α-niveaus 24 uur na bacteriële infectie met 
respectievelijk 15% en 20%. De resultaten van deze studie bevestigden het vermogen 
van PvdQ om als  quorum-quencher middel van P. aeruginosa-infectie te fungeren in 
een relevant diermodel. Daarmee wordt de vorige waarneming, gedaan in C. elegans, 
verder uitgebreid.
Fysiologische functie van AHL-acylases
Er is grote interesse voor het uitbreiden van het potentieel van QQ-enzymen voor 
therapeutische en industriële toepassingen. Daarmee is onderzoek naar de fundamentele 
basis van het bestaan van QQ-enzymen minder onder de aandacht geweest.
Na twee decennia sedert de vroegste bevinding van AHL-acylase en talloze nieuwe 
acylases ontdekkingen later, is van de meerderheid van deze enzymen de werkelijke 
fysiologische rol nog steeds onduidelijk. De enzymatische activiteit, hydrolyse van 
AHL’s, suggereert dat ze in de natuur betrokken zijn bij de afbraak van AHLs-
signalerende moleculen.
Desalniettemin is het ook mogelijk dat de natuurlijke substraten voor bepaalde acylases 
geen AHL’s zijn en dat ze betrokken zijn bij biologische systemen, die geen verband 
houden met QS. Hoofdstuk 6 vat de bevindingen met betrekking tot de fysiologische 
functies van QQ-enzymen in de natuur samen.
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Studies aan verschillende AHL-acylases onthullen hun rol in het moduleren van 
verschillende niveaus van interacties: intra-species (binnen één soort), inter-species 
(tussen twee of meer bacteriesoorten) of inter-kingdom (tussen een bacteriesoort 
en een organisme uit een ander koninkrijk van het leven). De voorbeelden van 
interacties waarin AHL-acylases participeren zijn behoorlijk divers: QS-afhankelijke 
virulentie in P. aeruginosa [28,31,337], regulatie van granulatie cyclus in een multi-
species korrelvormig slib [348,349] en de afzetting van zoösporen van het mariene 
macroalga Ulva [330,354]. Acylase-producerende bacteriën behoren mogelijk tot 
microbiële consortia, die betrokken zijn bij de AHL-omzetting in de natuur. Zo zijn 
bodem bacteriën beschreven, die AHL’s afbreken en/of mineraliseren en deze bacteriën 
gebruiken AHL’s als een voedingsbron [327,366]. Desalniettemin kunnen de tot nu 
toe bekende functies slechts het topje van de ijsberg zijn en wellicht zijn er nog steeds 
talloze onbekende enzymen en/of mechanismes, die nog wachten op ontdekking.
Conclusie en perspectief voor de toekomst
Bacteriën gedragen zich als intelligente organismen met een fascinerend 
aanpassingsvermogen aan omgevingsstimuli, zoals het verkrijgen van mechanismen 
om te ontsnappen aan antibiotica-aanvallen. Dit gegeven brengt ons de uitdagende 
taak om ideale vervangers voor antibiotica te vinden. We have shown that inducing 
communication breakdown in pathogenic bacteria by means of QS inhibition can 
be employed as a potential antibacterial therapy that provokes less pressure for 
resistance. We hebben aangetoond dat het onderbreken van cel-tot-cel communicatie 
in pathogene bacteriën door middel van QS-remming toegepast kan worden als een 
potentiële antibacteriële therapie met wellicht minder kans op resistentie. Hoewel QQ-
verbindingen geen bacteriën doden, kunnen ze wel het infectieproces vertragen en het 
immuunsysteem meer tijd geven om de infecties te klaren. De hier gepresenteerde 
studies bevestigden het potentieel van AHL-acylases als nieuwe antibacteriële 
kandidaten.
Het vermogen van AtPVA en PaPVA tot het hydrolyseren van AHL’s kan een 
verschuiving in de toepassing van deze enzymen bewerkstellen van de productie van 
semisynthetische antibiotica naar het gebruik als antibacterieel enzym.  
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De werkzaamheid van PvdQ-acylase in een muizen infectie model illustreert het 
mogelijke gebruik van QQ-enzym voor de behandeling van bacteriële infecties. 
Deze studie dient als een bewijs van het concept voor de therapeutische toepassing 
van PvdQ-acylase bij het verzwakken van een P. aeruginosa infectie in een relevant 
longinfectiemodel. QQ-enzymen, die extracellulaire doelwitten aanvallen, zouden 
minder selectieve druk kunnen geven in vergelijking met een klein molecuul QSI’s, die 
intracellulaire doelwitten remmen en daarom gevoelig zijn voor de ontwikkeling van 
resistentie via opgereguleerde effluxpompen [289]. Hoewel AHL-acylase op zichzelf 
als een antibacterieel medicijn gebruikt kan worden, kan het effect worden vergroot 
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